|
G |
MITF |
melanocyte inducing transcription factor |
increases expression |
EXP |
afzelin results in increased expression of MITF mRNA; afzelin results in increased expression of MITF protein |
CTD |
PMID:27287415 |
|
NCBI chr 3:69,739,464...69,968,332
Ensembl chr 3:69,739,456...69,968,336
|
|
G |
TYR |
tyrosinase |
multiple interactions increases expression |
EXP |
afzelin results in increased expression of and results in increased activity of TYR protein afzelin results in increased expression of TYR mRNA |
CTD |
PMID:27287415 |
|
NCBI chr11:89,177,875...89,295,759
Ensembl chr11:89,177,875...89,295,759
|
|
G |
TYRP1 |
tyrosinase related protein 1 |
increases expression |
EXP |
afzelin results in increased expression of TYRP1 mRNA; afzelin results in increased expression of TYRP1 protein |
CTD |
PMID:27287415 |
|
NCBI chr 9:12,693,385...12,710,285
Ensembl chr 9:12,685,439...12,710,285
|
|
|
G |
GYPA |
glycophorin A (MNS blood group) |
increases expression |
EXP |
apigetrin results in increased expression of GYPA protein |
CTD |
PMID:25058688 |
|
NCBI chr 4:144,109,303...144,140,718
Ensembl chr 4:144,109,303...144,140,751
|
|
|
G |
ACHE |
acetylcholinesterase (Yt blood group) |
multiple interactions increases expression |
ISO |
baicalin results in increased expression of and results in increased activity of ACHE protein baicalin results in increased expression of ACHE mRNA |
CTD |
PMID:27019979 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
AHR |
aryl hydrocarbon receptor |
increases activity |
ISO EXP |
baicalin results in increased activity of AHR protein |
CTD |
PMID:17869316 PMID:26204831 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
AIF1 |
allograft inflammatory factor 1 |
multiple interactions |
ISO |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of AIF1 protein] |
CTD |
PMID:38016618 |
|
NCBI chr 6:31,615,234...31,617,015
Ensembl chr 6:31,615,217...31,617,021
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
multiple interactions |
ISO |
baicalin inhibits the reaction [Hydrogen Peroxide affects the localization of and results in increased activity of ALOX5 protein] |
CTD |
PMID:20139896 |
|
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
|
|
G |
ANGPT1 |
angiopoietin 1 |
multiple interactions |
ISO |
baicalin inhibits the reaction [Streptozocin results in decreased expression of ANGPT1 mRNA] |
CTD |
PMID:34414639 |
|
NCBI chr 8:107,249,482...107,497,918
Ensembl chr 8:107,249,482...107,498,055
|
|
G |
ATF2 |
activating transcription factor 2 |
multiple interactions |
ISO |
baicalin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of ATF2 protein] |
CTD |
PMID:24312512 |
|
NCBI chr 2:175,072,259...175,168,203
Ensembl chr 2:175,072,250...175,168,382
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP ISO |
baicalin results in increased expression of BAX protein baicalin affects the reaction [Rotenone results in increased expression of BAX mRNA]; baicalin inhibits the reaction [Rotenone results in increased expression of BAX protein] baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; baicalin inhibits the reaction [Gentamicins results in increased expression of BAX mRNA]; baicalin inhibits the reaction [Gentamicins results in increased expression of BAX protein] baicalin inhibits the reaction [Rotenone affects the expression of BAX protein] |
CTD |
PMID:21457722 PMID:25423838 PMID:31021006 PMID:34333357 PMID:36446982 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions decreases expression |
ISO EXP |
baicalin inhibits the reaction [Rotenone affects the expression of BCL2 protein] baicalin affects the reaction [Rotenone results in decreased expression of BCL2 mRNA]; baicalin inhibits the reaction [Rotenone results in decreased expression of BCL2 protein] baicalin results in decreased expression of BCL2 protein baicalin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; baicalin inhibits the reaction [Gentamicins results in decreased expression of BCL2 mRNA]; baicalin inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein] |
CTD |
PMID:25423838 PMID:31021006 PMID:34333357 PMID:36446982 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
CASP1 |
caspase 1 |
multiple interactions |
ISO |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CASP1 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]] |
CTD |
PMID:38016618 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
ISO EXP |
baicalin inhibits the reaction [Rotenone affects the expression of CASP3 protein] baicalin affects the reaction [Rotenone results in decreased activity of CASP3 protein] baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; baicalin inhibits the reaction [Gentamicins results in increased cleavage of CASP3 protein] |
CTD |
PMID:25423838 PMID:31021006 PMID:34333357 PMID:36446982 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
baicalin inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein] |
CTD |
PMID:34333357 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCNA2 |
cyclin A2 |
decreases expression |
EXP |
baicalin results in decreased expression of CCNA2 protein |
CTD |
PMID:21457722 |
|
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
|
|
G |
CCND1 |
cyclin D1 |
increases expression decreases expression multiple interactions |
EXP |
baicalin results in increased expression of CCND1 mRNA baicalin results in decreased expression of CCND1 protein N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of CCND1 mRNA] |
CTD |
PMID:19160421 PMID:21457722 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
COL1A2 |
collagen type I alpha 2 chain |
multiple interactions |
ISO |
baicalin inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mRNA] |
CTD |
PMID:19474275 |
|
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
multiple interactions increases expression |
EXP |
3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A1 mRNA]; 3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A1 protein]; baicalin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] baicalin results in increased expression of CYP1A1 mRNA; baicalin results in increased expression of CYP1A1 protein |
CTD |
PMID:18451504 PMID:26204831 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
multiple interactions increases expression |
EXP ISO |
3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA]; 3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A2 protein] resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA]; resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 protein] baicalin results in increased expression of CYP1A2 mRNA; baicalin results in increased expression of CYP1A2 protein |
CTD |
PMID:26204831 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
EGF |
epidermal growth factor |
multiple interactions |
EXP |
baicalin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; baicalin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] |
CTD |
PMID:25625231 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions |
EXP |
baicalin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
CTD |
PMID:25625231 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
ELK1 |
ETS transcription factor ELK1 |
multiple interactions |
EXP |
baicalin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] |
CTD |
PMID:25625231 |
|
NCBI chr X:47,635,520...47,650,604
Ensembl chr X:47,635,521...47,650,604
|
|
G |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions |
ISO |
baicalin inhibits the reaction [Palmitic Acid results in increased phosphorylation of ERN1 protein] |
CTD |
PMID:29031535 |
|
NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
|
|
G |
FOXA2 |
forkhead box A2 |
decreases expression |
EXP |
baicalin results in decreased expression of FOXA2 mRNA; baicalin results in decreased expression of FOXA2 protein |
CTD |
PMID:32687838 |
|
NCBI chr20:22,580,998...22,585,490
Ensembl chr20:22,580,998...22,585,455
|
|
G |
GOT1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions |
ISO |
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein] |
CTD |
PMID:15645217 |
|
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein] |
CTD |
PMID:15645217 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
HES1 |
hes family bHLH transcription factor 1 |
increases expression multiple interactions |
EXP |
baicalin results in increased expression of HES1 mRNA N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HES1 mRNA] |
CTD |
PMID:19160421 |
|
NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732
|
|
G |
HEY1 |
hes related family bHLH transcription factor with YRPW motif 1 |
increases expression multiple interactions |
EXP |
baicalin results in increased expression of HEY1 mRNA N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY1 mRNA] |
CTD |
PMID:19160421 |
|
NCBI chr 8:79,764,010...79,767,767
Ensembl chr 8:79,762,371...79,767,857
|
|
G |
HEY2 |
hes related family bHLH transcription factor with YRPW motif 2 |
multiple interactions increases expression |
EXP |
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY2 mRNA] |
CTD |
PMID:19160421 |
|
NCBI chr 6:125,749,632...125,761,269
Ensembl chr 6:125,747,664...125,761,269
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein; baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of HMOX1 protein]; baicalin promotes the reaction [Carbon Tetrachloride results in increased expression of HMOX1 mRNA]; baicalin promotes the reaction [Carbon Tetrachloride results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein] baicalin results in increased expression of HMOX1 mRNA; baicalin results in increased expression of HMOX1 protein |
CTD |
PMID:16824337 PMID:18187930 PMID:38016618 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HNF1A |
HNF1 homeobox A |
decreases expression multiple interactions |
EXP ISO |
baicalin results in decreased expression of HNF1A mRNA; baicalin results in decreased expression of HNF1A protein baicalin inhibits the reaction [HNF4A protein binds to HNF1A promoter]; HNF1A protein promotes the reaction [baicalin results in decreased secretion of Hepatitis B Surface Antigens]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A mRNA]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A protein] |
CTD |
PMID:32687838 |
|
NCBI chr12:120,978,543...121,002,512
Ensembl chr12:120,978,543...121,002,512
|
|
G |
HNF4A |
hepatocyte nuclear factor 4 alpha |
decreases expression multiple interactions |
ISO EXP |
baicalin results in decreased expression of HNF4A protein baicalin inhibits the reaction [HNF4A protein binds to HNF1A promoter]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A mRNA]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A protein]; HNF4A protein promotes the reaction [baicalin results in decreased secretion of Hepatitis B Surface Antigens] baicalin results in decreased expression of HNF4A mRNA; baicalin results in decreased expression of HNF4A protein |
CTD |
PMID:32687838 |
|
NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,699...44,432,845
|
|
G |
HSPB1 |
heat shock protein family B (small) member 1 |
multiple interactions |
ISO |
baicalin inhibits the reaction [Streptozocin results in increased phosphorylation of HSPB1 protein] |
CTD |
PMID:34414639 |
|
NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO EXP |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B mRNA]; baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]; baicalin inhibits the reaction [Palmitic Acid results in increased secretion of IL1B protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]] baicalin inhibits the reaction [Rotenone results in increased expression of IL1B protein] |
CTD |
PMID:29031535 PMID:36446982 PMID:38016618 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
decreases expression multiple interactions |
ISO |
baicalin results in decreased expression of IL6 mRNA; baicalin results in decreased expression of IL6 protein baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL6 mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL6 mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 protein]; baicalin inhibits the reaction [Palmitic Acid results in increased secretion of IL6 protein] |
CTD |
PMID:22019745 PMID:29031535 PMID:34333357 PMID:38016618 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
multiple interactions |
ISO |
baicalin inhibits the reaction [Streptozocin results in decreased expression of INS1 protein] |
CTD |
PMID:34414639 |
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
multiple interactions |
ISO |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of KEAP1 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in decreased expression of KEAP1 protein] |
CTD |
PMID:38016618 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
baicalin inhibits the reaction [Streptozocin results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:34414639 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
baicalin inhibits the reaction [Streptozocin results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:34414639 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MYD88 |
MYD88 innate immune signal transduction adaptor |
decreases expression |
ISO |
baicalin results in decreased expression of MYD88 protein |
CTD |
PMID:22019745 |
|
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] affects the localization of NFE2L2 protein; baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NFE2L2 protein]; baicalin inhibits the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased ubiquitination of NFE2L2 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; baicalin promotes the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]] |
CTD |
PMID:38016618 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
increases expression |
ISO |
baicalin results in increased expression of NFKBIA protein |
CTD |
PMID:22019745 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NLRP3 |
NLR family pyrin domain containing 3 |
multiple interactions |
ISO |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of NLRP3 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]; baicalin inhibits the reaction [Palmitic Acid results in increased expression of NLRP3 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]] |
CTD |
PMID:29031535 PMID:38016618 |
|
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,416,156...247,449,108
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions decreases expression |
ISO |
baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA]; baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein] baicalin results in decreased expression of NOS2 mRNA; baicalin results in decreased expression of NOS2 protein baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; mifobate inhibits the reaction [baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] |
CTD |
PMID:18187930 PMID:22019745 PMID:24312512 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOTCH1 |
notch receptor 1 |
increases activity increases expression |
EXP |
baicalin results in increased activity of NOTCH1 protein baicalin results in increased expression of NOTCH1 mRNA |
CTD |
PMID:19160421 |
|
NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
|
|
G |
NR1H3 |
nuclear receptor subfamily 1 group H member 3 |
increases expression |
EXP |
Baicalin increases expression of NR1H3 mRNA and protein in foam cells |
RGD |
PMID:27389392 |
RGD:401842390 |
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
|
|
G |
PKM |
pyruvate kinase M1/2 |
increases activity |
EXP |
baicalin results in increased activity of PKM protein |
CTD |
PMID:25388478 |
|
NCBI chr15:72,199,029...72,231,591
Ensembl chr15:72,199,029...72,231,819
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
multiple interactions |
ISO |
baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and results in decreased activity of PPARG protein] |
CTD |
PMID:24312512 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PRIMA1 |
proline rich membrane anchor 1 |
increases expression |
ISO |
baicalin results in increased expression of PRIMA1 mRNA |
CTD |
PMID:27019979 |
|
NCBI chr14:93,718,298...93,788,994
Ensembl chr14:93,718,298...93,788,485
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression |
ISO |
baicalin results in decreased expression of PTGS2 mRNA; baicalin results in decreased expression of PTGS2 protein |
CTD |
PMID:22019745 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PYCARD |
PYD and CARD domain containing |
multiple interactions |
ISO |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PYCARD protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]] |
CTD |
PMID:38016618 |
|
NCBI chr16:31,201,486...31,202,760
Ensembl chr16:31,201,486...31,203,450
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
baicalin affects the localization of and results in decreased expression of RELA protein baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased phosphorylation of RELA protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased phosphorylation of RELA protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]] |
CTD |
PMID:22019745 PMID:34333357 PMID:38016618 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
SNCA |
synuclein alpha |
multiple interactions |
ISO |
[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] affects the localization of NFE2L2 protein; [baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL6 mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of TNF mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]; baicalin inhibits the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased ubiquitination of NFE2L2 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in decreased expression of KEAP1 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; baicalin promotes the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]] |
CTD |
PMID:38016618 |
|
NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
|
|
G |
TEK |
TEK receptor tyrosine kinase |
multiple interactions |
ISO |
baicalin inhibits the reaction [Streptozocin results in decreased expression of TEK mRNA] |
CTD |
PMID:34414639 |
|
NCBI chr 9:27,109,141...27,230,178
Ensembl chr 9:27,109,141...27,230,174
|
|
G |
TFAM |
transcription factor A, mitochondrial |
multiple interactions decreases expression |
EXP |
baicalin inhibits the reaction [Rotenone results in decreased expression of TFAM mRNA] baicalin results in decreased expression of TFAM mRNA |
CTD |
PMID:36446982 |
|
NCBI chr10:58,385,410...58,399,220
Ensembl chr10:58,385,345...58,399,220
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
ISO |
baicalin inhibits the reaction [Streptozocin results in decreased expression of TGFB1 mRNA]; baicalin inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mRNA] |
CTD |
PMID:19474275 PMID:34414639 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TH |
tyrosine hydroxylase |
multiple interactions |
ISO |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TH protein] |
CTD |
PMID:38016618 |
|
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
|
|
G |
TLR4 |
toll like receptor 4 |
decreases expression multiple interactions |
ISO |
baicalin results in decreased expression of TLR4 protein baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of TLR4 protein] baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein] |
CTD |
PMID:22019745 PMID:24312512 PMID:34333357 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions decreases expression |
ISO |
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of TNF mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of TNF protein]; baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF mRNA]; baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein] baicalin results in decreased expression of TNF mRNA; baicalin results in decreased expression of TNF protein baicalin inhibits the reaction [Paraquat results in increased expression of TNF protein] |
CTD |
PMID:16824337 PMID:18187930 PMID:22019745 PMID:34333357 PMID:38016618 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TP53 |
tumor protein p53 |
increases expression |
EXP |
baicalin results in increased expression of TP53 protein |
CTD |
PMID:21457722 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
TXNIP |
thioredoxin interacting protein |
multiple interactions |
ISO |
baicalin inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein]; dorsomorphin inhibits the reaction [baicalin inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein]] |
CTD |
PMID:29031535 |
|
NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
|
|
G |
USP27X |
ubiquitin specific peptidase 27 X-linked |
multiple interactions |
ISO |
baicalin inhibits the reaction [Streptozocin results in increased expression of USP27X protein] |
CTD |
PMID:34414639 |
|
NCBI chr X:49,879,484...49,882,558
Ensembl chr X:49,879,484...49,882,558
|
|
G |
VEGFC |
vascular endothelial growth factor C |
multiple interactions |
ISO |
baicalin inhibits the reaction [Streptozocin results in decreased expression of VEGFC mRNA] |
CTD |
PMID:34414639 |
|
NCBI chr 4:176,683,538...176,792,922
Ensembl chr 4:176,683,538...176,792,922
|
|
G |
XDH |
xanthine dehydrogenase |
multiple interactions |
ISO |
baicalin inhibits the reaction [[Biological Products co-treated with potassium oxonate] results in increased activity of XDH protein] |
CTD |
PMID:34044073 |
|
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
|
|
|
G |
AHR |
aryl hydrocarbon receptor |
multiple interactions |
ISO EXP |
Diosmin binds to and results in increased activity of AHR protein |
CTD |
PMID:14644660 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
BAD |
BCL2 associated agonist of cell death |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Lipopolysaccharides results in increased expression of BAD protein] |
CTD |
PMID:21477647 |
|
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of BAX protein] |
CTD |
PMID:32061149 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
ISO |
[Diosmin co-treated with Lipopolysaccharides] results in increased expression of BCL2 protein Diosmin inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein] |
CTD |
PMID:21477647 PMID:32061149 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP3 protein]; Diosmin inhibits the reaction [Acetic Acid results in increased expression of CASP3 protein]; Diosmin inhibits the reaction [Lipopolysaccharides results in increased activity of CASP3 protein] Diosmin inhibits the reaction [Benzo(a)pyrene results in increased cleavage of CASP3 protein] |
CTD |
PMID:21477647 PMID:23665045 PMID:29187079 PMID:32061149 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP7 |
caspase 7 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP7 protein] |
CTD |
PMID:23665045 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP9 protein] |
CTD |
PMID:23665045 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in decreased expression of CAT protein]; Diosmin inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of CAT protein] |
CTD |
PMID:22056647 PMID:23665045 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CEACAM1 |
CEA cell adhesion molecule 1 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of CEACAM1 protein] |
CTD |
PMID:35920545 |
|
NCBI chr19:42,507,306...42,528,481
Ensembl chr19:42,507,304...42,561,234
|
|
G |
CREB1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of CREB1 protein] |
CTD |
PMID:35920545 |
|
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of CYP2E1 protein] |
CTD |
PMID:23665045 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
ENO2 |
enolase 2 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of ENO2 protein] |
CTD |
PMID:35920545 |
|
NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in decreased expression of and results in decreased activity of GPX1 protein] |
CTD |
PMID:35920545 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions |
ISO |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in decreased expression of GSR protein] Diosmin inhibits the reaction [Benzo(a)pyrene results in decreased expression of GSR protein] |
CTD |
PMID:23665045 PMID:32061149 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of IL6 protein] |
CTD |
PMID:32061149 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein] |
CTD |
PMID:23665045 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
MPO |
myeloperoxidase |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Acetic Acid results in increased activity of MPO protein] |
CTD |
PMID:29187079 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of NOS2 protein] |
CTD |
PMID:23665045 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased cleavage of PARP1 protein] |
CTD |
PMID:32061149 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PCNA |
proliferating cell nuclear antigen |
multiple interactions |
ISO |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of PCNA protein]; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PCNA protein] |
CTD |
PMID:23665045 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PTGER2 |
prostaglandin E receptor 2 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGER2 protein] |
CTD |
PMID:35920545 |
|
NCBI chr14:52,314,312...52,328,598
Ensembl chr14:52,314,305...52,328,598
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PTGS2 protein]; Diosmin inhibits the reaction [Acetic Acid results in increased expression of PTGS2 protein] Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGS2 protein] |
CTD |
PMID:23665045 PMID:29187079 PMID:32061149 PMID:35920545 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of RELA protein] |
CTD |
PMID:32061149 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of TNF protein]; Diosmin inhibits the reaction [Acetic Acid results in increased expression of TNF protein]; Diosmin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] |
CTD |
PMID:21477647 PMID:23665045 PMID:29187079 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions |
ISO |
Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of TP53 protein] |
CTD |
PMID:23665045 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
XDH |
xanthine dehydrogenase |
multiple interactions |
ISO |
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of XDH protein] Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of XDH protein] |
CTD |
PMID:23665045 PMID:32061149 |
|
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
|
|
|
G |
ATF1 |
activating transcription factor 1 |
multiple interactions decreases phosphorylation |
ISO EXP |
gossypin inhibits the reaction [EGF protein results in increased phosphorylation of ATF1 protein] gossypin results in decreased phosphorylation of ATF1 protein |
CTD |
PMID:30536456 |
|
NCBI chr12:50,763,459...50,821,162
Ensembl chr12:50,763,710...50,821,162
|
|
G |
AURKA |
aurora kinase A |
multiple interactions |
EXP |
gossypin binds to and results in decreased activity of AURKA protein |
CTD |
PMID:30536456 |
|
NCBI chr20:56,369,390...56,392,215
Ensembl chr20:56,369,389...56,392,337
|
|
G |
BCL2L1 |
BCL2 like 1 |
decreases expression |
EXP |
gossypin results in decreased expression of BCL2L1 protein |
CTD |
PMID:30536456 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
CASP3 |
caspase 3 |
increases cleavage |
EXP |
gossypin results in increased cleavage of CASP3 protein |
CTD |
PMID:30536456 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP7 |
caspase 7 |
increases cleavage |
EXP |
gossypin results in increased cleavage of CASP7 protein |
CTD |
PMID:30536456 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP9 |
caspase 9 |
increases cleavage |
EXP |
gossypin results in increased cleavage of CASP9 protein |
CTD |
PMID:30536456 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in decreased expression of CAT protein]; gossypin inhibits the reaction [Oleic Acid results in increased activity of CAT protein] |
CTD |
PMID:37148149 PMID:37696682 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCNA2 |
cyclin A2 |
decreases expression |
EXP |
gossypin results in decreased expression of CCNA2 protein |
CTD |
PMID:30536456 |
|
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
|
|
G |
CCNB1 |
cyclin B1 |
decreases expression |
EXP |
gossypin results in decreased expression of CCNB1 protein |
CTD |
PMID:30536456 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CDK1 |
cyclin dependent kinase 1 |
decreases phosphorylation |
EXP |
gossypin results in decreased phosphorylation of CDK1 protein |
CTD |
PMID:30536456 |
|
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
|
|
G |
CRP |
C-reactive protein |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in increased expression of CRP protein] |
CTD |
PMID:37148149 |
|
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
EGF |
epidermal growth factor |
multiple interactions |
ISO |
gossypin inhibits the reaction [EGF protein results in increased phosphorylation of ATF1 protein] |
CTD |
PMID:30536456 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in decreased expression of HMOX1 protein] |
CTD |
PMID:37148149 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
IL10 |
interleukin 10 |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in decreased expression of IL10 protein] |
CTD |
PMID:37148149 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL13 |
interleukin 13 |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in increased expression of IL13 protein] |
CTD |
PMID:37148149 |
|
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
G |
IL17A |
interleukin 17A |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in increased expression of IL17A protein] |
CTD |
PMID:37148149 |
|
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL18 |
interleukin 18 |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in increased expression of IL18 protein] |
CTD |
PMID:37148149 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; gossypin inhibits the reaction [Oleic Acid results in increased expression of IL1B mRNA] |
CTD |
PMID:37148149 PMID:37696682 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL4 |
interleukin 4 |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in decreased expression of IL4 protein] |
CTD |
PMID:37148149 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL5 |
interleukin 5 |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in increased expression of IL5 protein] |
CTD |
PMID:37148149 |
|
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; gossypin inhibits the reaction [Oleic Acid results in increased expression of IL6 mRNA] |
CTD |
PMID:37148149 PMID:37696682 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases phosphorylation |
EXP |
gossypin results in decreased phosphorylation of JUN protein |
CTD |
PMID:30536456 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
MPO |
myeloperoxidase |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in increased expression of MPO protein] |
CTD |
PMID:37148149 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] |
CTD |
PMID:37148149 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases cleavage |
EXP |
gossypin results in increased cleavage of PARP1 protein |
CTD |
PMID:30536456 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] |
CTD |
PMID:37148149 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RPS6KA3 |
ribosomal protein S6 kinase A3 |
multiple interactions |
EXP |
gossypin binds to and results in decreased activity of RPS6KA3 protein |
CTD |
PMID:30536456 |
|
NCBI chr X:20,149,911...20,267,097
Ensembl chr X:20,149,911...20,267,519
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in increased expression of TGFB1 protein] |
CTD |
PMID:37148149 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
gossypin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; gossypin inhibits the reaction [Oleic Acid results in increased expression of TNF mRNA]; gossypin inhibits the reaction [Oleic Acid results in increased expression of TNF protein] |
CTD |
PMID:37148149 PMID:37696682 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
ADRB1 |
adrenoceptor beta 1 |
increases expression |
ISO |
icariin results in increased expression of ADRB1 mRNA |
CTD |
PMID:16490167 |
|
NCBI chr10:114,043,866...114,046,904
Ensembl chr10:114,043,866...114,046,904
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions increases phosphorylation |
ISO |
[paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of AKT1 mRNA; [paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of and results in decreased phosphorylation of AKT1 protein icariin results in increased phosphorylation of AKT1 protein afimoxifene inhibits the reaction [icariin results in increased phosphorylation of AKT1 protein]; icariin affects the reaction [Diethylhexyl Phthalate affects the phosphorylation of AKT1 protein]; icariin inhibits the reaction [Diethylhexyl Phthalate results in decreased phosphorylation of AKT1 protein]; icariin inhibits the reaction [MK 2206 results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:32344236 PMID:35259346 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
APP |
amyloid beta precursor protein |
multiple interactions |
ISO |
icariin inhibits the reaction [APP protein alternative form results in decreased expression of SOD2 mRNA]; icariin inhibits the reaction [APP protein alternative form results in increased expression of BACE1 mRNA] |
CTD |
PMID:19782061 |
|
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
|
|
G |
BACE1 |
beta-secretase 1 |
multiple interactions |
ISO |
icariin inhibits the reaction [APP protein alternative form results in increased expression of BACE1 mRNA] |
CTD |
PMID:19782061 |
|
NCBI chr11:117,285,698...117,316,256
Ensembl chr11:117,285,232...117,316,259
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
affects expression multiple interactions |
ISO EXP |
icariin affects the expression of BCL2 protein icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein] |
CTD |
PMID:25472572 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L11 |
BCL2 like 11 |
affects expression multiple interactions |
ISO EXP |
icariin affects the expression of BCL2L11 protein icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein] |
CTD |
PMID:25472572 |
|
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
|
|
G |
BGLAP |
bone gamma-carboxyglutamate protein |
multiple interactions increases expression |
ISO |
NOG protein inhibits the reaction [icariin results in increased expression of BGLAP mRNA]; SMAD6 protein inhibits the reaction [icariin results in increased expression of BGLAP mRNA] |
CTD |
PMID:18236786 PMID:18295595 |
|
NCBI chr 1:156,242,184...156,243,317
Ensembl chr 1:156,242,184...156,243,317
|
|
G |
BMP2 |
bone morphogenetic protein 2 |
multiple interactions increases expression |
ISO EXP |
NOG protein inhibits the reaction [icariin results in increased expression of BMP2 mRNA] |
CTD |
PMID:15724410 PMID:16543677 PMID:17355822 PMID:19747809 PMID:20019778 |
|
NCBI chr20:6,767,686...6,780,246
Ensembl chr20:6,767,686...6,780,246
|
|
G |
BMP4 |
bone morphogenetic protein 4 |
increases expression |
ISO |
icariin results in increased expression of BMP4 mRNA |
CTD |
PMID:18295595 PMID:20019778 |
|
NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
|
|
G |
CARTPT |
CART prepropeptide |
increases expression |
ISO |
icariin results in increased expression of CARTPT mRNA; icariin results in increased expression of CARTPT protein |
CTD |
PMID:19858766 |
|
NCBI chr 5:71,719,275...71,721,045
Ensembl chr 5:71,719,275...71,721,048
|
|
G |
CASP1 |
caspase 1 |
increases cleavage |
EXP |
icariin results in increased cleavage of CASP1 protein |
CTD |
PMID:35532261 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CREB1 |
cAMP responsive element binding protein 1 |
increases phosphorylation multiple interactions |
ISO |
icariin results in increased phosphorylation of CREB1 protein [naphthol AS-E phosphate co-treated with icariin] results in increased phosphorylation of CREB1 protein; icariin inhibits the reaction [Diethylhexyl Phthalate results in decreased phosphorylation of CREB1 protein]; icariin inhibits the reaction [MK 2206 results in decreased phosphorylation of CREB1 protein] |
CTD |
PMID:35259346 |
|
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
|
|
G |
CYP11A1 |
cytochrome P450 family 11 subfamily A member 1 |
increases expression multiple interactions |
ISO |
icariin results in increased expression of CYP11A1 mRNA; icariin results in increased expression of CYP11A1 protein [icariin co-treated with Diethylhexyl Phthalate] results in increased expression of CYP11A1 mRNA; [icariin co-treated with naphthol AS-E phosphate] results in decreased expression of CYP11A1 protein; [MK 2206 co-treated with icariin] results in increased expression of CYP11A1 mRNA; icariin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of CYP11A1 protein]; icariin inhibits the reaction [MK 2206 results in decreased expression of CYP11A1 protein] |
CTD |
PMID:31175881 PMID:35259346 |
|
NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions |
ISO |
[paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of and results in decreased phosphorylation of EGFR protein; [paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of EGFR mRNA |
CTD |
PMID:32344236 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
ISO |
icariin results in increased expression of FOS mRNA; icariin results in increased expression of FOS protein SB 203580 inhibits the reaction [icariin results in increased expression of FOS protein]; U 0126 inhibits the reaction [icariin results in increased expression of FOS protein] |
CTD |
PMID:18423597 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
FOXO3 |
forkhead box O3 |
multiple interactions affects localization |
EXP ISO |
icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased acetylation of and results in increased expression of FOXO3 protein]; Niacinamide inhibits the reaction [icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased acetylation of and results in increased expression of FOXO3 protein]] icariin affects the localization of FOXO3 protein |
CTD |
PMID:25472572 |
|
NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
|
|
G |
GATA4 |
GATA binding protein 4 |
increases expression |
ISO |
icariin results in increased expression of GATA4 mRNA |
CTD |
PMID:16490167 |
|
NCBI chr 8:11,676,935...11,760,002
Ensembl chr 8:11,676,959...11,760,002
|
|
G |
HSD3B1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
increases expression multiple interactions |
ISO |
icariin results in increased expression of HSD3B1 mRNA; icariin results in increased expression of HSD3B1 protein icariin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of HSD3B1 mRNA]; icariin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of HSD3B1 protein] |
CTD |
PMID:31175881 |
|
NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054
|
|
G |
ID1 |
inhibitor of DNA binding 1 |
increases expression |
ISO |
icariin results in increased expression of ID1 mRNA |
CTD |
PMID:18295595 |
|
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
|
|
G |
IGF1 |
insulin like growth factor 1 |
increases expression |
ISO |
icariin results in increased expression of IGF1 mRNA |
CTD |
PMID:18236786 |
|
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions increases expression |
ISO EXP |
[paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased secretion of IL1B protein icariin results in increased expression of IL1B protein |
CTD |
PMID:32344236 PMID:35532261 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
affects expression multiple interactions |
ISO |
icariin affects the expression of IL6 protein [paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased secretion of IL6 protein |
CTD |
PMID:25472572 PMID:32344236 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
ISO |
icariin results in increased expression of JUN mRNA; icariin results in increased expression of JUN protein SB 203580 inhibits the reaction [icariin results in increased expression of JUN protein]; U 0126 inhibits the reaction [icariin results in increased expression of JUN protein] |
CTD |
PMID:18423597 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO |
U 0126 inhibits the reaction [icariin results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:18423597 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
U 0126 inhibits the reaction [icariin results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:18423597 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MEF2C |
myocyte enhancer factor 2C |
affects localization increases expression multiple interactions |
ISO |
icariin affects the localization of MEF2C protein icariin results in increased expression of MEF2C mRNA SB 203580 inhibits the reaction [icariin affects the localization of MEF2C protein]; SB 203580 inhibits the reaction [icariin results in increased expression of MEF2C mRNA]; U 0126 inhibits the reaction [icariin affects the localization of MEF2C protein]; U 0126 inhibits the reaction [icariin results in increased expression of MEF2C mRNA] |
CTD |
PMID:18423597 |
|
NCBI chr 5:88,717,117...88,904,105
Ensembl chr 5:88,717,117...88,904,257
|
|
G |
MIR1224 |
microRNA 1224 |
decreases expression |
ISO |
icariin results in decreased expression of MIR1224 mRNA |
CTD |
PMID:30533443 |
|
NCBI chr 3:184,241,405...184,241,489
Ensembl chr 3:184,241,405...184,241,489
|
|
G |
MIR139 |
microRNA 139 |
decreases expression |
ISO |
icariin results in decreased expression of MIR139 mRNA |
CTD |
PMID:30533443 |
|
NCBI chr11:72,615,063...72,615,130
Ensembl chr11:72,615,063...72,615,130
|
|
G |
MIR140 |
microRNA 140 |
decreases expression |
ISO |
icariin results in decreased expression of MIR140 mRNA |
CTD |
PMID:30533443 |
|
NCBI chr16:69,933,081...69,933,180
Ensembl chr16:69,933,081...69,933,180
|
|
G |
MIR146B |
microRNA 146b |
increases expression |
ISO |
icariin results in increased expression of MIR146B mRNA |
CTD |
PMID:30533443 |
|
NCBI chr10:102,436,512...102,436,584
Ensembl chr10:102,436,512...102,436,584
|
|
G |
MIR150 |
microRNA 150 |
decreases expression |
ISO |
icariin results in decreased expression of MIR150 mRNA |
CTD |
PMID:30533443 |
|
NCBI chr19:49,500,785...49,500,868
Ensembl chr19:49,500,785...49,500,868
|
|
G |
MIR183 |
microRNA 183 |
increases expression |
ISO |
icariin results in increased expression of MIR183 mRNA |
CTD |
PMID:30533443 |
|
NCBI chr 7:129,774,905...129,775,014
Ensembl chr 7:129,774,905...129,775,014
|
|
G |
MIR199B |
microRNA 199b |
increases expression |
ISO |
icariin results in increased expression of MIR199B mRNA |
CTD |
PMID:30533443 |
|
NCBI chr 9:128,244,721...128,244,830
Ensembl chr 9:128,244,721...128,244,830
|
|
G |
MIR200A |
microRNA 200a |
increases expression |
ISO |
icariin results in increased expression of MIR200A mRNA |
CTD |
PMID:30533443 |
|
NCBI chr 1:1,167,863...1,167,952
Ensembl chr 1:1,167,863...1,167,952
|
|
G |
MIR200B |
microRNA 200b |
increases expression |
ISO |
icariin results in increased expression of MIR200B mRNA |
CTD |
PMID:30533443 |
|
NCBI chr 1:1,167,104...1,167,198
Ensembl chr 1:1,167,104...1,167,198
|
|
G |
MIR203B |
microRNA 203b |
increases expression |
ISO |
icariin results in increased expression of MIR203 mRNA |
CTD |
PMID:30533443 |
|
NCBI chr14:104,117,418...104,117,503
Ensembl chr14:104,117,418...104,117,503
|
|
G |
MIR205 |
microRNA 205 |
increases expression |
ISO |
icariin results in increased expression of MIR205 mRNA |
CTD |
PMID:30533443 |
|
NCBI chr 1:209,432,133...209,432,242
Ensembl chr 1:209,432,133...209,432,242
|
|
G |
MIR21 |
microRNA 21 |
increases expression |
ISO |
icariin results in increased expression of MIR21A mRNA |
CTD |
PMID:30533443 |
|
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
|
|
G |
MIR223 |
microRNA 223 |
decreases expression |
EXP |
icariin results in decreased expression of MIR223 mRNA |
CTD |
PMID:35532261 |
|
NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979
|
|
G |
MIR2861 |
microRNA 2861 |
decreases expression |
ISO |
icariin results in decreased expression of MIR2861 mRNA |
CTD |
PMID:30533443 |
|
NCBI chr 9:127,785,918...127,786,007
Ensembl chr 9:127,785,918...127,786,007
|
|
G |
MIR30E |
microRNA 30e |
increases expression |
ISO |
icariin results in increased expression of MIR30E mRNA |
CTD |
PMID:30533443 |
|
NCBI chr 1:40,754,355...40,754,446
Ensembl chr 1:40,754,355...40,754,446
|
|
G |
MIR429 |
microRNA 429 |
increases expression |
ISO |
icariin results in increased expression of MIR429 mRNA |
CTD |
PMID:30533443 |
|
NCBI chr 1:1,169,005...1,169,087
Ensembl chr 1:1,169,005...1,169,087
|
|
G |
MIR455 |
microRNA 455 |
decreases expression |
ISO |
icariin results in decreased expression of MIR455 mRNA |
CTD |
PMID:30533443 |
|
NCBI chr 9:114,209,434...114,209,529
Ensembl chr 9:114,209,434...114,209,529
|
|
G |
MIR511 |
microRNA 511 |
increases expression |
ISO |
icariin results in increased expression of MIR511 mRNA |
CTD |
PMID:30533443 |
|
NCBI chr10:17,845,107...17,845,193
Ensembl chr10:17,845,107...17,845,193
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
[paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] affects the secretion of MMP9 protein |
CTD |
PMID:32344236 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
multiple interactions |
ISO |
[paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of and results in decreased phosphorylation of MTOR protein; [paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of MTOR mRNA |
CTD |
PMID:32344236 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
[paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of MUC5AC mRNA; [paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased secretion of MUC5AC protein |
CTD |
PMID:32344236 |
|
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
|
|
G |
MUC5B |
mucin 5B, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
[paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of MUC5B mRNA |
CTD |
PMID:32344236 |
|
NCBI chr11:1,223,066...1,262,172
Ensembl chr11:1,223,066...1,262,172
|
|
G |
MYH6 |
myosin heavy chain 6 |
increases expression |
ISO |
icariin results in increased expression of MYH6 mRNA |
CTD |
PMID:15780198 PMID:16490167 |
|
NCBI chr14:23,381,987...23,408,273
Ensembl chr14:23,381,982...23,408,273
|
|
G |
MYL2 |
myosin light chain 2 |
increases expression |
ISO |
icariin results in increased expression of MYL2 mRNA |
CTD |
PMID:15780198 PMID:16490167 |
|
NCBI chr12:110,910,845...110,921,449
Ensembl chr12:110,910,819...110,921,443
|
|
G |
NFE2L1 |
NFE2 like bZIP transcription factor 1 |
increases expression |
ISO |
icariin results in increased expression of NFE2L1 mRNA; icariin results in increased expression of NFE2L1 protein |
CTD |
PMID:17883938 |
|
NCBI chr17:48,048,359...48,061,545
Ensembl chr17:48,048,329...48,061,545
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
ISO |
icariin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; icariin results in increased phosphorylation of and results in increased degradation of NFKBIA protein; SB 203580 inhibits the reaction [icariin results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; U 0126 inhibits the reaction [icariin results in increased phosphorylation of and results in increased degradation of NFKBIA protein] |
CTD |
PMID:18423597 PMID:20686223 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NKX2-5 |
NK2 homeobox 5 |
increases expression |
ISO |
icariin results in increased expression of NKX2-5 mRNA |
CTD |
PMID:16490167 |
|
NCBI chr 5:173,232,109...173,235,206
Ensembl chr 5:173,232,109...173,235,311
|
|
G |
NLRP3 |
NLR family pyrin domain containing 3 |
increases expression |
EXP |
icariin results in increased expression of NLRP3 mRNA; icariin results in increased expression of NLRP3 protein |
CTD |
PMID:35532261 |
|
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,416,156...247,449,108
|
|
G |
NOG |
noggin |
multiple interactions |
ISO |
NOG protein inhibits the reaction [icariin results in decreased expression of TNFSF11 mRNA]; NOG protein inhibits the reaction [icariin results in increased expression of BGLAP mRNA]; NOG protein inhibits the reaction [icariin results in increased expression of BMP2 mRNA]; NOG protein inhibits the reaction [icariin results in increased expression of RUNX2 mRNA]; NOG protein inhibits the reaction [icariin results in increased expression of SMAD4 mRNA]; NOG protein inhibits the reaction [icariin results in increased expression of SPP1 mRNA]; NOG protein inhibits the reaction [icariin results in increased expression of TNFRSF11B mRNA] |
CTD |
PMID:18295595 PMID:19747809 |
|
NCBI chr17:56,593,699...56,595,611
Ensembl chr17:56,593,699...56,595,611
|
|
G |
NOS1 |
nitric oxide synthase 1 |
increases expression |
ISO |
icariin results in increased expression of NOS1 mRNA |
CTD |
PMID:16281085 |
|
NCBI chr12:117,208,142...117,361,626
Ensembl chr12:117,208,142...117,452,170
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
ISO |
icariin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; icariin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] icariin results in increased expression of NOS2 mRNA; icariin results in increased expression of NOS2 protein |
CTD |
PMID:15329286 PMID:16281085 PMID:20686223 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
increases expression multiple interactions |
EXP ISO |
icariin results in increased expression of NOS3 mRNA icariin results in increased expression of NOS3 mRNA; icariin results in increased expression of NOS3 protein icariin promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide]; icariin results in increased expression of and results in increased activity of NOS3 protein |
CTD |
PMID:15329286 PMID:17499557 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NR5A1 |
nuclear receptor subfamily 5 group A member 1 |
multiple interactions increases expression |
ISO |
icariin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of NR5A1 mRNA]; icariin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of NR5A1 protein] icariin results in increased expression of NR5A1 mRNA; icariin results in increased expression of NR5A1 protein |
CTD |
PMID:31175881 PMID:35259346 |
|
NCBI chr 9:124,481,236...124,507,399
Ensembl chr 9:124,481,236...124,507,420
|
|
G |
PDE5A |
phosphodiesterase 5A |
decreases activity decreases expression |
EXP ISO |
icariin analog results in decreased activity of PDE5A protein; icariin results in decreased activity of PDE5A protein icariin results in decreased expression of PDE5A mRNA alternative form |
CTD |
PMID:17120748 PMID:18778098 |
|
NCBI chr 4:119,494,403...119,628,804
Ensembl chr 4:119,494,397...119,628,804
|
|
G |
PGR |
progesterone receptor |
increases expression multiple interactions |
EXP |
icariin results in increased expression of PGR mRNA fulvestrant inhibits the reaction [icariin results in increased expression of PGR mRNA] |
CTD |
PMID:15541416 |
|
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
increases expression |
ISO |
icariin results in increased expression of PPARA mRNA; icariin results in increased expression of PPARA protein |
CTD |
PMID:17883938 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
|
|
G |
PPARGC1A |
PPARG coactivator 1 alpha |
increases expression multiple interactions |
ISO |
icariin results in increased expression of PPARGC1A mRNA; icariin results in increased expression of PPARGC1A protein Histone Deacetylase Inhibitors inhibits the reaction [icariin inhibits the reaction [Rotenone results in decreased expression of PPARGC1A protein]]; icariin inhibits the reaction [Rotenone results in decreased expression of PPARGC1A protein] |
CTD |
PMID:17883938 PMID:31251943 |
|
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
icariin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; icariin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] |
CTD |
PMID:20686223 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
increases activity multiple interactions |
EXP ISO |
icariin results in increased activity of RELA protein icariin inhibits the reaction [Lipopolysaccharides results in increased localization of RELA protein]; icariin results in increased expression of and affects the localization of RELA protein; SB 203580 inhibits the reaction [icariin results in increased expression of and affects the localization of RELA protein]; U 0126 inhibits the reaction [icariin results in increased expression of and affects the localization of RELA protein] |
CTD |
PMID:17499557 PMID:18423597 PMID:20686223 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RUNX2 |
RUNX family transcription factor 2 |
increases expression multiple interactions |
ISO |
icariin results in increased expression of RUNX2 mRNA NOG protein inhibits the reaction [icariin results in increased expression of RUNX2 mRNA] |
CTD |
PMID:18295595 PMID:19747809 PMID:20019778 |
|
NCBI chr 6:45,328,330...45,551,082
Ensembl chr 6:45,328,157...45,664,349
|
|
G |
SIRT1 |
sirtuin 1 |
multiple interactions affects expression increases expression |
ISO EXP |
icariin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 mRNA]; icariin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 protein]; SB 203580 inhibits the reaction [icariin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 mRNA]]; SB 203580 inhibits the reaction [icariin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT1 protein]] icariin affects the expression of SIRT1 mRNA; icariin affects the expression of SIRT1 protein icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of SIRT1 protein]; Niacinamide inhibits the reaction [icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of SIRT1 protein]] icariin results in increased expression of SIRT1 mRNA; icariin results in increased expression of SIRT1 protein |
CTD |
PMID:19303870 PMID:25472572 |
|
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
|
|
G |
SIRT3 |
sirtuin 3 |
multiple interactions |
ISO |
Histone Deacetylase Inhibitors inhibits the reaction [icariin inhibits the reaction [Rotenone results in decreased expression of SIRT3 protein]]; icariin inhibits the reaction [Rotenone results in decreased expression of SIRT3 protein] |
CTD |
PMID:31251943 |
|
NCBI chr11:215,030...236,931
Ensembl chr11:215,030...236,931
|
|
G |
SLCO1B3 |
solute carrier organic anion transporter family member 1B3 |
multiple interactions decreases activity |
EXP |
[icariin results in decreased activity of SLCO1B3 protein] which results in decreased uptake of Sincalide |
CTD |
PMID:24265111 |
|
NCBI chr12:20,810,705...20,916,911
Ensembl chr12:20,810,702...20,916,911
|
|
G |
SLCO2B1 |
solute carrier organic anion transporter family member 2B1 |
multiple interactions decreases activity |
EXP |
[icariin results in decreased activity of SLCO2B1 protein] which results in decreased uptake of estrone sulfate |
CTD |
PMID:24265111 |
|
NCBI chr11:75,151,107...75,206,549
Ensembl chr11:75,100,563...75,206,549
|
|
G |
SMAD4 |
SMAD family member 4 |
increases expression multiple interactions |
ISO |
icariin results in increased expression of SMAD4 mRNA NOG protein inhibits the reaction [icariin results in increased expression of SMAD4 mRNA] |
CTD |
PMID:19747809 |
|
NCBI chr18:51,030,213...51,085,042
Ensembl chr18:51,028,528...51,085,045
|
|
G |
SMAD6 |
SMAD family member 6 |
multiple interactions |
ISO |
SMAD6 protein inhibits the reaction [icariin results in increased expression of BGLAP mRNA]; SMAD6 protein inhibits the reaction [icariin results in increased expression of SPP1 mRNA] |
CTD |
PMID:18295595 |
|
NCBI chr15:66,702,236...66,782,849
Ensembl chr15:66,702,236...66,782,849
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions affects expression |
ISO EXP |
icariin inhibits the reaction [APP protein alternative form results in decreased expression of SOD2 mRNA] icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of SOD2 protein] icariin affects the expression of SOD2 protein |
CTD |
PMID:19782061 PMID:25472572 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
SPP1 |
secreted phosphoprotein 1 |
multiple interactions increases expression |
ISO |
NOG protein inhibits the reaction [icariin results in increased expression of SPP1 mRNA]; SMAD6 protein inhibits the reaction [icariin results in increased expression of SPP1 mRNA] |
CTD |
PMID:16696327 PMID:18236786 PMID:18295595 |
|
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
|
|
G |
SRC |
SRC proto-oncogene, non-receptor tyrosine kinase |
increases phosphorylation multiple interactions |
ISO |
icariin results in increased phosphorylation of SRC protein afimoxifene inhibits the reaction [icariin results in increased phosphorylation of SRC protein]; icariin inhibits the reaction [Diethylhexyl Phthalate results in decreased phosphorylation of SRC protein] |
CTD |
PMID:35259346 |
|
NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,685...37,406,050
|
|
G |
TFF1 |
trefoil factor 1 |
multiple interactions increases expression |
EXP |
fulvestrant inhibits the reaction [icariin results in increased expression of TFF1 mRNA] |
CTD |
PMID:15541416 |
|
NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
increases expression |
ISO |
icariin results in increased expression of TGFB1 mRNA |
CTD |
PMID:18236786 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TH |
tyrosine hydroxylase |
multiple interactions |
ISO |
icariin inhibits the reaction [Rotenone results in decreased expression of TH protein] |
CTD |
PMID:31251943 |
|
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
|
|
G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions |
ISO |
[paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] affects the secretion of TIMP1 protein |
CTD |
PMID:32344236 |
|
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions affects expression |
ISO |
icariin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; icariin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] [paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased secretion of TNF protein icariin affects the expression of TNF protein |
CTD |
PMID:20686223 PMID:25472572 PMID:32344236 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF11B |
TNF receptor superfamily member 11b |
increases expression multiple interactions |
ISO |
icariin results in increased expression of TNFRSF11B mRNA NOG protein inhibits the reaction [icariin results in increased expression of TNFRSF11B mRNA] |
CTD |
PMID:19747809 |
|
NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885
|
|
G |
TNFSF11 |
TNF superfamily member 11 |
decreases expression multiple interactions |
ISO |
icariin results in decreased expression of TNFSF11 mRNA NOG protein inhibits the reaction [icariin results in decreased expression of TNFSF11 mRNA] |
CTD |
PMID:19747809 |
|
NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013
|
|
G |
TP53 |
tumor protein p53 |
increases expression |
ISO |
icariin results in increased expression of TRP53 mRNA; icariin results in increased expression of TRP53 protein |
CTD |
PMID:15878162 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
ISO EXP |
baohuoside I results in decreased expression of ABCB11 mRNA; baohuoside I results in decreased expression of ABCB11 protein |
CTD |
PMID:35802278 |
|
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
decreases expression |
ISO EXP |
baohuoside I results in decreased expression of ABCC2 mRNA; baohuoside I results in decreased expression of ABCC2 protein |
CTD |
PMID:35802278 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation multiple interactions |
EXP |
baohuoside I results in decreased phosphorylation of AKT1 protein baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:25119583 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
AKT1S1 |
AKT1 substrate 1 |
multiple interactions decreases phosphorylation |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1S1 protein] baohuoside I results in decreased phosphorylation of AKT1S1 protein |
CTD |
PMID:25119583 |
|
NCBI chr19:49,869,033...49,878,356
Ensembl chr19:49,869,033...49,878,459
|
|
G |
ALPL |
alkaline phosphatase, biomineralization associated |
increases expression increases secretion |
ISO |
baohuoside I results in increased expression of ALPL mRNA baohuoside I results in increased secretion of ALPL protein |
CTD |
PMID:17764702 PMID:35802278 |
|
NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression |
EXP |
baohuoside I results in increased expression of BAX protein |
CTD |
PMID:22687635 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression |
EXP |
baohuoside I results in decreased expression of BCL2 protein |
CTD |
PMID:22687635 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BGLAP |
bone gamma-carboxyglutamate protein |
increases expression |
ISO |
baohuoside I results in increased expression of BGLAP mRNA |
CTD |
PMID:17764702 |
|
NCBI chr 1:156,242,184...156,243,317
Ensembl chr 1:156,242,184...156,243,317
|
|
G |
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
decreases phosphorylation multiple interactions |
EXP |
baohuoside I results in decreased phosphorylation of BRAF protein baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of BRAF protein] |
CTD |
PMID:25119583 |
|
NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
|
|
G |
CASP3 |
caspase 3 |
increases cleavage increases activity |
EXP |
baohuoside I results in increased cleavage of CASP3 protein baohuoside I results in increased activity of CASP3 protein |
CTD |
PMID:19289254 PMID:22687635 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
increases activity |
EXP |
baohuoside I results in increased activity of CASP8 protein |
CTD |
PMID:19289254 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
increases activity increases cleavage |
EXP |
baohuoside I results in increased activity of CASP9 protein baohuoside I results in increased cleavage of CASP9 protein |
CTD |
PMID:19289254 PMID:22687635 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
COL1A2 |
collagen type I alpha 2 chain |
increases expression |
ISO |
baohuoside I results in increased expression of COL1A2 mRNA |
CTD |
PMID:17764702 |
|
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
|
|
G |
CYP7A1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression |
ISO EXP |
baohuoside I results in increased expression of CYP7A1 mRNA; baohuoside I results in increased expression of CYP7A1 protein |
CTD |
PMID:35802278 |
|
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
|
|
G |
EGF |
epidermal growth factor |
multiple interactions |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of AKT1S1 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of BRAF protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MTOR protein] |
CTD |
PMID:25119583 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions decreases phosphorylation |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] baohuoside I results in decreased phosphorylation of EGFR protein |
CTD |
PMID:25119583 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions |
EXP |
baohuoside I binds to and results in increased degradation of ESR1 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [baohuoside I results in increased degradation of ESR1 protein]; ESR1 inhibits the reaction [baohuoside I results in decreased expression of and affects the localization of NR0B2 protein] |
CTD |
PMID:35802278 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
GOT1 |
glutamic-oxaloacetic transaminase 1 |
increases secretion |
ISO EXP |
baohuoside I results in increased secretion of GOT1 protein |
CTD |
PMID:35802278 |
|
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
|
|
G |
GPT |
glutamic--pyruvic transaminase |
increases secretion |
ISO EXP |
baohuoside I results in increased secretion of GPT protein |
CTD |
PMID:35802278 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
decreases phosphorylation |
EXP |
baohuoside I results in decreased phosphorylation of GSK3B protein |
CTD |
PMID:25119583 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions decreases phosphorylation |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] baohuoside I results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:25119583 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions decreases phosphorylation |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein] baohuoside I results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:25119583 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
decreases expression |
EXP |
baohuoside I results in decreased expression of MKI67 protein |
CTD |
PMID:25119583 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
multiple interactions decreases phosphorylation |
EXP |
baohuoside I inhibits the reaction [EGF protein results in increased phosphorylation of MTOR protein] baohuoside I results in decreased phosphorylation of MTOR protein |
CTD |
PMID:25119583 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
NOS2 |
nitric oxide synthase 2 |
decreases expression |
EXP |
baohuoside I results in decreased expression of NOS2 |
CTD |
PMID:19289254 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NR0B2 |
nuclear receptor subfamily 0 group B member 2 |
decreases expression multiple interactions |
ISO EXP |
baohuoside I results in decreased expression of NR0B2 mRNA; baohuoside I results in decreased expression of NR0B2 protein baohuoside I results in decreased expression of and results in decreased activity of and affects the localization of NR0B2 protein; ESR1 inhibits the reaction [baohuoside I results in decreased expression of and affects the localization of NR0B2 protein] |
CTD |
PMID:35802278 |
|
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
|
|
G |
NR1H4 |
nuclear receptor subfamily 1 group H member 4 |
decreases expression |
EXP ISO |
baohuoside I results in decreased expression of NR1H4 mRNA; baohuoside I results in decreased expression of NR1H4 protein |
CTD |
PMID:35802278 |
|
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases cleavage multiple interactions |
EXP |
baohuoside I results in increased cleavage of PARP1 protein Dinoprostone inhibits the reaction [baohuoside I results in increased cleavage of PARP1 protein]; PTGS2 mutant form promotes the reaction [baohuoside I results in increased cleavage of PARP1 protein] |
CTD |
PMID:19289254 PMID:22687635 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PDPK1 |
3-phosphoinositide dependent protein kinase 1 |
decreases phosphorylation |
EXP |
baohuoside I results in decreased phosphorylation of PDPK1 protein |
CTD |
PMID:25119583 |
|
NCBI chr16:2,538,021...2,603,188
Ensembl chr16:2,537,979...2,603,188
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression multiple interactions |
EXP |
baohuoside I results in decreased expression of PTGS2 [baohuoside I results in decreased expression of PTGS2] which results in decreased abundance of Dinoprostone; PTGS2 mutant form promotes the reaction [baohuoside I results in increased cleavage of PARP1 protein] |
CTD |
PMID:19289254 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
SLC10A1 |
solute carrier family 10 member 1 |
increases expression |
ISO EXP |
baohuoside I results in increased expression of SLC10A1 mRNA; baohuoside I results in increased expression of SLC10A1 protein |
CTD |
PMID:35802278 |
|
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
|
|
G |
SLCO1A2 |
solute carrier organic anion transporter family member 1A2 |
decreases expression |
EXP |
baohuoside I results in decreased expression of SLCO1A1 mRNA |
CTD |
PMID:35802278 |
|
NCBI chr12:21,264,600...21,419,634
Ensembl chr12:21,264,600...21,419,594
|
|
G |
TNFRSF11B |
TNF receptor superfamily member 11b |
increases expression |
ISO |
baohuoside I results in increased expression of TNFRSF11B mRNA |
CTD |
PMID:17764702 |
|
NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885
|
|
G |
TNFSF11 |
TNF superfamily member 11 |
decreases expression |
ISO |
baohuoside I results in decreased expression of TNFSF11 mRNA |
CTD |
PMID:17764702 |
|
NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013
|
|
G |
VEGFA |
vascular endothelial growth factor A |
decreases expression |
EXP |
baohuoside I results in decreased expression of VEGFA |
CTD |
PMID:19289254 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
|
G |
PLA2G2A |
phospholipase A2 group IIA |
affects activity |
EXP |
kaempferol-3-O-galactoside affects the activity of PLA2G2A protein |
CTD |
PMID:8190018 |
|
NCBI chr 1:19,975,431...19,980,434
Ensembl chr 1:19,975,431...19,980,416
|
|
|
G |
APP |
amyloid beta precursor protein |
multiple interactions |
ISO |
astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in decreased expression of APP protein] |
CTD |
PMID:35537655 |
|
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in decreased expression of CAT protein] |
CTD |
PMID:35537655 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] |
CTD |
PMID:22210036 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL3 |
C-C motif chemokine ligand 3 |
multiple interactions |
ISO |
astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA] |
CTD |
PMID:22210036 |
|
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
|
|
G |
HES1 |
hes family bHLH transcription factor 1 |
multiple interactions |
ISO |
astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of HES1 protein] |
CTD |
PMID:35537655 |
|
NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732
|
|
G |
IL10 |
interleukin 10 |
multiple interactions |
ISO |
astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in decreased expression of IL10 protein] |
CTD |
PMID:35537655 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IL1B protein]; astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] |
CTD |
PMID:22210036 PMID:35537655 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IL6 protein]; astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] |
CTD |
PMID:22210036 PMID:35537655 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
ISO |
astragalin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein] |
CTD |
PMID:22210036 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] |
CTD |
PMID:22210036 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOTCH1 |
notch receptor 1 |
multiple interactions |
ISO |
astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of NOTCH1 protein] |
CTD |
PMID:35537655 |
|
NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] |
CTD |
PMID:22210036 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RBPJ |
recombination signal binding protein for immunoglobulin kappa J region |
multiple interactions |
ISO |
astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of RBPJ protein] |
CTD |
PMID:35537655 |
|
NCBI chr 4:26,105,449...26,435,131
Ensembl chr 4:26,163,455...26,435,131
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of and results in increased phosphorylation of RELA protein]; astragalin inhibits the reaction [Lipopolysaccharides results in increased localization of RELA protein] |
CTD |
PMID:22210036 PMID:35537655 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TNF protein]; astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] |
CTD |
PMID:22210036 PMID:35537655 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
EXP |
[luteolin-7-glucoside co-treated with Hydrogen Peroxide] results in increased phosphorylation of AKT1 protein luteolin-7-glucoside results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:31157476 PMID:34165247 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression |
EXP |
luteolin-7-glucoside results in increased expression of BAX protein |
CTD |
PMID:34165247 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions decreases expression |
EXP |
luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]; luteolin-7-glucoside inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] luteolin-7-glucoside results in decreased expression of BCL2 protein |
CTD |
PMID:31157476 PMID:31381935 PMID:34165247 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
decreases expression |
EXP |
luteolin-7-glucoside results in decreased expression of BCL2L1 protein |
CTD |
PMID:34165247 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BID |
BH3 interacting domain death agonist |
increases expression |
EXP |
luteolin-7-glucoside results in increased expression of BID protein alternative form |
CTD |
PMID:34165247 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases cleavage |
EXP |
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [luteolin-7-glucoside results in increased cleavage of CASP3 protein]; luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CASP3 protein modified form]; luteolin-7-glucoside inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP3 protein] |
CTD |
PMID:31157476 PMID:31381935 PMID:34165247 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
increases cleavage |
EXP |
luteolin-7-glucoside results in increased cleavage of CASP8 protein |
CTD |
PMID:34165247 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
increases cleavage |
EXP |
luteolin-7-glucoside results in increased cleavage of CASP9 protein |
CTD |
PMID:34165247 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions |
EXP |
luteolin-7-glucoside inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein] |
CTD |
PMID:31157476 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCNA2 |
cyclin A2 |
decreases expression |
EXP |
luteolin-7-glucoside results in decreased expression of CCNA2 protein |
CTD |
PMID:34165247 |
|
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
|
|
G |
CCNB1 |
cyclin B1 |
decreases expression |
EXP |
luteolin-7-glucoside results in decreased expression of CCNB1 protein |
CTD |
PMID:34165247 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CDK1 |
cyclin dependent kinase 1 |
decreases phosphorylation |
EXP |
luteolin-7-glucoside results in decreased phosphorylation of CDK1 protein |
CTD |
PMID:34165247 |
|
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
|
|
G |
CDK2 |
cyclin dependent kinase 2 |
decreases expression |
EXP |
luteolin-7-glucoside results in decreased expression of CDK2 protein |
CTD |
PMID:34165247 |
|
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
increases expression |
EXP |
luteolin-7-glucoside results in increased expression of CDKN1A protein |
CTD |
PMID:34165247 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions increases activity |
EXP |
1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of ESR1 protein]]; Fulvestrant inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of ESR1 protein]]; luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of ESR1 protein] luteolin-7-glucoside results in increased activity of ESR1 protein |
CTD |
PMID:31381935 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
ESR2 |
estrogen receptor 2 |
increases activity multiple interactions |
EXP |
luteolin-7-glucoside results in increased activity of ESR2 protein 4-(2-phenyl-5,7-bis(trifluoromethyl)pyrazolo(1,5-a)pyrimidin-3-yl)phenol inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of ESR2 protein]]; Fulvestrant inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of ESR2 protein]]; luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of ESR2 protein] |
CTD |
PMID:31381935 |
|
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
|
|
G |
FAS |
Fas cell surface death receptor |
increases expression |
EXP |
luteolin-7-glucoside results in increased expression of FAS protein |
CTD |
PMID:34165247 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of FOS protein]]; 4-(2-phenyl-5,7-bis(trifluoromethyl)pyrazolo(1,5-a)pyrimidin-3-yl)phenol inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of FOS protein]]; Fulvestrant inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of FOS protein]]; luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of FOS protein] |
CTD |
PMID:31381935 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
luteolin-7-glucoside inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of IL6 protein] |
CTD |
PMID:11123379 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
decreases phosphorylation multiple interactions |
EXP |
luteolin-7-glucoside results in decreased phosphorylation of MAPK1 protein 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK1 protein]]; 4-(2-phenyl-5,7-bis(trifluoromethyl)pyrazolo(1,5-a)pyrimidin-3-yl)phenol inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK1 protein]]; Fulvestrant inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK1 protein]]; luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:31381935 PMID:34165247 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions decreases phosphorylation |
EXP |
1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK3 protein]]; 4-(2-phenyl-5,7-bis(trifluoromethyl)pyrazolo(1,5-a)pyrimidin-3-yl)phenol inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK3 protein]]; Fulvestrant inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK3 protein]]; luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK3 protein] luteolin-7-glucoside results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:31381935 PMID:34165247 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [luteolin-7-glucoside results in increased cleavage of PARP1 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [luteolin-7-glucoside results in increased cleavage of PARP1 protein]; pyrazolanthrone inhibits the reaction [luteolin-7-glucoside results in increased cleavage of PARP1 protein]; SB 203580 promotes the reaction [luteolin-7-glucoside results in increased cleavage of PARP1 protein]; U 0126 inhibits the reaction [luteolin-7-glucoside results in increased cleavage of PARP1 protein] |
CTD |
PMID:34165247 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
RIPK1 |
receptor interacting serine/threonine kinase 1 |
increases expression |
EXP |
luteolin-7-glucoside results in increased expression of RIPK1 protein |
CTD |
PMID:34165247 |
|
NCBI chr 6:3,063,967...3,115,187
Ensembl chr 6:3,063,824...3,115,187
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
multiple interactions |
EXP |
1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of STAT3 protein]]; 4-(2-phenyl-5,7-bis(trifluoromethyl)pyrazolo(1,5-a)pyrimidin-3-yl)phenol inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of STAT3 protein]]; Fulvestrant inhibits the reaction [luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of STAT3 protein]]; luteolin-7-glucoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of STAT3 protein] |
CTD |
PMID:31381935 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
luteolin-7-glucoside inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of TNF protein] |
CTD |
PMID:11123379 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF10B |
TNF receptor superfamily member 10b |
increases expression |
EXP |
luteolin-7-glucoside results in increased expression of TNFRSF10B protein |
CTD |
PMID:34165247 |
|
NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
increases expression |
EXP |
luteolin-7-glucoside results in increased expression of TNFRSF1A protein |
CTD |
PMID:34165247 |
|
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
|
G |
ACADM |
acyl-CoA dehydrogenase medium chain |
multiple interactions |
ISO |
quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of ACADM mRNA] |
CTD |
PMID:26190035 |
|
NCBI chr 1:75,724,709...75,763,679
Ensembl chr 1:75,724,431...75,787,575
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
multiple interactions |
EXP |
quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine binds to ADRB2 protein] |
CTD |
PMID:24929186 |
|
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
|
|
G |
AGT |
angiotensinogen |
multiple interactions |
EXP |
quercetin 3-O-glucuronide analog inhibits the reaction [AGT protein results in increased phosphorylation of JUN protein] |
CTD |
PMID:12054679 |
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
multiple interactions |
EXP |
quercetin 3-O-glucuronide inhibits the reaction [ALOX5 protein results in increased chemical synthesis of Leukotriene B4] |
CTD |
PMID:18096136 |
|
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
|
|
G |
APP |
amyloid beta precursor protein |
multiple interactions decreases expression |
EXP |
quercetin 3-O-glucuronide inhibits the reaction [APP protein binds to APP protein modified form] quercetin 3-O-glucuronide results in decreased expression of APP protein |
CTD |
PMID:23097297 |
|
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
[quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of CAT mRNA; [quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of CAT protein |
CTD |
PMID:25716194 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CAV1 |
caveolin 1 |
multiple interactions |
EXP |
quercetin 3-O-glucuronide inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA] |
CTD |
PMID:27257344 |
|
NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179
|
|
G |
CD36 |
CD36 molecule (CD36 blood group) |
decreases expression |
ISO |
quercetin 3-O-glucuronide results in decreased expression of CD36 mRNA |
CTD |
PMID:18199750 |
|
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
|
|
G |
CPT1A |
carnitine palmitoyltransferase 1A |
multiple interactions |
ISO |
quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of CPT1A mRNA] |
CTD |
PMID:26190035 |
|
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
|
|
G |
FAS |
Fas cell surface death receptor |
multiple interactions |
ISO |
quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FAS mRNA]; quercetin 3-O-glucuronide inhibits the reaction [Dietary Fats results in increased expression of FAS mRNA] |
CTD |
PMID:26190035 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
multiple interactions |
ISO |
[quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of GCLC mRNA; [quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of GCLC protein |
CTD |
PMID:25716194 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
EXP ISO |
quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased expression of HMOX1 mRNA] [quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of HMOX1 mRNA; [quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of HMOX1 protein |
CTD |
PMID:24929186 PMID:25716194 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
multiple interactions |
EXP |
quercetin 3-O-glucuronide inhibits the reaction [Lysophosphatidylcholines results in increased expression of ICAM1 mRNA] |
CTD |
PMID:27257344 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
EXP |
quercetin 3-O-glucuronide inhibits the reaction [Palmitates results in increased phosphorylation of IKBKB protein] |
CTD |
PMID:23504962 |
|
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein] |
CTD |
PMID:26190035 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
EXP |
quercetin 3-O-glucuronide inhibits the reaction [Palmitates results in increased secretion of IL6 protein] |
CTD |
PMID:23504962 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INS |
insulin |
multiple interactions |
EXP |
quercetin 3-O-glucuronide inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased chemical synthesis of Nitric Oxide]]; quercetin 3-O-glucuronide inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]]; quercetin 3-O-glucuronide inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]] |
CTD |
PMID:23504962 |
|
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
|
|
G |
IRS1 |
insulin receptor substrate 1 |
multiple interactions |
EXP |
quercetin 3-O-glucuronide inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]]; quercetin 3-O-glucuronide inhibits the reaction [Palmitates results in increased phosphorylation of IRS1 protein] |
CTD |
PMID:23504962 |
|
NCBI chr 2:226,731,312...226,799,820
Ensembl chr 2:226,731,312...226,799,820
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
quercetin 3-O-glucuronide analog inhibits the reaction [AGT protein results in increased phosphorylation of JUN protein] |
CTD |
PMID:12054679 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased expression of MMP2 mRNA] |
CTD |
PMID:24929186 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions |
EXP |
quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased activity of MMP9 protein]; quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA] |
CTD |
PMID:24929186 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MSR1 |
macrophage scavenger receptor 1 |
decreases expression |
ISO |
quercetin 3-O-glucuronide results in decreased expression of MSR1 mRNA |
CTD |
PMID:18199750 |
|
NCBI chr 8:16,107,881...16,192,651
Ensembl chr 8:16,107,878...16,567,490
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
quercetin 3-O-glucuronide inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein] |
CTD |
PMID:27257013 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
multiple interactions |
EXP |
quercetin 3-O-glucuronide inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]] |
CTD |
PMID:23504962 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA protein]; quercetin 3-O-glucuronide inhibits the reaction [Dietary Fats results in decreased expression of PPARA protein] |
CTD |
PMID:26190035 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
increases expression |
EXP |
quercetin 3-O-glucuronide results in increased expression of PPARG mRNA |
CTD |
PMID:25765892 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
quercetin 3-O-glucuronide inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of PTGS2 protein] |
CTD |
PMID:27257013 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
quercetin 3-O-glucuronide inhibits the reaction [Palmitates results in increased phosphorylation of RELA protein] |
CTD |
PMID:23504962 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
SLC22A8 |
solute carrier family 22 member 8 |
multiple interactions increases uptake |
EXP |
quercetin 3-O-glucuronide analog inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein]; quercetin 3-O-glucuronide inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein] SLC22A8 protein results in increased uptake of quercetin 3-O-glucuronide analog |
CTD |
PMID:21244849 |
|
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
|
|
G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
ISO |
quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of SREBF1 mRNA]; quercetin 3-O-glucuronide inhibits the reaction [Dietary Fats results in increased expression of SREBF1 mRNA] |
CTD |
PMID:26190035 |
|
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
EXP ISO |
quercetin 3-O-glucuronide inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with TNF protein] results in increased expression of VCAM1 protein]; quercetin 3-O-glucuronide inhibits the reaction [Palmitates results in increased secretion of TNF protein] quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein] |
CTD |
PMID:17880982 PMID:23504962 PMID:26190035 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFSF11 |
TNF superfamily member 11 |
decreases activity |
ISO |
quercetin 3-O-glucuronide results in decreased activity of TNFSF11 protein |
CTD |
PMID:19495926 |
|
NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
multiple interactions |
EXP |
quercetin 3-O-glucuronide inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with TNF protein] results in increased expression of VCAM1 protein] |
CTD |
PMID:17880982 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
myricitrin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] |
CTD |
PMID:25656916 |
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,935,074...88,991,339
|
|
G |
ALPL |
alkaline phosphatase, biomineralization associated |
multiple interactions |
ISO EXP |
myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of ALPL mRNA] |
CTD |
PMID:25130202 |
|
NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410
|
|
G |
APOE |
apolipoprotein E |
multiple interactions |
ISO |
myricitrin inhibits the reaction [APOE gene mutant form results in decreased activity of CAT protein]; myricitrin inhibits the reaction [APOE gene mutant form results in increased activity of CASP3 protein]; myricitrin inhibits the reaction [APOE gene mutant form results in increased expression of CCL2 protein]; myricitrin inhibits the reaction [APOE gene mutant form results in increased expression of CRP protein]; myricitrin inhibits the reaction [APOE gene mutant form results in increased expression of ICAM1 protein] |
CTD |
PMID:23639522 |
|
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
myricitrin inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein] |
CTD |
PMID:23639522 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
EXP |
myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] |
CTD |
PMID:23639522 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BGLAP |
bone gamma-carboxyglutamate protein |
multiple interactions |
ISO EXP |
myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BGLAP mRNA] |
CTD |
PMID:25130202 |
|
NCBI chr 1:156,242,184...156,243,317
Ensembl chr 1:156,242,184...156,243,317
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
EXP ISO |
myricitrin inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein] myricitrin inhibits the reaction [APOE gene mutant form results in increased activity of CASP3 protein] |
CTD |
PMID:23639522 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CAT |
catalase |
multiple interactions |
EXP ISO |
myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein] myricitrin inhibits the reaction [APOE gene mutant form results in decreased activity of CAT protein] |
CTD |
PMID:23639522 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
myricitrin inhibits the reaction [APOE gene mutant form results in increased expression of CCL2 protein] |
CTD |
PMID:23639522 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO EXP |
myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of COL1A1 mRNA] |
CTD |
PMID:25130202 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
CRP |
C-reactive protein |
multiple interactions |
ISO |
myricitrin inhibits the reaction [APOE gene mutant form results in increased expression of CRP protein] |
CTD |
PMID:23639522 |
|
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
multiple interactions |
ISO |
myricitrin inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP2E1 protein] |
CTD |
PMID:25656916 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
myricitrin inhibits the reaction [Carbon Tetrachloride results in increased activity of GPT protein] |
CTD |
PMID:25656916 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions |
EXP |
myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased activity of GPX1 protein] |
CTD |
PMID:23639522 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
myricitrin inhibits the reaction [APOE gene mutant form results in increased expression of ICAM1 protein] |
CTD |
PMID:23639522 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
EXP ISO |
myricitrin inhibits the reaction [Hydrogen Peroxide results in increased expression of IL6 protein] |
CTD |
PMID:25130202 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
myricitrin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:23639522 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP |
myricitrin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:23639522 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP |
myricitrin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:23639522 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
NOS3 |
nitric oxide synthase 3 |
multiple interactions |
EXP |
myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased activity of NOS3 protein] |
CTD |
PMID:23639522 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
PCNA |
proliferating cell nuclear antigen |
multiple interactions |
ISO |
myricitrin promotes the reaction [Carbon Tetrachloride results in increased expression of PCNA protein] |
CTD |
PMID:25656916 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
multiple interactions |
EXP |
myricitrin inhibits the reaction [Hydrogen Peroxide results in increased expression of PPARG mRNA] |
CTD |
PMID:25130202 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
myricitrin inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein] |
CTD |
PMID:25656916 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
ISO |
myricitrin inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein] |
CTD |
PMID:25656916 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
myricitrin inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein] |
CTD |
PMID:25656916 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFSF11 |
TNF superfamily member 11 |
multiple interactions |
ISO EXP |
myricitrin inhibits the reaction [Hydrogen Peroxide results in increased expression of TNFSF11 protein] |
CTD |
PMID:25130202 |
|
NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions |
EXP |
myricitrin inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 protein] |
CTD |
PMID:23639522 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
|
G |
ACHE |
acetylcholinesterase (Yt blood group) |
increases expression multiple interactions |
ISO |
hyperoside results in increased expression of ACHE mRNA hyperoside results in increased expression of and results in increased activity of ACHE protein |
CTD |
PMID:27019979 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP ISO |
hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of BAX protein] hyperoside inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein] |
CTD |
PMID:18552516 PMID:31326407 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
ISO |
hyperoside inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] |
CTD |
PMID:31326407 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BIRC5 |
baculoviral IAP repeat containing 5 |
multiple interactions |
EXP |
[Quercetin co-treated with hyperoside] results in decreased expression of BIRC5 mRNA; [Quercetin co-treated with hyperoside] results in decreased expression of BIRC5 protein |
CTD |
PMID:24173369 |
|
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
EXP |
[Quercetin co-treated with hyperoside] results in increased cleavage of CASP3 protein |
CTD |
PMID:24173369 PMID:25354548 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
cyclopamine inhibits the reaction [hyperoside inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein]]; hyperoside inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein] |
CTD |
PMID:31326407 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CYCS |
cytochrome c, somatic |
multiple interactions |
EXP |
hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of CYCS protein] |
CTD |
PMID:18552516 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
decreases activity multiple interactions |
ISO |
hyperoside results in decreased activity of CYP2E1 protein hyperoside inhibits the reaction [Acetaminophen results in decreased activity of CYP2E1 protein] |
CTD |
PMID:26772156 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions |
EXP |
hyperoside inhibits the reaction [Estradiol results in increased activity of ESR1 protein] |
CTD |
PMID:22613215 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
GLI1 |
GLI family zinc finger 1 |
multiple interactions increases expression |
ISO |
hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of GLI1 mRNA]; hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of GLI1 protein] hyperoside results in increased expression of GLI1 mRNA; hyperoside results in increased expression of GLI1 protein |
CTD |
PMID:31326407 |
|
NCBI chr12:57,459,785...57,472,268
Ensembl chr12:57,459,785...57,472,268
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
hyperoside inhibits the reaction [Acetaminophen results in increased activity of GPT protein] |
CTD |
PMID:26772156 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:30125551 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:30125551 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MIR21 |
microRNA 21 |
multiple interactions |
EXP |
[Quercetin co-treated with hyperoside] results in decreased expression of MIR21 mRNA; MIR21 mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of PDCD4 mRNA]; MIR21 mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of PDCD4 protein]; MIR21 mRNA results in decreased susceptibility to [Quercetin co-treated with hyperoside] |
CTD |
PMID:25354548 |
|
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
|
|
G |
MIR27A |
microRNA 27a |
multiple interactions |
EXP |
[Quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in decreased expression of ZBTB10 mRNA]; [Quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in increased expression of SP1 mRNA]; [Quercetin co-treated with hyperoside] results in decreased expression of MIR27A mRNA; MIR27A mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of ZBTB10 mRNA] |
CTD |
PMID:24173369 |
|
NCBI chr19:13,836,440...13,836,517
Ensembl chr19:13,836,440...13,836,517
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
affects localization |
ISO |
hyperoside affects the localization of NFE2L2 protein |
CTD |
PMID:26772156 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
ISO |
hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein] |
CTD |
PMID:30125551 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
Hyperoside increases expression of Nqo1 protein in liver |
RGD |
PMID:31399183 |
RGD:25823190 |
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions |
EXP |
[Quercetin co-treated with hyperoside] results in increased cleavage of PARP1 protein |
CTD |
PMID:24173369 PMID:25354548 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PDCD4 |
programmed cell death 4 |
multiple interactions |
EXP |
[Quercetin co-treated with hyperoside] results in increased expression of PDCD4 mRNA; [Quercetin co-treated with hyperoside] results in increased expression of PDCD4 protein; MIR21 mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of PDCD4 mRNA]; MIR21 mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of PDCD4 protein] |
CTD |
PMID:25354548 |
|
NCBI chr10:110,871,928...110,900,006
Ensembl chr10:110,871,795...110,900,006
|
|
G |
PRIMA1 |
proline rich membrane anchor 1 |
increases expression |
ISO |
hyperoside results in increased expression of PRIMA1 mRNA |
CTD |
PMID:27019979 |
|
NCBI chr14:93,718,298...93,788,994
Ensembl chr14:93,718,298...93,788,485
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein] |
CTD |
PMID:30125551 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
SHH |
sonic hedgehog signaling molecule |
multiple interactions increases expression |
ISO |
hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SHH mRNA]; hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SHH protein] hyperoside results in increased expression of SHH mRNA; hyperoside results in increased expression of SHH protein |
CTD |
PMID:31326407 |
|
NCBI chr 7:155,799,980...155,812,463
Ensembl chr 7:155,799,980...155,812,463
|
|
G |
SIRT1 |
sirtuin 1 |
multiple interactions |
EXP |
hyperoside inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SIRT1 protein] |
CTD |
PMID:18552516 |
|
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
|
|
G |
SLC2A2 |
solute carrier family 2 member 2 |
increases expression |
EXP |
hyperoside analog results in increased expression of SLC2A2 mRNA |
CTD |
PMID:33493636 |
|
NCBI chr 3:170,996,347...171,026,720
Ensembl chr 3:170,996,347...171,026,743
|
|
G |
SLC5A1 |
solute carrier family 5 member 1 |
increases expression |
EXP |
hyperoside analog results in increased expression of SLC5A1 mRNA |
CTD |
PMID:33493636 |
|
NCBI chr22:32,043,261...32,113,029
Ensembl chr22:32,043,261...32,113,029
|
|
G |
SMO |
smoothened, frizzled class receptor |
multiple interactions increases expression |
ISO |
hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SMO mRNA]; hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SMO protein] hyperoside results in increased expression of SMO mRNA; hyperoside results in increased expression of SMO protein |
CTD |
PMID:31326407 |
|
NCBI chr 7:129,188,633...129,213,545
Ensembl chr 7:129,188,633...129,213,545
|
|
G |
SP1 |
Sp1 transcription factor |
multiple interactions |
EXP |
[Quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in increased expression of SP1 mRNA]; [Quercetin co-treated with hyperoside] results in decreased expression of SP1 mRNA; [Quercetin co-treated with hyperoside] results in decreased expression of SP1 protein |
CTD |
PMID:24173369 |
|
NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446
|
|
G |
SP3 |
Sp3 transcription factor |
multiple interactions |
EXP |
[Quercetin co-treated with hyperoside] results in decreased expression of SP3 mRNA; [Quercetin co-treated with hyperoside] results in decreased expression of SP3 protein |
CTD |
PMID:24173369 |
|
NCBI chr 2:173,900,775...173,965,702
Ensembl chr 2:173,880,850...173,965,373
|
|
G |
SP4 |
Sp4 transcription factor |
multiple interactions |
EXP |
[Quercetin co-treated with hyperoside] results in decreased expression of SP4 mRNA; [Quercetin co-treated with hyperoside] results in decreased expression of SP4 protein |
CTD |
PMID:24173369 |
|
NCBI chr 7:21,428,083...21,514,822
Ensembl chr 7:21,428,043...21,514,822
|
|
G |
SULT1A2 |
sulfotransferase family 1A member 2 |
multiple interactions |
ISO |
hyperoside inhibits the reaction [Acetaminophen results in decreased expression of SULT1A1 mRNA] |
CTD |
PMID:26772156 |
|
NCBI chr16:28,591,943...28,597,050
Ensembl chr16:28,591,943...28,597,050
|
|
G |
SULT2A1 |
sulfotransferase family 2A member 1 |
multiple interactions increases expression |
ISO |
hyperoside inhibits the reaction [Acetaminophen results in decreased expression of SULT2A1 mRNA] hyperoside results in increased expression of SULT2A1 mRNA |
CTD |
PMID:26772156 |
|
NCBI chr19:47,870,467...47,886,315
Ensembl chr19:47,870,467...47,886,315
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
hyperoside inhibits the reaction [TNF protein results in increased expression of TNFRSF1A protein]; hyperoside inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; hyperoside inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]; hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]; hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein] |
CTD |
PMID:30125551 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
multiple interactions |
ISO |
hyperoside inhibits the reaction [TNF protein results in increased expression of TNFRSF1A protein] |
CTD |
PMID:30125551 |
|
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
G |
UGT1A1 |
UDP glucuronosyltransferase family 1 member A1 |
multiple interactions increases expression |
ISO |
hyperoside inhibits the reaction [Acetaminophen results in decreased expression of UGT1A1 mRNA] hyperoside results in increased expression of UGT1A1 mRNA |
CTD |
PMID:26772156 |
|
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
|
|
G |
UGT1A10 |
UDP glucuronosyltransferase family 1 member A10 |
increases expression multiple interactions |
ISO |
hyperoside results in increased expression of UGT1A10 mRNA hyperoside inhibits the reaction [Acetaminophen results in decreased expression of UGT1A10 mRNA] |
CTD |
PMID:26772156 |
|
NCBI chr 2:233,636,448...233,773,300
Ensembl chr 2:233,636,448...233,773,300
|
|
G |
UGT1A6 |
UDP glucuronosyltransferase family 1 member A6 |
multiple interactions |
ISO |
hyperoside inhibits the reaction [Acetaminophen results in decreased expression of UGT1A6 mRNA] |
CTD |
PMID:26772156 |
|
NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
|
|
G |
UGT2B17 |
UDP glucuronosyltransferase family 2 member B17 |
multiple interactions increases expression |
ISO |
hyperoside inhibits the reaction [Acetaminophen results in decreased expression of UGT2B1 mRNA] hyperoside results in increased expression of UGT2B1 mRNA |
CTD |
PMID:26772156 |
|
NCBI chr 4:68,537,173...68,576,322
Ensembl chr 4:68,537,173...68,576,413
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
hyperoside inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; hyperoside inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] |
CTD |
PMID:30125551 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|
G |
ZBTB10 |
zinc finger and BTB domain containing 10 |
multiple interactions |
EXP |
[Quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in decreased expression of ZBTB10 mRNA]; [Quercetin co-treated with hyperoside] results in increased expression of ZBTB10 mRNA; MIR27A mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of ZBTB10 mRNA] |
CTD |
PMID:24173369 |
|
NCBI chr 8:80,485,593...80,526,265
Ensembl chr 8:80,485,619...80,526,265
|
|
|
G |
ACAT2 |
acetyl-CoA acetyltransferase 2 |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of ACAT2 mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,762,045...159,779,112
|
|
G |
AKR7A3 |
aldo-keto reductase family 7 member A3 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of AKR7A3 mRNA |
CTD |
PMID:20033131 |
|
NCBI chr 1:19,274,229...19,288,770
Ensembl chr 1:19,282,573...19,288,770
|
|
G |
APOA1 |
apolipoprotein A1 |
increases secretion |
EXP |
isoquercitrin results in increased secretion of APOA1 protein |
CTD |
PMID:24963805 |
|
NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
|
|
G |
ATF6 |
activating transcription factor 6 |
increases expression |
ISO |
isoquercitrin results in increased expression of ATF6 mRNA |
CTD |
PMID:30365939 |
|
NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,298...161,977,574
|
|
G |
ATXN2 |
ataxin 2 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of ATXN2 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr12:111,452,214...111,599,673
Ensembl chr12:111,443,485...111,599,676
|
|
G |
ATXN3 |
ataxin 3 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of ATXN3 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr14:92,044,775...92,106,582
Ensembl chr14:92,044,496...92,106,621
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression |
EXP |
isoquercitrin results in decreased expression of BCL2 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
CASP3 |
caspase 3 |
affects expression |
EXP |
isoquercitrin affects the expression of CASP3 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
decreases expression |
EXP |
isoquercitrin results in decreased expression of CASP8 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with Dietary Fats co-treated with Canrenoic Acid co-treated with isoquercitrin analog] results in increased expression of CAT mRNA; isoquercitrin inhibits the reaction [Streptozocin results in decreased activity of CAT protein] |
CTD |
PMID:30298849 PMID:30817903 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA] |
CTD |
PMID:21295105 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] |
CTD |
PMID:14654164 |
|
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CDKN2B |
cyclin dependent kinase inhibitor 2B |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDKN2B mRNA] |
CTD |
PMID:21295105 |
|
NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
|
|
G |
CTNNB1 |
catenin beta 1 |
affects expression |
EXP |
isoquercitrin affects the expression of CTNNB1 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CXCL2 protein] |
CTD |
PMID:14654164 |
|
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
increases expression |
EXP |
isoquercitrin results in increased expression of CXCL8 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
multiple interactions decreases activity |
ISO EXP |
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A1 mRNA isoquercitrin results in decreased activity of CYP1A1 protein |
CTD |
PMID:16271822 PMID:20033131 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA |
CTD |
PMID:20033131 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
decreases activity |
EXP |
isoquercitrin results in decreased activity of CYP1B1 protein |
CTD |
PMID:16271822 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP51A1 |
cytochrome P450 family 51 subfamily A member 1 |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of CYP51A1 mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803
|
|
G |
DHCR7 |
7-dehydrocholesterol reductase |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of DHCR7 mRNA |
CTD |
PMID:18032389 |
|
NCBI chr11:71,434,411...71,448,393
Ensembl chr11:71,428,193...71,452,868
|
|
G |
EGF |
epidermal growth factor |
multiple interactions |
EXP |
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of PTK2 protein] |
CTD |
PMID:26109002 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions |
EXP |
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
CTD |
PMID:26109002 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EGLN1 |
egl-9 family hypoxia inducible factor 1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of EGLN1 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 1:231,363,756...231,422,287
Ensembl chr 1:231,363,751...231,422,287
|
|
G |
FDFT1 |
farnesyl-diphosphate farnesyltransferase 1 |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of FDFT1 mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 8:11,795,582...11,839,309
Ensembl chr 8:11,795,573...11,839,395
|
|
G |
FDPS |
farnesyl diphosphate synthase |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of FDPS mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,308,748...155,320,666
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
[isoquercitrin analog co-treated with Propylthiouracil] results in decreased expression of FOS mRNA |
CTD |
PMID:31068541 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
GPX2 |
glutathione peroxidase 2 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GPX2 mRNA |
CTD |
PMID:20033131 |
|
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
|
|
G |
GRIA3 |
glutamate ionotropic receptor AMPA type subunit 3 |
multiple interactions |
ISO |
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of GRIA3 mRNA] |
CTD |
PMID:31068541 |
|
NCBI chr X:123,184,278...123,490,915
Ensembl chr X:123,184,153...123,490,915
|
|
G |
GSTA5 |
glutathione S-transferase alpha 5 |
multiple interactions |
ISO |
[isoquercitrin co-treated with oxfendazole co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTA5 mRNA] |
CTD |
PMID:20033131 PMID:20045035 |
|
NCBI chr 6:52,831,692...52,846,245
Ensembl chr 6:52,831,655...52,840,843
|
|
G |
GSTM1 |
glutathione S-transferase mu 1 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GSTM1 mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA] |
CTD |
PMID:20033131 PMID:20045035 |
|
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
|
|
G |
HMGCR |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of HMGCR mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
|
|
G |
HMGCS1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of HMGCS1 mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [beta-Naphthoflavone results in increased expression of HMOX1 protein]; isoquercitrin inhibits the reaction [Streptozocin results in increased expression of HMOX1 mRNA] |
CTD |
PMID:21295105 PMID:30817903 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
IBSP |
integrin binding sialoprotein |
increases expression |
ISO |
isoquercitrin results in increased expression of IBSP mRNA |
CTD |
PMID:30365939 |
|
NCBI chr 4:87,799,554...87,812,435
Ensembl chr 4:87,799,554...87,812,435
|
|
G |
IL1A |
interleukin 1 alpha |
multiple interactions |
ISO |
[isoquercitrin analog co-treated with Propylthiouracil] results in increased expression of IL1A mRNA; [isoquercitrin co-treated with Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IL1A mRNA |
CTD |
PMID:21295105 PMID:31068541 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of IL1B mRNA] |
CTD |
PMID:30817903 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of IL6 mRNA] |
CTD |
PMID:30817903 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of INS1 protein] |
CTD |
PMID:30817903 |
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
INSIG1 |
insulin induced gene 1 |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of INSIG1 mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
|
|
G |
JAK1 |
Janus kinase 1 |
increases expression |
EXP |
isoquercitrin results in increased expression of JAK1 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 1:64,833,229...65,067,746
Ensembl chr 1:64,833,223...65,067,754
|
|
G |
JAK2 |
Janus kinase 2 |
increases expression |
EXP |
isoquercitrin results in increased expression of JAK2 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Streptozocin results in decreased expression of KEAP1 mRNA] |
CTD |
PMID:30817903 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
LCT |
lactase |
multiple interactions |
ISO |
[migalastat results in decreased activity of LCT protein] which results in decreased hydrolysis of isoquercitrin |
CTD |
PMID:12663055 |
|
NCBI chr 2:135,787,850...135,837,184
Ensembl chr 2:135,787,850...135,837,184
|
|
G |
LDLR |
low density lipoprotein receptor |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of LDLR mRNA |
CTD |
PMID:18032389 |
|
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:26109002 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP |
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:26109002 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MCL1 |
MCL1 apoptosis regulator, BCL2 family member |
affects expression |
EXP |
isoquercitrin affects the expression of MCL1 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738
|
|
G |
ME1 |
malic enzyme 1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of ME1 mRNA] |
CTD |
PMID:20033131 |
|
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
isoquercitrin results in decreased expression of and results in decreased activity of MMP2 protein |
CTD |
PMID:18715546 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions |
EXP |
isoquercitrin results in decreased expression of and results in decreased activity of MMP9 protein |
CTD |
PMID:18715546 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of NFE2L2 mRNA] |
CTD |
PMID:30817903 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
[isoquercitrin analog co-treated with Propylthiouracil] results in decreased expression of NFKB1 mRNA |
CTD |
PMID:31068541 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NFKBIA mRNA] |
CTD |
PMID:20045035 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOS2 mRNA] |
CTD |
PMID:21295105 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of NQO1 mRNA; isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of NQO1 mRNA] |
CTD |
PMID:20033131 PMID:31068541 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
NR3C2 |
nuclear receptor subfamily 3 group C member 2 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with Dietary Fats co-treated with Canrenoic Acid co-treated with isoquercitrin analog] results in increased expression of NR3C2 mRNA |
CTD |
PMID:30298849 |
|
NCBI chr 4:148,078,764...148,445,508
Ensembl chr 4:148,078,762...148,444,698
|
|
G |
NSF |
N-ethylmaleimide sensitive factor, vesicle fusing ATPase |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of NSF mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr17:46,590,669...46,757,464
Ensembl chr17:46,590,669...46,757,679
|
|
G |
NSG1 |
neuronal vesicle trafficking associated 1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of NSG1 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 4:4,386,532...4,419,058
Ensembl chr 4:4,348,140...4,419,058
|
|
G |
OPA1 |
OPA1 mitochondrial dynamin like GTPase |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of OPA1 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 3:193,593,208...193,697,811
Ensembl chr 3:193,593,144...193,697,811
|
|
G |
OTX2 |
orthodenticle homeobox 2 |
multiple interactions |
ISO |
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA] |
CTD |
PMID:31068541 |
|
NCBI chr14:56,799,905...56,810,479
Ensembl chr14:56,799,905...56,816,693
|
|
G |
PARK7 |
Parkinsonism associated deglycase |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PARK7 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 1:7,961,711...7,985,505
Ensembl chr 1:7,954,291...7,985,505
|
|
G |
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
affects expression |
EXP |
isoquercitrin affects the expression of PIK3CA mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 3:179,148,126...179,240,093
Ensembl chr 3:179,148,114...179,240,093
|
|
G |
PIK3R1 |
phosphoinositide-3-kinase regulatory subunit 1 |
increases expression |
EXP |
isoquercitrin results in increased expression of PIK3R1 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821
|
|
G |
PPID |
peptidylprolyl isomerase D |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PPID mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 4:158,709,127...158,723,396
Ensembl chr 4:158,709,127...158,723,396
|
|
G |
PRKN |
parkin RBR E3 ubiquitin protein ligase |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PRKN mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 mRNA]; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 protein]; isoquercitrin inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA]; isoquercitrin inhibits the reaction [Streptozocin results in increased expression of PTGS2 mRNA] |
CTD |
PMID:14654164 PMID:20045035 PMID:30817903 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTK2 |
protein tyrosine kinase 2 |
multiple interactions |
EXP |
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of PTK2 protein] |
CTD |
PMID:26109002 |
|
NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216
|
|
G |
RELB |
RELB proto-oncogene, NF-kB subunit |
increases expression |
EXP |
isoquercitrin results in increased expression of RELB mRNA |
CTD |
PMID:30597948 |
|
NCBI chr19:45,001,464...45,038,192
Ensembl chr19:45,001,461...45,038,192
|
|
G |
RUNX2 |
RUNX family transcription factor 2 |
increases expression |
ISO |
isoquercitrin results in increased expression of RUNX2 mRNA |
CTD |
PMID:30365939 |
|
NCBI chr 6:45,328,330...45,551,082
Ensembl chr 6:45,328,157...45,664,349
|
|
G |
SC5D |
sterol-C5-desaturase |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SC5D mRNA |
CTD |
PMID:18032389 |
|
NCBI chr11:121,292,771...121,313,410
Ensembl chr11:121,292,681...121,313,410
|
|
G |
SERPINE1 |
serpin family E member 1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:20045035 |
|
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
SLC5A1 |
solute carrier family 5 member 1 |
multiple interactions |
EXP |
isoquercitrin inhibits the reaction [SLC5A1 protein results in increased uptake of methylglucoside] |
CTD |
PMID:17495124 |
|
NCBI chr22:32,043,261...32,113,029
Ensembl chr22:32,043,261...32,113,029
|
|
G |
SQLE |
squalene epoxidase |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SQLE mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283
|
|
G |
SREBF2 |
sterol regulatory element binding transcription factor 2 |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased cleavage of and results in increased activity of SREBF2 protein; [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SREBF2 mRNA; SREBF2 protein affects the susceptibility to [isoquercitrin co-treated with Hydrogen Peroxide] |
CTD |
PMID:18032389 |
|
NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,105...41,907,306
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
increases expression |
EXP |
isoquercitrin results in increased expression of STAT3 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
STAT6 |
signal transducer and activator of transcription 6 |
increases expression |
EXP |
isoquercitrin results in increased expression of STAT6 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr12:57,095,408...57,111,362
Ensembl chr12:57,095,408...57,132,139
|
|
G |
STUB1 |
STIP1 homology and U-box containing protein 1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of STUB1 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr16:680,410...682,801
Ensembl chr16:680,224...682,870
|
|
G |
TH |
tyrosine hydroxylase |
multiple interactions |
ISO |
isoquercitrin promotes the reaction [Oxidopamine results in decreased expression of TH mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
|
|
G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
EXP |
isoquercitrin results in increased expression of TIMP1 protein |
CTD |
PMID:18715546 |
|
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TNF mRNA]; isoquercitrin inhibits the reaction [Carrageenan results in increased expression of TNF protein]; isoquercitrin inhibits the reaction [Streptozocin results in increased expression of TNF mRNA] |
CTD |
PMID:14654164 PMID:21295105 PMID:30817903 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TNFRSF1A protein] |
CTD |
PMID:21295105 |
|
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of TP53 mRNA] |
CTD |
PMID:30817903 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
TRADD |
TNFRSF1A associated via death domain |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TRADD protein] |
CTD |
PMID:21295105 |
|
NCBI chr16:67,154,185...67,159,909
Ensembl chr16:67,154,185...67,159,909
|
|
G |
TXN |
thioredoxin |
multiple interactions |
ISO |
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of TXN1 mRNA] |
CTD |
PMID:31068541 |
|
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
|
|
G |
TYK2 |
tyrosine kinase 2 |
affects expression |
EXP |
isoquercitrin affects the expression of TYK2 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr19:10,350,533...10,380,572
Ensembl chr19:10,350,533...10,380,608
|
|
G |
UCHL1 |
ubiquitin C-terminal hydrolase L1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of UCHL1 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 4:41,256,928...41,268,455
Ensembl chr 4:41,256,413...41,268,455
|
|
|
G |
ACAT2 |
acetyl-CoA acetyltransferase 2 |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of ACAT2 mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,762,045...159,779,112
|
|
G |
AKR7A3 |
aldo-keto reductase family 7 member A3 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of AKR7A3 mRNA |
CTD |
PMID:20033131 |
|
NCBI chr 1:19,274,229...19,288,770
Ensembl chr 1:19,282,573...19,288,770
|
|
G |
APOA1 |
apolipoprotein A1 |
increases secretion |
EXP |
isoquercitrin results in increased secretion of APOA1 protein |
CTD |
PMID:24963805 |
|
NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
|
|
G |
ATF6 |
activating transcription factor 6 |
increases expression |
ISO |
isoquercitrin results in increased expression of ATF6 mRNA |
CTD |
PMID:30365939 |
|
NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,298...161,977,574
|
|
G |
ATXN2 |
ataxin 2 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of ATXN2 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr12:111,452,214...111,599,673
Ensembl chr12:111,443,485...111,599,676
|
|
G |
ATXN3 |
ataxin 3 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of ATXN3 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr14:92,044,775...92,106,582
Ensembl chr14:92,044,496...92,106,621
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression |
EXP |
isoquercitrin results in decreased expression of BCL2 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
CASP3 |
caspase 3 |
affects expression |
EXP |
isoquercitrin affects the expression of CASP3 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
decreases expression |
EXP |
isoquercitrin results in decreased expression of CASP8 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with Dietary Fats co-treated with Canrenoic Acid co-treated with isoquercitrin analog] results in increased expression of CAT mRNA; isoquercitrin inhibits the reaction [Streptozocin results in decreased activity of CAT protein] |
CTD |
PMID:30298849 PMID:30817903 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA] |
CTD |
PMID:21295105 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] |
CTD |
PMID:14654164 |
|
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CDKN2B |
cyclin dependent kinase inhibitor 2B |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDKN2B mRNA] |
CTD |
PMID:21295105 |
|
NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
|
|
G |
CTNNB1 |
catenin beta 1 |
affects expression |
EXP |
isoquercitrin affects the expression of CTNNB1 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CXCL2 protein] |
CTD |
PMID:14654164 |
|
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
increases expression |
EXP |
isoquercitrin results in increased expression of CXCL8 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
decreases activity multiple interactions |
EXP ISO |
isoquercitrin results in decreased activity of CYP1A1 protein [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A1 mRNA |
CTD |
PMID:16271822 PMID:20033131 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA |
CTD |
PMID:20033131 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
decreases activity |
EXP |
isoquercitrin results in decreased activity of CYP1B1 protein |
CTD |
PMID:16271822 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP51A1 |
cytochrome P450 family 51 subfamily A member 1 |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of CYP51A1 mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803
|
|
G |
DHCR7 |
7-dehydrocholesterol reductase |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of DHCR7 mRNA |
CTD |
PMID:18032389 |
|
NCBI chr11:71,434,411...71,448,393
Ensembl chr11:71,428,193...71,452,868
|
|
G |
EGF |
epidermal growth factor |
multiple interactions |
EXP |
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of PTK2 protein] |
CTD |
PMID:26109002 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions |
EXP |
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
CTD |
PMID:26109002 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EGLN1 |
egl-9 family hypoxia inducible factor 1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of EGLN1 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 1:231,363,756...231,422,287
Ensembl chr 1:231,363,751...231,422,287
|
|
G |
FDFT1 |
farnesyl-diphosphate farnesyltransferase 1 |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of FDFT1 mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 8:11,795,582...11,839,309
Ensembl chr 8:11,795,573...11,839,395
|
|
G |
FDPS |
farnesyl diphosphate synthase |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of FDPS mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,308,748...155,320,666
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
[isoquercitrin analog co-treated with Propylthiouracil] results in decreased expression of FOS mRNA |
CTD |
PMID:31068541 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
GPX2 |
glutathione peroxidase 2 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GPX2 mRNA |
CTD |
PMID:20033131 |
|
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
|
|
G |
GRIA3 |
glutamate ionotropic receptor AMPA type subunit 3 |
multiple interactions |
ISO |
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of GRIA3 mRNA] |
CTD |
PMID:31068541 |
|
NCBI chr X:123,184,278...123,490,915
Ensembl chr X:123,184,153...123,490,915
|
|
G |
GSTA5 |
glutathione S-transferase alpha 5 |
multiple interactions |
ISO |
[isoquercitrin co-treated with oxfendazole co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTA5 mRNA] |
CTD |
PMID:20033131 PMID:20045035 |
|
NCBI chr 6:52,831,692...52,846,245
Ensembl chr 6:52,831,655...52,840,843
|
|
G |
GSTM1 |
glutathione S-transferase mu 1 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GSTM1 mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA] |
CTD |
PMID:20033131 PMID:20045035 |
|
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
|
|
G |
HMGCR |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of HMGCR mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
|
|
G |
HMGCS1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of HMGCS1 mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [beta-Naphthoflavone results in increased expression of HMOX1 protein]; isoquercitrin inhibits the reaction [Streptozocin results in increased expression of HMOX1 mRNA] |
CTD |
PMID:21295105 PMID:30817903 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
IBSP |
integrin binding sialoprotein |
increases expression |
ISO |
isoquercitrin results in increased expression of IBSP mRNA |
CTD |
PMID:30365939 |
|
NCBI chr 4:87,799,554...87,812,435
Ensembl chr 4:87,799,554...87,812,435
|
|
G |
IL1A |
interleukin 1 alpha |
multiple interactions |
ISO |
[isoquercitrin analog co-treated with Propylthiouracil] results in increased expression of IL1A mRNA; [isoquercitrin co-treated with Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IL1A mRNA |
CTD |
PMID:21295105 PMID:31068541 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of IL1B mRNA] |
CTD |
PMID:30817903 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of IL6 mRNA] |
CTD |
PMID:30817903 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of INS1 protein] |
CTD |
PMID:30817903 |
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
INSIG1 |
insulin induced gene 1 |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of INSIG1 mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
|
|
G |
JAK1 |
Janus kinase 1 |
increases expression |
EXP |
isoquercitrin results in increased expression of JAK1 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 1:64,833,229...65,067,746
Ensembl chr 1:64,833,223...65,067,754
|
|
G |
JAK2 |
Janus kinase 2 |
increases expression |
EXP |
isoquercitrin results in increased expression of JAK2 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Streptozocin results in decreased expression of KEAP1 mRNA] |
CTD |
PMID:30817903 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
LCT |
lactase |
multiple interactions |
ISO |
[migalastat results in decreased activity of LCT protein] which results in decreased hydrolysis of isoquercitrin |
CTD |
PMID:12663055 |
|
NCBI chr 2:135,787,850...135,837,184
Ensembl chr 2:135,787,850...135,837,184
|
|
G |
LDLR |
low density lipoprotein receptor |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of LDLR mRNA |
CTD |
PMID:18032389 |
|
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:26109002 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP |
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:26109002 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MCL1 |
MCL1 apoptosis regulator, BCL2 family member |
affects expression |
EXP |
isoquercitrin affects the expression of MCL1 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738
|
|
G |
ME1 |
malic enzyme 1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of ME1 mRNA] |
CTD |
PMID:20033131 |
|
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
isoquercitrin results in decreased expression of and results in decreased activity of MMP2 protein |
CTD |
PMID:18715546 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions |
EXP |
isoquercitrin results in decreased expression of and results in decreased activity of MMP9 protein |
CTD |
PMID:18715546 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of NFE2L2 mRNA] |
CTD |
PMID:30817903 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
[isoquercitrin analog co-treated with Propylthiouracil] results in decreased expression of NFKB1 mRNA |
CTD |
PMID:31068541 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NFKBIA mRNA] |
CTD |
PMID:20045035 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOS2 mRNA] |
CTD |
PMID:21295105 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of NQO1 mRNA; isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of NQO1 mRNA] |
CTD |
PMID:20033131 PMID:31068541 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
NR3C2 |
nuclear receptor subfamily 3 group C member 2 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with Dietary Fats co-treated with Canrenoic Acid co-treated with isoquercitrin analog] results in increased expression of NR3C2 mRNA |
CTD |
PMID:30298849 |
|
NCBI chr 4:148,078,764...148,445,508
Ensembl chr 4:148,078,762...148,444,698
|
|
G |
NSF |
N-ethylmaleimide sensitive factor, vesicle fusing ATPase |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of NSF mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr17:46,590,669...46,757,464
Ensembl chr17:46,590,669...46,757,679
|
|
G |
NSG1 |
neuronal vesicle trafficking associated 1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of NSG1 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 4:4,386,532...4,419,058
Ensembl chr 4:4,348,140...4,419,058
|
|
G |
OPA1 |
OPA1 mitochondrial dynamin like GTPase |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of OPA1 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 3:193,593,208...193,697,811
Ensembl chr 3:193,593,144...193,697,811
|
|
G |
OTX2 |
orthodenticle homeobox 2 |
multiple interactions |
ISO |
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA] |
CTD |
PMID:31068541 |
|
NCBI chr14:56,799,905...56,810,479
Ensembl chr14:56,799,905...56,816,693
|
|
G |
PARK7 |
Parkinsonism associated deglycase |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PARK7 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 1:7,961,711...7,985,505
Ensembl chr 1:7,954,291...7,985,505
|
|
G |
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
affects expression |
EXP |
isoquercitrin affects the expression of PIK3CA mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 3:179,148,126...179,240,093
Ensembl chr 3:179,148,114...179,240,093
|
|
G |
PIK3R1 |
phosphoinositide-3-kinase regulatory subunit 1 |
increases expression |
EXP |
isoquercitrin results in increased expression of PIK3R1 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821
|
|
G |
PPID |
peptidylprolyl isomerase D |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PPID mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 4:158,709,127...158,723,396
Ensembl chr 4:158,709,127...158,723,396
|
|
G |
PRKN |
parkin RBR E3 ubiquitin protein ligase |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PRKN mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 mRNA]; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 protein]; isoquercitrin inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA]; isoquercitrin inhibits the reaction [Streptozocin results in increased expression of PTGS2 mRNA] |
CTD |
PMID:14654164 PMID:20045035 PMID:30817903 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTK2 |
protein tyrosine kinase 2 |
multiple interactions |
EXP |
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of PTK2 protein] |
CTD |
PMID:26109002 |
|
NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216
|
|
G |
RELB |
RELB proto-oncogene, NF-kB subunit |
increases expression |
EXP |
isoquercitrin results in increased expression of RELB mRNA |
CTD |
PMID:30597948 |
|
NCBI chr19:45,001,464...45,038,192
Ensembl chr19:45,001,461...45,038,192
|
|
G |
RUNX2 |
RUNX family transcription factor 2 |
increases expression |
ISO |
isoquercitrin results in increased expression of RUNX2 mRNA |
CTD |
PMID:30365939 |
|
NCBI chr 6:45,328,330...45,551,082
Ensembl chr 6:45,328,157...45,664,349
|
|
G |
SC5D |
sterol-C5-desaturase |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SC5D mRNA |
CTD |
PMID:18032389 |
|
NCBI chr11:121,292,771...121,313,410
Ensembl chr11:121,292,681...121,313,410
|
|
G |
SERPINE1 |
serpin family E member 1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:20045035 |
|
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
SLC5A1 |
solute carrier family 5 member 1 |
multiple interactions |
EXP |
isoquercitrin inhibits the reaction [SLC5A1 protein results in increased uptake of methylglucoside] |
CTD |
PMID:17495124 |
|
NCBI chr22:32,043,261...32,113,029
Ensembl chr22:32,043,261...32,113,029
|
|
G |
SQLE |
squalene epoxidase |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SQLE mRNA |
CTD |
PMID:18032389 |
|
NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283
|
|
G |
SREBF2 |
sterol regulatory element binding transcription factor 2 |
multiple interactions |
EXP |
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased cleavage of and results in increased activity of SREBF2 protein; [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SREBF2 mRNA; SREBF2 protein affects the susceptibility to [isoquercitrin co-treated with Hydrogen Peroxide] |
CTD |
PMID:18032389 |
|
NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,105...41,907,306
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
increases expression |
EXP |
isoquercitrin results in increased expression of STAT3 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
STAT6 |
signal transducer and activator of transcription 6 |
increases expression |
EXP |
isoquercitrin results in increased expression of STAT6 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr12:57,095,408...57,111,362
Ensembl chr12:57,095,408...57,132,139
|
|
G |
STUB1 |
STIP1 homology and U-box containing protein 1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of STUB1 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr16:680,410...682,801
Ensembl chr16:680,224...682,870
|
|
G |
TH |
tyrosine hydroxylase |
multiple interactions |
ISO |
isoquercitrin promotes the reaction [Oxidopamine results in decreased expression of TH mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
|
|
G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
EXP |
isoquercitrin results in increased expression of TIMP1 protein |
CTD |
PMID:18715546 |
|
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TNF mRNA]; isoquercitrin inhibits the reaction [Carrageenan results in increased expression of TNF protein]; isoquercitrin inhibits the reaction [Streptozocin results in increased expression of TNF mRNA] |
CTD |
PMID:14654164 PMID:21295105 PMID:30817903 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TNFRSF1A protein] |
CTD |
PMID:21295105 |
|
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of TP53 mRNA] |
CTD |
PMID:30817903 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
TRADD |
TNFRSF1A associated via death domain |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TRADD protein] |
CTD |
PMID:21295105 |
|
NCBI chr16:67,154,185...67,159,909
Ensembl chr16:67,154,185...67,159,909
|
|
G |
TXN |
thioredoxin |
multiple interactions |
ISO |
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of TXN1 mRNA] |
CTD |
PMID:31068541 |
|
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
|
|
G |
TYK2 |
tyrosine kinase 2 |
affects expression |
EXP |
isoquercitrin affects the expression of TYK2 mRNA |
CTD |
PMID:30597948 |
|
NCBI chr19:10,350,533...10,380,572
Ensembl chr19:10,350,533...10,380,608
|
|
G |
UCHL1 |
ubiquitin C-terminal hydrolase L1 |
multiple interactions |
ISO |
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of UCHL1 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 4:41,256,928...41,268,455
Ensembl chr 4:41,256,413...41,268,455
|
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; spiraeoside inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:32602595 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
AP5M1 |
adaptor related protein complex 5 subunit mu 1 |
decreases expression |
EXP |
spiraeoside results in decreased expression of AP5M1 protein |
CTD |
PMID:34116102 |
|
NCBI chr14:57,268,971...57,298,742
Ensembl chr14:57,268,924...57,298,742
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in increased expression of BAX protein]]; spiraeoside inhibits the reaction [Glucose results in increased expression of BAX protein] |
CTD |
PMID:32602595 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions decreases expression |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein] spiraeoside results in decreased expression of BCL2 protein |
CTD |
PMID:32602595 PMID:34116102 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BID |
BH3 interacting domain death agonist |
decreases expression |
EXP |
spiraeoside results in decreased expression of BID protein |
CTD |
PMID:34116102 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
CASP3 |
caspase 3 |
decreases expression |
EXP |
spiraeoside results in decreased expression of CASP3 protein |
CTD |
PMID:34116102 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP9 |
caspase 9 |
decreases expression |
EXP |
spiraeoside results in decreased expression of CASP9 protein |
CTD |
PMID:34116102 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in increased activity of CAT protein]]; spiraeoside inhibits the reaction [Glucose results in increased activity of CAT protein] |
CTD |
PMID:32602595 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CDK2 |
cyclin dependent kinase 2 |
decreases expression |
EXP |
spiraeoside results in decreased expression of CDK2 protein |
CTD |
PMID:34116102 |
|
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
|
|
G |
CRYZ |
crystallin zeta |
increases activity |
ISO |
spiraeoside results in increased activity of CRYZ protein |
CTD |
PMID:8968052 |
|
NCBI chr 1:74,705,486...74,733,050
Ensembl chr 1:74,705,482...74,733,408
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]]; spiraeoside inhibits the reaction [Glucose results in decreased expression of HMOX1 protein] |
CTD |
PMID:32602595 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
LCT |
lactase |
multiple interactions |
ISO |
[migalastat results in decreased activity of LCT protein] which results in decreased hydrolysis of spiraeoside |
CTD |
PMID:12663055 |
|
NCBI chr 2:135,787,850...135,837,184
Ensembl chr 2:135,787,850...135,837,184
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]]; spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein] |
CTD |
PMID:32602595 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
PLCG2 |
phospholipase C gamma 2 |
decreases phosphorylation |
EXP |
spiraeoside results in decreased phosphorylation of PLCG2 protein |
CTD |
PMID:15613018 |
|
NCBI chr16:81,779,291...81,962,685
Ensembl chr16:81,779,279...81,962,685
|
|
G |
SLC5A1 |
solute carrier family 5 member 1 |
multiple interactions |
ISO EXP |
[Phlorhizin results in decreased activity of SLC5A1 protein] which results in decreased uptake of spiraeoside spiraeoside inhibits the reaction [SLC5A1 protein results in increased uptake of methylglucoside] |
CTD |
PMID:12663055 PMID:17495124 |
|
NCBI chr22:32,043,261...32,113,029
Ensembl chr22:32,043,261...32,113,029
|
|
G |
SYK |
spleen associated tyrosine kinase |
decreases phosphorylation |
EXP |
spiraeoside results in decreased phosphorylation of SYK protein |
CTD |
PMID:15613018 |
|
NCBI chr 9:90,801,600...90,898,549
Ensembl chr 9:90,801,787...90,898,549
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions |
EXP |
quercitrin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]] |
CTD |
PMID:34217736 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCC4 |
ATP binding cassette subfamily C member 4 (PEL blood group) |
decreases expression |
EXP |
quercitrin results in decreased expression of ABCC4 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
|
|
G |
ABCF2 |
ATP binding cassette subfamily F member 2 |
increases expression |
EXP |
quercitrin results in increased expression of ABCF2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 7:151,211,484...151,227,205
Ensembl chr 7:151,211,484...151,227,205
|
|
G |
ACBD6 |
acyl-CoA binding domain containing 6 |
decreases expression |
EXP |
quercitrin results in decreased expression of ACBD6 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:180,269,653...180,502,577
Ensembl chr 1:180,269,653...180,502,954
|
|
G |
ACBD7 |
acyl-CoA binding domain containing 7 |
increases expression |
EXP |
quercitrin results in increased expression of ACBD7 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr10:15,075,475...15,088,776
Ensembl chr10:15,075,475...15,088,776
|
|
G |
ACTN1 |
actinin alpha 1 |
affects expression |
EXP |
quercitrin affects the expression of ACTN1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr14:68,874,128...68,979,302
Ensembl chr14:68,874,128...68,979,440
|
|
G |
ACTN4 |
actinin alpha 4 |
affects expression |
EXP |
quercitrin affects the expression of ACTN4 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:38,647,649...38,731,589
Ensembl chr19:38,647,649...38,731,589
|
|
G |
ADGRB1 |
adhesion G protein-coupled receptor B1 |
decreases expression |
EXP |
quercitrin results in decreased expression of ADGRB1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 8:142,449,649...142,545,007
Ensembl chr 8:142,449,430...142,545,009
|
|
G |
ADGRF1 |
adhesion G protein-coupled receptor F1 |
decreases expression |
EXP |
quercitrin results in decreased expression of ADGRF1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:46,997,708...47,042,332
Ensembl chr 6:46,997,708...47,042,350
|
|
G |
ADGRG1 |
adhesion G protein-coupled receptor G1 |
decreases expression |
EXP |
quercitrin results in decreased expression of ADGRG1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr16:57,619,738...57,665,567
Ensembl chr16:57,610,652...57,665,580
|
|
G |
ADGRG6 |
adhesion G protein-coupled receptor G6 |
decreases expression |
EXP |
quercitrin results in decreased expression of ADGRG6 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:142,302,007...142,446,261
Ensembl chr 6:142,301,854...142,446,266
|
|
G |
ADGRG7 |
adhesion G protein-coupled receptor G7 |
increases expression |
EXP |
quercitrin results in increased expression of ADGRG7 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 3:100,609,601...100,695,479
Ensembl chr 3:100,609,601...100,695,479
|
|
G |
ADGRV1 |
adhesion G protein-coupled receptor V1 |
increases expression |
EXP |
quercitrin results in increased expression of ADGRV1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 5:90,558,797...91,164,437
Ensembl chr 5:90,529,344...91,164,437
|
|
G |
ADK |
adenosine kinase |
decreases expression |
EXP |
quercitrin results in decreased expression of ADK mRNA |
CTD |
PMID:25193878 |
|
NCBI chr10:74,151,221...74,709,290
Ensembl chr10:74,151,202...74,709,963
|
|
G |
ADRA2C |
adrenoceptor alpha 2C |
increases expression |
EXP |
quercitrin results in increased expression of ADRA2C mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 4:3,766,385...3,768,526
Ensembl chr 4:3,766,348...3,768,526
|
|
G |
AHNAK2 |
AHNAK nucleoprotein 2 |
increases expression |
EXP |
quercitrin results in increased expression of AHNAK2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr14:104,937,253...104,978,374
Ensembl chr14:104,937,244...104,978,374
|
|
G |
ALKBH7 |
alkB homolog 7 |
increases expression |
EXP |
quercitrin results in increased expression of ALKBH7 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:6,372,794...6,375,250
Ensembl chr19:6,372,794...6,375,250
|
|
G |
ANAPC15 |
anaphase promoting complex subunit 15 |
decreases expression |
EXP |
quercitrin results in decreased expression of ANAPC15 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:72,106,372...72,112,780
Ensembl chr11:72,106,378...72,112,780
|
|
G |
AR |
androgen receptor |
increases expression |
EXP |
quercitrin results in increased expression of AR mRNA |
CTD |
PMID:25193878 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
ARAP2 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
increases expression |
EXP |
quercitrin results in increased expression of ARAP2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 4:36,005,404...36,244,784
Ensembl chr 4:35,948,221...36,244,514
|
|
G |
ASB6 |
ankyrin repeat and SOCS box containing 6 |
increases expression |
EXP |
quercitrin results in increased expression of ASB6 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 9:129,634,605...129,642,151
Ensembl chr 9:129,634,604...129,642,169
|
|
G |
ATG7 |
autophagy related 7 |
decreases expression |
EXP |
quercitrin results in decreased expression of ATG7 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 3:11,272,397...11,576,353
Ensembl chr 3:11,272,309...11,557,665
|
|
G |
BAIAP2 |
BAR/IMD domain containing adaptor protein 2 |
affects expression |
EXP |
quercitrin affects the expression of BAIAP2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr17:81,035,151...81,117,434
Ensembl chr17:81,035,122...81,117,434
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of BAX protein] |
CTD |
PMID:23138875 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BDKRB1 |
bradykinin receptor B1 |
decreases expression |
EXP |
quercitrin results in decreased expression of BDKRB1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr14:96,256,210...96,264,763
Ensembl chr14:96,256,210...96,268,967
|
|
G |
C2orf49 |
chromosome 2 open reading frame 49 |
decreases expression |
EXP |
quercitrin results in decreased expression of C2ORF49 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:105,337,540...105,385,899
Ensembl chr 2:105,337,532...105,349,211
|
|
G |
CAMK2B |
calcium/calmodulin dependent protein kinase II beta |
decreases expression |
EXP |
quercitrin results in decreased expression of CAMK2B mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 7:44,217,154...44,326,013
Ensembl chr 7:44,210,019...44,334,577
|
|
G |
CASP3 |
caspase 3 |
increases activity multiple interactions |
EXP ISO |
quercitrin results in increased activity of CASP3 protein quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of CASP3 protein] |
CTD |
PMID:23138875 PMID:25193878 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
increases expression |
EXP |
quercitrin results in increased expression of CASP8 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CCR9 |
C-C motif chemokine receptor 9 |
decreases expression |
EXP |
quercitrin results in decreased expression of CCR9 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 3:45,886,064...45,903,174
Ensembl chr 3:45,884,425...45,903,174
|
|
G |
CCRL2 |
C-C motif chemokine receptor like 2 |
increases expression |
EXP |
quercitrin results in increased expression of CCRL2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 3:46,407,259...46,409,523
Ensembl chr 3:46,407,166...46,412,997
|
|
G |
CD302 |
CD302 molecule |
decreases expression |
EXP |
quercitrin results in decreased expression of CD302 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:159,768,628...159,798,208
Ensembl chr 2:159,768,628...159,798,255
|
|
G |
CD38 |
CD38 molecule |
decreases expression |
EXP |
quercitrin results in decreased expression of CD38 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 4:15,778,328...15,853,232
Ensembl chr 4:15,778,275...15,853,232
|
|
G |
CD74 |
CD74 molecule |
affects expression |
EXP |
quercitrin affects the expression of CD74 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 5:150,401,639...150,412,910
Ensembl chr 5:150,401,637...150,412,969
|
|
G |
CDH1 |
cadherin 1 |
decreases expression |
EXP |
quercitrin results in decreased expression of CDH1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
|
|
G |
CDKN3 |
cyclin dependent kinase inhibitor 3 |
decreases expression |
EXP |
quercitrin results in decreased expression of CDKN3 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr14:54,397,007...54,420,218
Ensembl chr14:54,396,849...54,420,218
|
|
G |
CELSR3 |
cadherin EGF LAG seven-pass G-type receptor 3 |
increases expression |
EXP |
quercitrin results in increased expression of CELSR3 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 3:48,636,463...48,662,886
Ensembl chr 3:48,636,463...48,662,886
|
|
G |
CEP95 |
centrosomal protein 95 |
increases expression |
EXP |
quercitrin results in increased expression of CEP95 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr17:64,506,762...64,537,946
Ensembl chr17:64,506,865...64,542,461
|
|
G |
CERS5 |
ceramide synthase 5 |
increases expression |
EXP |
quercitrin results in increased expression of CERS5 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr12:50,129,289...50,167,369
Ensembl chr12:50,129,289...50,167,533
|
|
G |
CFAP298 |
cilia and flagella associated protein 298 |
decreases expression |
EXP |
quercitrin results in decreased expression of CFAP298 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr21:32,599,354...32,612,377
Ensembl chr21:32,592,079...32,612,603
|
|
G |
CHD2 |
chromodomain helicase DNA binding protein 2 |
decreases expression |
EXP |
quercitrin results in decreased expression of CHD2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr15:92,900,324...93,027,996
Ensembl chr15:92,886,203...93,027,996
|
|
G |
CLDN10 |
claudin 10 |
affects expression |
EXP |
quercitrin affects the expression of CLDN10 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr13:95,433,755...95,579,759
Ensembl chr13:95,433,604...95,579,759
|
|
G |
CLDN23 |
claudin 23 |
affects expression |
EXP |
quercitrin affects the expression of CLDN23 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 8:8,701,937...8,704,096
Ensembl chr 8:8,701,937...8,704,096
|
|
G |
CLDN4 |
claudin 4 |
affects expression |
EXP |
quercitrin affects the expression of CLDN4 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 7:73,830,996...73,832,690
Ensembl chr 7:73,799,542...73,832,690
|
|
G |
CLDN8 |
claudin 8 |
affects expression |
EXP |
quercitrin affects the expression of CLDN8 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr21:30,214,006...30,216,097
Ensembl chr21:30,214,006...30,216,097
|
|
G |
COL3A1 |
collagen type III alpha 1 chain |
decreases expression |
EXP |
quercitrin results in decreased expression of COL3A1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
|
|
G |
COQ3 |
coenzyme Q3, methyltransferase |
decreases expression |
EXP |
quercitrin results in decreased expression of COQ3 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:99,369,401...99,394,195
Ensembl chr 6:99,369,401...99,394,195
|
|
G |
CRISP1 |
cysteine rich secretory protein 1 |
decreases expression |
EXP |
quercitrin results in decreased expression of CRISP1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:49,834,257...49,877,096
Ensembl chr 6:49,834,257...49,877,096
|
|
G |
CRYZL1 |
crystallin zeta like 1 |
decreases expression |
EXP |
quercitrin results in decreased expression of CRYZL1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr21:33,589,341...33,641,741
Ensembl chr21:33,589,341...33,643,926
|
|
G |
CSNK2A1 |
casein kinase 2 alpha 1 |
affects expression |
EXP |
quercitrin affects the expression of CSNK2A1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr20:472,498...543,790
Ensembl chr20:472,498...543,835
|
|
G |
CSNK2A2 |
casein kinase 2 alpha 2 |
affects expression |
EXP |
quercitrin affects the expression of CSNK2A2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr16:58,157,907...58,198,106
Ensembl chr16:58,157,907...58,198,106
|
|
G |
CTDSPL2 |
CTD small phosphatase like 2 |
decreases expression |
EXP |
quercitrin results in decreased expression of CTDSPL2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr15:44,427,629...44,529,038
Ensembl chr15:44,427,622...44,529,038
|
|
G |
CTSB |
cathepsin B |
affects expression |
EXP |
quercitrin affects the expression of CTSB mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
decreases activity |
EXP |
quercitrin results in decreased activity of CYP1A1 protein |
CTD |
PMID:16271822 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
decreases activity |
EXP |
quercitrin results in decreased activity of CYP1B1 protein |
CTD |
PMID:16271822 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP26B1 |
cytochrome P450 family 26 subfamily B member 1 |
increases expression |
EXP |
quercitrin results in increased expression of CYP26B1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:72,129,238...72,147,862
Ensembl chr 2:72,129,238...72,147,862
|
|
G |
DCUN1D5 |
defective in cullin neddylation 1 domain containing 5 |
decreases expression |
EXP |
quercitrin results in decreased expression of DCUN1D5 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:103,050,686...103,092,160
Ensembl chr11:103,050,686...103,092,194
|
|
G |
DDX19B |
DEAD-box helicase 19B |
decreases expression |
EXP |
quercitrin results in decreased expression of DDX19B mRNA |
CTD |
PMID:25193878 |
|
NCBI chr16:70,289,767...70,335,305
Ensembl chr16:70,289,663...70,335,305
|
|
G |
DELE1 |
DAP3 binding cell death enhancer 1 |
decreases expression |
EXP |
quercitrin results in decreased expression of DELE1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 5:141,923,871...141,942,047
Ensembl chr 5:141,923,855...141,942,047
|
|
G |
DGKQ |
diacylglycerol kinase theta |
affects expression |
EXP |
quercitrin affects the expression of DGKQ mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 4:958,887...973,569
Ensembl chr 4:958,887...986,895
|
|
G |
DHRS11 |
dehydrogenase/reductase 11 |
decreases activity |
EXP |
quercitrin results in decreased activity of DHRS11 protein |
CTD |
PMID:30926317 |
|
NCBI chr17:36,591,879...36,600,804
Ensembl chr17:36,591,879...36,600,804
|
|
G |
DTWD1 |
DTW domain containing 1 |
decreases expression |
EXP |
quercitrin results in decreased expression of DTWD1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr15:49,621,048...49,656,232
Ensembl chr15:49,621,037...49,656,232
|
|
G |
EEIG1 |
estrogen-induced osteoclastogenesis regulator 1 |
increases expression |
EXP |
quercitrin results in increased expression of EEIG1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 9:127,940,582...127,980,989
Ensembl chr 9:127,940,582...127,980,989
|
|
G |
EGR2 |
early growth response 2 |
increases expression |
EXP |
quercitrin results in increased expression of EGR2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr10:62,811,996...62,819,167
Ensembl chr10:62,811,996...62,819,167
|
|
G |
EPAS1 |
endothelial PAS domain protein 1 |
increases expression |
EXP |
quercitrin results in increased expression of EPAS1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:46,297,407...46,386,697
Ensembl chr 2:46,293,667...46,386,697
|
|
G |
ERCC1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
decreases expression |
EXP |
quercitrin results in decreased expression of ERCC1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:45,407,334...45,451,547
Ensembl chr19:45,407,334...45,478,828
|
|
G |
ERCC2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
decreases expression |
EXP |
quercitrin results in decreased expression of ERCC2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:45,349,837...45,370,573
Ensembl chr19:45,349,837...45,370,918
|
|
G |
ERI2 |
ERI1 exoribonuclease family member 2 |
increases expression |
EXP |
quercitrin results in increased expression of ERI2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr16:20,780,193...20,806,472
Ensembl chr16:20,780,193...20,900,349
|
|
G |
EVA1A |
eva-1 homolog A, regulator of programmed cell death |
decreases expression |
EXP |
quercitrin results in decreased expression of EVA1A mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:75,492,318...75,569,719
Ensembl chr 2:75,469,302...75,569,722
|
|
G |
F11R |
F11 receptor |
affects expression |
EXP |
quercitrin affects the expression of F11R mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:160,995,211...161,021,152
Ensembl chr 1:160,995,211...161,021,175
|
|
G |
F2RL1 |
F2R like trypsin receptor 1 |
increases expression |
EXP |
quercitrin results in increased expression of F2RL1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 5:76,819,030...76,835,315
Ensembl chr 5:76,818,933...76,835,315
|
|
G |
F2RL2 |
coagulation factor II thrombin receptor like 2 |
decreases expression |
EXP |
quercitrin results in decreased expression of F2RL2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 5:76,615,482...76,623,403
Ensembl chr 5:76,615,482...76,623,413
|
|
G |
F3 |
coagulation factor III, tissue factor |
increases expression |
EXP |
quercitrin results in increased expression of F3 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
|
|
G |
FAHD2A |
fumarylacetoacetate hydrolase domain containing 2A |
decreases expression |
EXP |
quercitrin results in decreased expression of FAHD2A mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:95,402,708...95,421,656
Ensembl chr 2:95,402,708...95,416,616
|
|
G |
FAIM |
Fas apoptotic inhibitory molecule |
increases expression |
EXP |
quercitrin results in increased expression of FAIM mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 3:138,608,771...138,633,376
Ensembl chr 3:138,608,606...138,633,376
|
|
G |
FAM216A |
family with sequence similarity 216 member A |
decreases expression |
EXP |
quercitrin results in decreased expression of FAM216A mRNA |
CTD |
PMID:25193878 |
|
NCBI chr12:110,468,427...110,490,385
Ensembl chr12:110,468,415...110,490,385
|
|
G |
FAM3C |
FAM3 metabolism regulating signaling molecule C |
increases expression |
EXP |
quercitrin results in increased expression of FAM3C mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 7:121,348,878...121,396,396
Ensembl chr 7:121,348,878...121,396,364
|
|
G |
FAM43A |
family with sequence similarity 43 member A |
increases expression |
EXP |
quercitrin results in increased expression of FAM43A mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 3:194,685,883...194,689,037
Ensembl chr 3:194,685,883...194,689,037
|
|
G |
FAM50A |
family with sequence similarity 50 member A |
increases expression |
EXP |
quercitrin results in increased expression of FAM50A mRNA |
CTD |
PMID:25193878 |
|
NCBI chr X:154,444,141...154,450,654
Ensembl chr X:154,444,141...154,450,654
|
|
G |
FAS |
Fas cell surface death receptor |
increases expression |
EXP |
quercitrin results in increased expression of FAS mRNA |
CTD |
PMID:25193878 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FDCSP |
follicular dendritic cell secreted protein |
decreases expression |
EXP |
quercitrin results in decreased expression of FDCSP mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 4:70,226,124...70,235,252
Ensembl chr 4:70,226,124...70,235,252
|
|
G |
FLG |
filaggrin |
increases expression |
EXP |
quercitrin results in increased expression of FLG mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:152,302,165...152,325,239
Ensembl chr 1:152,302,165...152,325,239
|
|
G |
FZD4 |
frizzled class receptor 4 |
increases expression |
EXP |
quercitrin results in increased expression of FZD4 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:86,945,679...86,955,395
Ensembl chr11:86,945,679...86,955,395
|
|
G |
GABBR2 |
gamma-aminobutyric acid type B receptor subunit 2 |
increases expression |
EXP |
quercitrin results in increased expression of GABBR2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 9:98,288,109...98,708,935
Ensembl chr 9:98,288,109...98,708,935
|
|
G |
GADD45A |
growth arrest and DNA damage inducible alpha |
affects expression |
EXP |
quercitrin affects the expression of GADD45 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
|
|
G |
GALK2 |
galactokinase 2 |
increases expression |
EXP |
quercitrin results in increased expression of GALK2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr15:49,155,774...49,367,740
Ensembl chr15:49,155,656...49,367,869
|
|
G |
GALR3 |
galanin receptor 3 |
increases expression |
EXP |
quercitrin results in increased expression of GALR3 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr22:37,823,382...37,825,485
Ensembl chr22:37,823,382...37,825,485
|
|
G |
GIMAP6 |
GTPase, IMAP family member 6 |
increases expression |
EXP |
quercitrin results in increased expression of GIMAP6 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 7:150,625,375...150,632,385
Ensembl chr 7:150,625,375...150,632,648
|
|
G |
GLIPR1 |
GLI pathogenesis related 1 |
decreases expression |
EXP |
quercitrin results in decreased expression of GLIPR1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr12:75,480,755...75,503,863
Ensembl chr12:75,480,753...75,503,863
|
|
G |
GOLIM4 |
golgi integral membrane protein 4 |
increases expression |
EXP |
quercitrin results in increased expression of GOLIM4 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 3:168,008,689...168,095,924
Ensembl chr 3:168,008,689...168,095,924
|
|
G |
GPR137B |
G protein-coupled receptor 137B |
increases expression |
EXP |
quercitrin results in increased expression of GPR137B mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:236,142,539...236,208,907
Ensembl chr 1:236,142,505...236,221,865
|
|
G |
GPR173 |
G protein-coupled receptor 173 |
increases expression |
EXP |
quercitrin results in increased expression of GPR173 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr X:53,048,789...53,080,615
Ensembl chr X:53,048,789...53,080,615
|
|
G |
GPR174 |
G protein-coupled receptor 174 |
increases expression |
EXP |
quercitrin results in increased expression of GPR174 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr X:79,144,688...79,175,318
Ensembl chr X:79,144,688...79,175,318
|
|
G |
GPR19 |
G protein-coupled receptor 19 |
increases expression |
EXP |
quercitrin results in increased expression of GPR19 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr12:12,660,890...12,717,246
Ensembl chr12:12,660,890...12,696,207
|
|
G |
GPR4 |
G protein-coupled receptor 4 |
increases expression |
EXP |
quercitrin results in increased expression of GPR4 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:45,589,764...45,602,212
Ensembl chr19:45,589,764...45,602,212
|
|
G |
GPR63 |
G protein-coupled receptor 63 |
increases expression |
EXP |
quercitrin results in increased expression of GPR63 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:96,794,125...96,837,477
Ensembl chr 6:96,794,125...96,837,477
|
|
G |
GPR83 |
G protein-coupled receptor 83 |
increases expression |
EXP |
quercitrin results in increased expression of GPR83 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:94,377,316...94,401,419
Ensembl chr11:94,377,316...94,401,419
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
decreases expression |
EXP |
quercitrin results in decreased expression of GSTP1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
|
|
G |
HAVCR2 |
hepatitis A virus cellular receptor 2 |
increases expression |
EXP |
quercitrin results in increased expression of HAVCR2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 5:157,085,832...157,109,044
Ensembl chr 5:157,085,422...157,142,869
|
|
G |
HGF |
hepatocyte growth factor |
increases expression |
EXP |
quercitrin results in increased expression of HGF mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
|
|
G |
HLA-A |
major histocompatibility complex, class I, A |
affects expression |
EXP |
quercitrin affects the expression of HLA-A mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:29,942,532...29,945,870
Ensembl chr 6:29,941,260...29,949,572
|
|
G |
HLA-DQA1 |
major histocompatibility complex, class II, DQ alpha 1 |
affects expression |
EXP |
quercitrin affects the expression of HLA-DQA1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
|
|
G |
HLA-DRB4 |
major histocompatibility complex, class II, DR beta 4 |
affects expression |
EXP |
quercitrin affects the expression of HLA-DRB4 mRNA |
CTD |
PMID:25193878 |
|
|
|
G |
HLA-E |
major histocompatibility complex, class I, E |
affects expression |
EXP |
quercitrin affects the expression of HLA-E mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:30,489,509...30,494,194
Ensembl chr 6:30,489,509...30,494,194
|
|
G |
HMGA2 |
high mobility group AT-hook 2 |
increases expression |
EXP |
quercitrin results in increased expression of HMGA2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr12:65,824,460...65,966,291
Ensembl chr12:65,824,460...65,966,291
|
|
G |
HMGB2 |
high mobility group box 2 |
decreases expression |
EXP |
quercitrin results in decreased expression of HMGB2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 4:173,331,376...173,334,358
Ensembl chr 4:173,331,376...173,334,432
|
|
G |
HNF4A |
hepatocyte nuclear factor 4 alpha |
decreases expression |
EXP |
quercitrin results in decreased expression of HNF4A mRNA |
CTD |
PMID:25193878 |
|
NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,699...44,432,845
|
|
G |
HSP90AA1 |
heat shock protein 90 alpha family class A member 1 |
affects expression |
EXP |
quercitrin affects the expression of HSP90AA1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
|
|
G |
HSPA1L |
heat shock protein family A (Hsp70) member 1 like |
affects expression |
EXP |
quercitrin affects the expression of HSPA1L mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:31,809,619...31,815,283
Ensembl chr 6:31,809,619...31,815,283
|
|
G |
HSPA6 |
heat shock protein family A (Hsp70) member 6 |
affects expression |
EXP |
quercitrin affects the expression of HSPA6 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:161,524,540...161,526,894
Ensembl chr 1:161,524,540...161,526,894
|
|
G |
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
affects expression |
EXP |
quercitrin affects the expression of HSPA8 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
|
|
G |
IFNA1 |
interferon alpha 1 |
affects expression |
EXP |
quercitrin affects the expression of IFNA1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 9:21,440,439...21,441,316
Ensembl chr 9:21,440,439...21,441,316
|
|
G |
IFNA6 |
interferon alpha 6 |
affects expression |
EXP |
quercitrin affects the expression of IFNA6 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 9:21,350,318...21,350,887
Ensembl chr 9:21,350,253...21,350,956
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
ISO |
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of BAX protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of RELA protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in decreased expression of NFKBIA protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased cleavage of PARP1 protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of CASP3 protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein] |
CTD |
PMID:23138875 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IGF1R |
insulin like growth factor 1 receptor |
affects expression |
EXP |
quercitrin affects the expression of IGF1R mRNA |
CTD |
PMID:25193878 |
|
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
|
|
G |
IL15 |
interleukin 15 |
decreases expression |
EXP |
quercitrin results in decreased expression of IL15 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of BAX protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of RELA protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in decreased expression of NFKBIA protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased cleavage of PARP1 protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of CASP3 protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein] |
CTD |
PMID:23138875 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
INO80C |
INO80 complex subunit C |
decreases expression |
EXP |
quercitrin results in decreased expression of INO80C mRNA |
CTD |
PMID:25193878 |
|
NCBI chr18:35,468,333...35,497,960
Ensembl chr18:35,452,230...35,497,979
|
|
G |
INPP4A |
inositol polyphosphate-4-phosphatase type I A |
affects expression |
EXP |
quercitrin affects the expression of INPP4A mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:98,444,587...98,594,392
Ensembl chr 2:98,444,854...98,594,392
|
|
G |
INPP5D |
inositol polyphosphate-5-phosphatase D |
affects expression |
EXP |
quercitrin affects the expression of INPP5D mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:233,060,342...233,207,903
Ensembl chr 2:233,059,967...233,207,903
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
multiple interactions |
ISO |
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]] |
CTD |
PMID:23138875 |
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
INSR |
insulin receptor |
affects expression |
EXP |
quercitrin affects the expression of INSR mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:7,112,265...7,294,414
Ensembl chr19:7,112,255...7,294,414
|
|
G |
IRF2BP2 |
interferon regulatory factor 2 binding protein 2 |
increases expression |
EXP |
quercitrin results in increased expression of IRF2BP2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:234,604,269...234,610,178
Ensembl chr 1:234,604,269...234,610,178
|
|
G |
ITGB1 |
integrin subunit beta 1 |
affects expression |
EXP |
quercitrin affects the expression of ITGB1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr10:32,900,318...32,958,230
Ensembl chr10:32,887,273...33,005,792
|
|
G |
JAML |
junction adhesion molecule like |
increases expression |
EXP |
quercitrin results in increased expression of JAML mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:118,193,725...118,225,011
Ensembl chr11:118,193,725...118,225,092
|
|
G |
JPT2 |
Jupiter microtubule associated homolog 2 |
increases expression |
EXP |
quercitrin results in increased expression of JPT2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr16:1,678,279...1,702,086
Ensembl chr16:1,678,256...1,702,280
|
|
G |
KAT5 |
lysine acetyltransferase 5 |
affects expression |
EXP |
quercitrin affects the expression of KAT5 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:65,712,018...65,719,604
Ensembl chr11:65,711,996...65,719,604
|
|
G |
KDM3A |
lysine demethylase 3A |
increases expression |
EXP |
quercitrin results in increased expression of KDM3A mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:86,437,044...86,492,716
Ensembl chr 2:86,440,647...86,492,716
|
|
G |
KDR |
kinase insert domain receptor |
increases expression |
EXP |
quercitrin results in increased expression of KDR mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
increases expression |
EXP |
quercitrin results in increased expression of KEAP1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
KIR2DL3 |
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3 |
affects expression |
EXP |
quercitrin affects the expression of KIR2DL3 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:54,738,513...54,753,052
Ensembl chr19:54,738,513...54,753,052
|
|
G |
KIR2DL4 |
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4 |
affects expression |
EXP |
quercitrin affects the expression of KIR2DL4 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:54,803,610...54,814,517
Ensembl chr19:54,803,610...54,814,517
|
|
G |
KIR2DS5 |
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 5 |
affects expression |
EXP |
quercitrin affects the expression of KIR2DS5 mRNA |
CTD |
PMID:25193878 |
|
|
|
G |
KIR3DL3 |
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 3 |
affects expression |
EXP |
quercitrin affects the expression of KIR3DL3 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:54,724,442...54,736,632
Ensembl chr19:54,724,442...54,736,632
|
|
G |
KLHL28 |
kelch like family member 28 |
increases expression |
EXP |
quercitrin results in increased expression of KLHL28 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr14:44,924,324...44,961,947
Ensembl chr14:44,924,324...45,042,322
|
|
G |
KRT81 |
keratin 81 |
decreases expression |
EXP |
quercitrin results in decreased expression of KRT81 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr12:52,285,913...52,308,624
Ensembl chr12:52,285,913...52,291,534
|
|
G |
LEF1 |
lymphoid enhancer binding factor 1 |
affects expression |
EXP |
quercitrin affects the expression of LEF1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 4:108,047,548...108,168,932
Ensembl chr 4:108,047,545...108,168,956
|
|
G |
LINC01558 |
long intergenic non-protein coding RNA 1558 |
increases expression |
EXP |
quercitrin results in increased expression of LINC01558 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:167,784,537...167,796,859
Ensembl chr 6:167,784,537...167,796,872
|
|
G |
LPAR3 |
lysophosphatidic acid receptor 3 |
increases expression |
EXP |
quercitrin results in increased expression of LPAR3 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:84,811,602...84,893,206
Ensembl chr 1:84,811,602...84,893,206
|
|
G |
LPAR5 |
lysophosphatidic acid receptor 5 |
increases expression |
EXP |
quercitrin results in increased expression of LPAR5 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr12:6,618,835...6,635,959
Ensembl chr12:6,618,835...6,635,960
|
|
G |
LPAR6 |
lysophosphatidic acid receptor 6 |
decreases expression |
EXP |
quercitrin results in decreased expression of LPAR6 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr13:48,389,571...48,444,669
Ensembl chr13:48,389,567...48,444,704
|
|
G |
MAT2A |
methionine adenosyltransferase 2A |
increases expression |
EXP |
quercitrin results in increased expression of MAT2A mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:85,539,168...85,545,281
Ensembl chr 2:85,539,168...85,545,281
|
|
G |
MC1R |
melanocortin 1 receptor |
increases expression |
EXP |
quercitrin results in increased expression of MC1R mRNA |
CTD |
PMID:25193878 |
|
NCBI chr16:89,918,862...89,920,972
Ensembl chr16:89,912,119...89,920,973
|
|
G |
MCTS1 |
MCTS1 re-initiation and release factor |
decreases expression |
EXP |
quercitrin results in decreased expression of MCTS1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr X:120,604,101...120,621,159
Ensembl chr X:120,594,010...120,621,159
|
|
G |
MRPL12 |
mitochondrial ribosomal protein L12 |
decreases expression |
EXP |
quercitrin results in decreased expression of MRPL12 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr17:81,703,367...81,707,517
Ensembl chr17:81,703,367...81,707,517
|
|
G |
MRPL22 |
mitochondrial ribosomal protein L22 |
decreases expression |
EXP |
quercitrin results in decreased expression of MRPL22 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 5:154,941,073...154,969,411
Ensembl chr 5:154,941,073...154,969,411
|
|
G |
MSN |
moesin |
affects expression |
EXP |
quercitrin affects the expression of MSN mRNA |
CTD |
PMID:25193878 |
|
NCBI chr X:65,588,377...65,741,931
Ensembl chr X:65,588,377...65,741,931
|
|
G |
MYL2 |
myosin light chain 2 |
affects expression |
EXP |
quercitrin affects the expression of MYL2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr12:110,910,845...110,921,449
Ensembl chr12:110,910,819...110,921,443
|
|
G |
MYL9 |
myosin light chain 9 |
affects expression |
EXP |
quercitrin affects the expression of MYL9 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr20:36,541,519...36,551,447
Ensembl chr20:36,541,497...36,551,447
|
|
G |
MYOM2 |
myomesin 2 |
increases expression |
EXP |
quercitrin results in increased expression of MYOM2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 8:2,045,046...2,145,456
Ensembl chr 8:2,045,046...2,165,552
|
|
G |
NAA38 |
N-alpha-acetyltransferase 38, NatC auxiliary subunit |
decreases expression |
EXP |
quercitrin results in decreased expression of LSMD1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr17:7,856,685...7,885,420
Ensembl chr17:7,856,685...7,885,238
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
ISO |
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in decreased expression of NFKBIA protein] |
CTD |
PMID:23138875 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NFRKB |
nuclear factor related to kappaB binding protein |
increases expression |
EXP |
quercitrin results in increased expression of NFRKB mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:129,863,636...129,895,578
Ensembl chr11:129,863,636...129,895,590
|
|
G |
NMUR1 |
neuromedin U receptor 1 |
decreases expression |
EXP |
quercitrin results in decreased expression of NMUR1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:231,518,455...231,530,445
Ensembl chr 2:231,523,187...231,530,445
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein] |
CTD |
PMID:23138875 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NPBWR1 |
neuropeptides B and W receptor 1 |
increases expression |
EXP |
quercitrin results in increased expression of NPBWR1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 8:52,939,182...52,943,734
Ensembl chr 8:52,939,182...52,943,734
|
|
G |
NPFFR2 |
neuropeptide FF receptor 2 |
decreases expression |
EXP |
quercitrin results in decreased expression of NPFFR2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 4:72,032,000...72,148,305
Ensembl chr 4:72,031,902...72,148,305
|
|
G |
NPY5R |
neuropeptide Y receptor Y5 |
increases expression |
EXP |
quercitrin results in increased expression of NPY5R mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 4:163,343,892...163,352,403
Ensembl chr 4:163,343,892...163,351,934
|
|
G |
NUAK2 |
NUAK family kinase 2 |
decreases expression |
EXP |
quercitrin results in decreased expression of NUAK2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:205,302,063...205,321,745
Ensembl chr 1:205,302,063...205,321,745
|
|
G |
OCLN |
occludin |
affects expression |
EXP |
quercitrin affects the expression of OCLN mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
|
|
G |
ODC1 |
ornithine decarboxylase 1 |
increases expression |
EXP |
quercitrin results in increased expression of ODC1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:10,439,968...10,448,327
Ensembl chr 2:10,439,968...10,448,327
|
|
G |
OGA |
O-GlcNAcase |
increases expression |
EXP |
quercitrin results in increased expression of OGA mRNA |
CTD |
PMID:25193878 |
|
NCBI chr10:101,784,450...101,818,444
Ensembl chr10:101,784,443...101,818,465
|
|
G |
OGFOD2 |
2-oxoglutarate and iron dependent oxygenase domain containing 2 |
increases expression |
EXP |
quercitrin results in increased expression of OGFOD2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr12:122,974,726...122,980,042
Ensembl chr12:122,974,580...122,980,043
|
|
G |
OMA1 |
OMA1 zinc metallopeptidase |
increases expression |
EXP |
quercitrin results in increased expression of OMA1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:58,480,719...58,546,726
Ensembl chr 1:58,415,384...58,546,802
|
|
G |
P2RX2 |
purinergic receptor P2X 2 |
increases expression |
EXP |
quercitrin results in increased expression of P2RX2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr12:132,618,776...132,622,388
Ensembl chr12:132,618,776...132,622,388
|
|
G |
P2RX3 |
purinergic receptor P2X 3 |
increases expression |
EXP |
quercitrin results in increased expression of P2RX3 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:57,335,950...57,372,396
Ensembl chr11:57,338,352...57,372,396
|
|
G |
P2RY11 |
purinergic receptor P2Y11 |
increases expression |
EXP |
quercitrin results in increased expression of P2RY11 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:10,111,693...10,115,372
Ensembl chr19:10,111,693...10,115,372
|
|
G |
P2RY6 |
pyrimidinergic receptor P2Y6 |
decreases expression |
EXP |
quercitrin results in decreased expression of P2RY6 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:73,264,506...73,298,625
Ensembl chr11:73,264,498...73,305,103
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased cleavage of PARP1 protein] |
CTD |
PMID:23138875 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PATZ1 |
POZ/BTB and AT hook containing zinc finger 1 |
decreases expression |
EXP |
quercitrin results in decreased expression of PATZ1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr22:31,325,804...31,346,346
Ensembl chr22:31,325,804...31,346,346
|
|
G |
PEX16 |
peroxisomal biogenesis factor 16 |
decreases expression |
EXP |
quercitrin results in decreased expression of PEX16 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:45,909,663...45,918,822
Ensembl chr11:45,909,663...45,918,812
|
|
G |
PGA3 |
pepsinogen A3 |
increases expression |
EXP |
quercitrin results in increased expression of PGA3 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:61,203,515...61,213,098
Ensembl chr11:61,203,307...61,213,098
|
|
G |
PIDD1 |
p53-induced death domain protein 1 |
increases expression |
EXP |
quercitrin results in increased expression of PIDD1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:799,184...809,501
Ensembl chr11:799,179...809,753
|
|
G |
PIK3C2A |
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha |
affects expression |
EXP |
quercitrin affects the expression of PIK3C2A mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:17,086,575...17,207,986
Ensembl chr11:17,077,730...17,207,986
|
|
G |
PIK3R1 |
phosphoinositide-3-kinase regulatory subunit 1 |
affects expression |
EXP |
quercitrin affects the expression of PIK3R1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821
|
|
G |
PLCB2 |
phospholipase C beta 2 |
affects expression |
EXP |
quercitrin affects the expression of PLCB2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr15:40,284,256...40,307,935
Ensembl chr15:40,278,176...40,307,935
|
|
G |
PLCE1 |
phospholipase C epsilon 1 |
affects expression |
EXP |
quercitrin affects the expression of PLCE1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr10:93,993,931...94,332,823
Ensembl chr10:93,993,931...94,332,823
|
|
G |
PLGRKT |
plasminogen receptor with a C-terminal lysine |
decreases expression |
EXP |
quercitrin results in decreased expression of PLGRKT mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 9:5,357,971...5,438,377
Ensembl chr 9:5,357,971...5,437,925
|
|
G |
POC1A |
POC1 centriolar protein A |
decreases expression |
EXP |
quercitrin results in decreased expression of POC1A mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 3:52,075,226...52,154,423
Ensembl chr 3:52,075,226...52,154,690
|
|
G |
POLH |
DNA polymerase eta |
increases expression |
EXP |
quercitrin results in increased expression of POLH mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:43,576,185...43,620,523
Ensembl chr 6:43,576,185...43,620,523
|
|
G |
POLRMT |
RNA polymerase mitochondrial |
decreases expression |
EXP |
quercitrin results in decreased expression of POLRMT mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:617,221...633,537
Ensembl chr19:617,221...633,537
|
|
G |
POMT2 |
protein O-mannosyltransferase 2 |
increases expression |
EXP |
quercitrin results in increased expression of POMT2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr14:77,274,956...77,320,883
Ensembl chr14:77,274,956...77,320,883
|
|
G |
POU5F2 |
POU domain class 5, transcription factor 2 |
decreases expression |
EXP |
quercitrin results in decreased expression of POU5F2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 5:93,733,220...93,741,600
Ensembl chr 5:93,733,220...93,741,600
|
|
G |
PRKCB |
protein kinase C beta |
affects expression |
EXP |
quercitrin affects the expression of PRKCB mRNA |
CTD |
PMID:25193878 |
|
NCBI chr16:23,835,983...24,220,611
Ensembl chr16:23,835,983...24,220,611
|
|
G |
PRR3 |
proline rich 3 |
decreases expression |
EXP |
quercitrin results in decreased expression of PRR3 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:30,556,709...30,563,723
Ensembl chr 6:30,557,280...30,563,723
|
|
G |
PSD4 |
pleckstrin and Sec7 domain containing 4 |
increases expression |
EXP |
quercitrin results in increased expression of PSD4 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:113,173,971...113,209,391
Ensembl chr 2:113,157,325...113,209,396
|
|
G |
PSMA6 |
proteasome 20S subunit alpha 6 |
decreases expression |
EXP |
quercitrin results in decreased expression of PSMA6 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr14:35,278,558...35,317,493
Ensembl chr14:35,278,633...35,317,493
|
|
G |
PSMA8 |
proteasome 20S subunit alpha 8 |
decreases expression |
EXP |
quercitrin results in decreased expression of PSMA8 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr18:26,133,869...26,193,355
Ensembl chr18:26,133,852...26,193,355
|
|
G |
PSMB6 |
proteasome 20S subunit beta 6 |
decreases expression |
EXP |
quercitrin results in decreased expression of PSMB6 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr17:4,796,164...4,798,495
Ensembl chr17:4,796,144...4,798,502
|
|
G |
PSMB9 |
proteasome 20S subunit beta 9 |
decreases expression |
EXP |
quercitrin results in decreased expression of PSMB9 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:32,854,192...32,859,851
Ensembl chr 6:32,844,136...32,859,851
|
|
G |
PTGDR2 |
prostaglandin D2 receptor 2 |
increases expression |
EXP |
quercitrin results in increased expression of PTGDR2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:60,850,933...60,855,950
Ensembl chr11:60,850,933...60,855,950
|
|
G |
PTK2B |
protein tyrosine kinase 2 beta |
affects expression |
EXP |
quercitrin affects the expression of PTK2B mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 8:27,310,506...27,459,391
Ensembl chr 8:27,311,482...27,459,391
|
|
G |
PTPRU |
protein tyrosine phosphatase receptor type U |
decreases expression |
EXP |
quercitrin results in decreased expression of PTPRU mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:29,236,522...29,326,800
Ensembl chr 1:29,236,516...29,326,813
|
|
G |
RAC3 |
Rac family small GTPase 3 |
affects expression |
EXP |
quercitrin affects the expression of RAC3 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr17:82,031,678...82,034,204
Ensembl chr17:82,031,678...82,034,204
|
|
G |
RAP1A |
RAP1A, member of RAS oncogene family |
affects expression |
EXP |
quercitrin affects the expression of RAP1A mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:111,542,009...111,716,691
Ensembl chr 1:111,542,218...111,716,691
|
|
G |
RBAK |
RB associated KRAB zinc finger |
increases expression |
EXP |
quercitrin results in increased expression of RBAK mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 7:5,045,860...5,069,487
Ensembl chr 7:5,045,821...5,069,487
|
|
G |
RBKS |
ribokinase |
decreases expression |
EXP |
quercitrin results in decreased expression of RBKS mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:27,781,379...27,890,387
Ensembl chr 2:27,781,379...27,890,681
|
|
G |
RBM15B |
RNA binding motif protein 15B |
increases expression |
EXP |
quercitrin results in increased expression of RBM15B mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 3:51,391,285...51,397,908
Ensembl chr 3:51,391,285...51,397,908
|
|
G |
RBM38 |
RNA binding motif protein 38 |
increases expression |
EXP |
quercitrin results in increased expression of RBM38 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr20:57,391,396...57,409,333
Ensembl chr20:57,391,396...57,409,333
|
|
G |
RBM39 |
RNA binding motif protein 39 |
increases expression |
EXP |
quercitrin results in increased expression of RBM39 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr20:35,701,347...35,742,260
Ensembl chr20:35,701,347...35,742,312
|
|
G |
RCHY1 |
ring finger and CHY zinc finger domain containing 1 |
decreases expression |
EXP |
quercitrin results in decreased expression of RCHY1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 4:75,479,033...75,514,715
Ensembl chr 4:75,479,033...75,514,764
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of RELA protein] |
CTD |
PMID:23138875 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RIOK1 |
RIO kinase 1 |
increases expression |
EXP |
quercitrin results in increased expression of RIOK1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:7,389,808...7,418,037
Ensembl chr 6:7,389,793...7,418,037
|
|
G |
RNF14 |
ring finger protein 14 |
decreases expression |
EXP |
quercitrin results in decreased expression of RNF14 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 5:141,949,337...141,990,292
Ensembl chr 5:141,958,328...141,990,292
|
|
G |
ROCK1 |
Rho associated coiled-coil containing protein kinase 1 |
affects expression |
EXP |
quercitrin affects the expression of ROCK1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr18:20,946,906...21,111,813
Ensembl chr18:20,944,612...21,111,813
|
|
G |
SAP18 |
Sin3A associated protein 18 |
increases expression |
EXP |
quercitrin results in increased expression of SAP18 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr13:21,140,119...21,149,097
Ensembl chr13:21,140,119...21,149,097
|
|
G |
SAT1 |
spermidine/spermine N1-acetyltransferase 1 |
decreases expression |
EXP |
quercitrin results in decreased expression of SAT1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr X:23,783,173...23,786,210
Ensembl chr X:23,783,173...23,786,210
|
|
G |
SERTAD1 |
SERTA domain containing 1 |
increases expression |
EXP |
quercitrin results in increased expression of SERTAD1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:40,421,589...40,425,992
Ensembl chr19:40,421,589...40,425,992
|
|
G |
SF3B1 |
splicing factor 3b subunit 1 |
decreases expression |
EXP |
quercitrin results in decreased expression of SF3B1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:197,389,784...197,435,093
Ensembl chr 2:197,388,515...197,435,079
|
|
G |
SLC16A13 |
solute carrier family 16 member 13 |
decreases expression |
EXP |
quercitrin results in decreased expression of SLC16A13 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr17:7,036,015...7,040,117
Ensembl chr17:7,036,015...7,040,117
|
|
G |
SLC16A4 |
solute carrier family 16 member 4 |
decreases expression |
EXP |
quercitrin results in decreased expression of SLC16A4 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:110,362,857...110,391,026
Ensembl chr 1:110,362,851...110,391,082
|
|
G |
SLC22A18 |
solute carrier family 22 member 18 |
decreases expression |
EXP |
quercitrin results in decreased expression of SLC22A18 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:2,899,691...2,925,246
Ensembl chr11:2,899,721...2,925,246
|
|
G |
SLC25A40 |
solute carrier family 25 member 40 |
decreases expression |
EXP |
quercitrin results in decreased expression of SLC25A40 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 7:87,833,568...87,876,360
Ensembl chr 7:87,833,568...87,876,360
|
|
G |
SLC39A8 |
solute carrier family 39 member 8 |
decreases expression |
EXP |
quercitrin results in decreased expression of SLC39A8 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 4:102,251,041...102,345,482
Ensembl chr 4:102,251,080...102,431,258
|
|
G |
SLC7A9 |
solute carrier family 7 member 9 |
increases expression |
EXP |
quercitrin results in increased expression of SLC7A9 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:32,830,511...32,869,767
Ensembl chr19:32,830,509...32,869,767
|
|
G |
SLFNL1 |
schlafen like 1 |
increases expression |
EXP |
quercitrin results in increased expression of SLFNL1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:41,015,597...41,021,725
Ensembl chr 1:41,015,589...41,023,237
|
|
G |
SMAD3 |
SMAD family member 3 |
increases expression |
EXP |
quercitrin results in increased expression of SMAD3 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
|
|
G |
SMPD1 |
sphingomyelin phosphodiesterase 1 |
increases expression |
EXP |
quercitrin results in increased expression of SMPD1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:6,390,474...6,394,996
Ensembl chr11:6,390,440...6,394,998
|
|
G |
SNAI2 |
snail family transcriptional repressor 2 |
affects expression |
EXP |
quercitrin affects the expression of SNAI2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 8:48,917,598...48,921,429
Ensembl chr 8:48,917,598...48,921,740
|
|
G |
SORBS1 |
sorbin and SH3 domain containing 1 |
affects expression |
EXP |
quercitrin affects the expression of SORBS1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr10:95,311,773...95,561,371
Ensembl chr10:95,311,771...95,561,414
|
|
G |
SORL1 |
sortilin related receptor 1 |
decreases expression |
EXP |
quercitrin results in decreased expression of SORL1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr11:121,452,314...121,633,763
Ensembl chr11:121,452,314...121,633,763
|
|
G |
SP4 |
Sp4 transcription factor |
increases expression |
EXP |
quercitrin results in increased expression of SP4 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 7:21,428,083...21,514,822
Ensembl chr 7:21,428,043...21,514,822
|
|
G |
SPATA18 |
spermatogenesis associated 18 |
increases expression |
EXP |
quercitrin results in increased expression of SPATA18 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 4:52,051,304...52,097,299
Ensembl chr 4:52,051,304...52,097,299
|
|
G |
SRC |
SRC proto-oncogene, non-receptor tyrosine kinase |
affects expression |
EXP |
quercitrin affects the expression of SRC mRNA |
CTD |
PMID:25193878 |
|
NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,685...37,406,050
|
|
G |
SRD5A3 |
steroid 5 alpha-reductase 3 |
increases expression |
EXP |
quercitrin results in increased expression of SRD5A3 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 4:55,346,242...55,373,100
Ensembl chr 4:55,346,213...55,373,100
|
|
G |
SRRM2 |
serine/arginine repetitive matrix 2 |
increases expression |
EXP |
quercitrin results in increased expression of SRRM2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr16:2,752,638...2,771,412
Ensembl chr16:2,752,626...2,772,538
|
|
G |
SUGCT |
succinyl-CoA:glutarate-CoA transferase |
increases expression |
EXP |
quercitrin results in increased expression of SUGCT mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 7:40,135,005...41,038,816
Ensembl chr 7:40,135,005...40,860,763
|
|
G |
SUGP1 |
SURP and G-patch domain containing 1 |
increases expression |
EXP |
quercitrin results in increased expression of SUGP1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:19,276,033...19,320,509
Ensembl chr19:19,276,018...19,320,509
|
|
G |
TCEA1 |
transcription elongation factor A1 |
decreases expression |
EXP |
quercitrin results in decreased expression of TCEA1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 8:53,966,556...54,022,448
Ensembl chr 8:53,966,552...54,022,448
|
|
G |
TCEA2 |
transcription elongation factor A2 |
decreases expression |
EXP |
quercitrin results in decreased expression of TCEA2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr20:64,055,596...64,072,347
Ensembl chr20:64,049,836...64,072,347
|
|
G |
TCF7 |
transcription factor 7 |
affects expression |
EXP |
quercitrin affects the expression of TCF7 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 5:134,108,218...134,148,210
Ensembl chr 5:134,114,681...134,151,865
|
|
G |
TFB1M |
transcription factor B1, mitochondrial |
decreases expression |
EXP |
quercitrin results in decreased expression of TFB1M mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:155,229,871...155,314,484
Ensembl chr 6:155,256,134...155,314,493
|
|
G |
TGIF2 |
TGFB induced factor homeobox 2 |
decreases expression |
EXP |
quercitrin results in decreased expression of TGIF2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr20:36,573,464...36,593,950
Ensembl chr20:36,573,488...36,593,950
|
|
G |
TGM2 |
transglutaminase 2 |
decreases expression |
EXP |
quercitrin results in decreased expression of TGM2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr20:38,127,385...38,168,475
Ensembl chr20:38,127,385...38,166,578
|
|
G |
THSD1 |
thrombospondin type 1 domain containing 1 |
increases expression |
EXP |
quercitrin results in increased expression of THSD1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr13:52,377,167...52,406,172
Ensembl chr13:52,377,167...52,416,373
|
|
G |
TMEM160 |
transmembrane protein 160 |
decreases expression |
EXP |
quercitrin results in decreased expression of TMEM160 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:47,045,909...47,048,624
Ensembl chr19:47,045,909...47,048,624
|
|
G |
TMEM208 |
transmembrane protein 208 |
decreases expression |
EXP |
quercitrin results in decreased expression of TMEM208 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr16:67,227,130...67,229,278
Ensembl chr16:67,227,103...67,229,278
|
|
G |
TMEM242 |
transmembrane protein 242 |
increases expression |
EXP |
quercitrin results in increased expression of TMEM242 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 6:157,289,025...157,323,519
Ensembl chr 6:157,289,025...157,323,601
|
|
G |
TMX1 |
thioredoxin related transmembrane protein 1 |
decreases expression |
EXP |
quercitrin results in decreased expression of TMX1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr14:51,240,247...51,257,655
Ensembl chr14:51,240,162...51,257,655
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of BAX protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of RELA protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in decreased expression of NFKBIA protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased cleavage of PARP1 protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of CASP3 protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein] |
CTD |
PMID:23138875 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
decreases expression |
EXP |
quercitrin results in decreased expression of TNFRSF1A mRNA |
CTD |
PMID:25193878 |
|
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
decreases expression |
EXP |
quercitrin results in decreased expression of TNFRSF1B mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
|
|
G |
TP63 |
tumor protein p63 |
decreases expression |
EXP |
quercitrin results in decreased expression of TP63 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 3:189,596,746...189,897,276
Ensembl chr 3:189,631,389...189,897,276
|
|
G |
TSPAN14 |
tetraspanin 14 |
decreases expression |
EXP |
quercitrin results in decreased expression of TSPAN14 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr10:80,454,310...80,522,631
Ensembl chr10:80,454,265...80,533,124
|
|
G |
U2AF2 |
U2 small nuclear RNA auxiliary factor 2 |
increases expression |
EXP |
quercitrin results in increased expression of U2AF2 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:55,655,035...55,674,716
Ensembl chr19:55,654,146...55,674,716
|
|
G |
UTS2R |
urotensin 2 receptor |
increases expression |
EXP |
quercitrin results in increased expression of UTS2R mRNA |
CTD |
PMID:25193878 |
|
NCBI chr17:82,371,765...82,377,458
Ensembl chr17:82,371,765...82,377,458
|
|
G |
VN1R1 |
vomeronasal 1 receptor 1 |
increases expression |
EXP |
quercitrin results in increased expression of VN1R1 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr19:57,454,790...57,457,140
Ensembl chr19:57,454,790...57,457,140
|
|
G |
VWA8 |
von Willebrand factor A domain containing 8 |
decreases expression |
EXP |
quercitrin results in decreased expression of VWA8 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr13:41,566,835...41,961,109
Ensembl chr13:41,566,835...41,961,120
|
|
G |
WAS |
WASP actin nucleation promoting factor |
affects expression |
EXP |
quercitrin affects the expression of WAS mRNA |
CTD |
PMID:25193878 |
|
NCBI chr X:48,676,636...48,691,427
Ensembl chr X:48,676,596...48,691,431
|
|
G |
WDR33 |
WD repeat domain 33 |
decreases expression |
EXP |
quercitrin results in decreased expression of WDR33 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 2:127,701,027...127,811,171
Ensembl chr 2:127,701,027...127,811,187
|
|
G |
WWOX |
WW domain containing oxidoreductase |
decreases expression |
EXP |
quercitrin results in decreased expression of WWOX mRNA |
CTD |
PMID:25193878 |
|
NCBI chr16:78,099,654...79,212,667
Ensembl chr16:78,099,400...79,212,667
|
|
G |
ZAN |
zonadhesin |
increases expression |
EXP |
quercitrin results in increased expression of ZAN mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 7:100,733,595...100,797,797
Ensembl chr 7:100,733,595...100,797,797
|
|
G |
ZCCHC14 |
zinc finger CCHC-type containing 14 |
increases expression |
EXP |
quercitrin results in increased expression of ZCCHC14 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr16:87,406,248...87,493,024
Ensembl chr16:87,406,246...87,493,024
|
|
G |
ZCCHC18 |
zinc finger CCHC-type containing 18 |
increases expression |
EXP |
quercitrin results in increased expression of ZCCHC18 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr X:104,112,523...104,115,842
Ensembl chr X:104,112,131...104,115,842
|
|
G |
ZNF502 |
zinc finger protein 502 |
increases expression |
EXP |
quercitrin results in increased expression of ZNF502 mRNA |
CTD |
PMID:25193878 |
|
NCBI chr 3:44,712,660...44,723,831
Ensembl chr 3:44,712,643...44,723,831
|
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
affects activity |
EXP |
robinin affects the activity of ABCC1 protein |
CTD |
PMID:15796199 |
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
|
G |
ABCA1 |
ATP binding cassette subfamily A member 1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABCA1 mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABCA1 protein] |
CTD |
PMID:25478064 |
|
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions |
EXP |
Rutin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]] |
CTD |
PMID:34217736 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ACHE |
acetylcholinesterase (Yt blood group) |
multiple interactions |
ISO |
Rutin inhibits the reaction [[Copper Sulfate results in increased abundance of Copper] which results in decreased activity of ACHE protein]; Rutin inhibits the reaction [Acrylamide results in increased expression of ACHE protein] |
CTD |
PMID:32881150 PMID:36657526 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
ACLY |
ATP citrate lyase |
decreases activity |
ISO |
Rutin results in decreased activity of ACLY protein |
CTD |
PMID:17032037 |
|
NCBI chr17:41,866,917...41,930,545
Ensembl chr17:41,866,917...41,930,542
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
multiple interactions |
EXP |
Rutin inhibits the reaction [Glucose results in increased expression of AGER mRNA] |
CTD |
PMID:19557821 |
|
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
|
|
G |
AGT |
angiotensinogen |
multiple interactions |
ISO |
Rutin inhibits the reaction [Isoproterenol results in increased expression of AGT protein] |
CTD |
PMID:24117263 |
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
G |
AHR |
aryl hydrocarbon receptor |
decreases localization multiple interactions |
EXP |
Rutin results in decreased localization of AHR protein Rutin promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased localization of AHR protein] |
CTD |
PMID:21756928 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in decreased phosphorylation of AKT1 protein] Rutin inhibits the reaction [Cisplatin results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:22426011 PMID:35304134 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
ARNT |
aryl hydrocarbon receptor nuclear translocator |
increases localization |
EXP |
Rutin results in increased localization of ARNT protein |
CTD |
PMID:21756928 |
|
NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708
|
|
G |
ATXN2 |
ataxin 2 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Oxidopamine results in increased expression of ATXN2 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr12:111,452,214...111,599,673
Ensembl chr12:111,443,485...111,599,676
|
|
G |
ATXN3 |
ataxin 3 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Oxidopamine results in increased expression of ATXN3 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr14:92,044,775...92,106,582
Ensembl chr14:92,044,496...92,106,621
|
|
G |
BAD |
BCL2 associated agonist of cell death |
multiple interactions |
ISO |
Rutin inhibits the reaction [Cisplatin results in increased expression of BAD protein] |
CTD |
PMID:35304134 |
|
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
affects expression multiple interactions increases expression |
EXP ISO |
Rutin affects the expression of BAX protein Rutin inhibits the reaction [[Copper Sulfate results in increased abundance of Copper] which results in increased expression of BAX protein]; Rutin inhibits the reaction [Oxygen deficiency results in increased expression of BAX mRNA]; Rutin inhibits the reaction [Oxygen deficiency results in increased expression of BAX protein] Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of BAX protein] Rutin results in increased expression of BAX protein |
CTD |
PMID:15975156 PMID:28811126 PMID:29522708 PMID:32881150 PMID:33413359 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BBC3 |
BCL2 binding component 3 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of BBC3 mRNA] |
CTD |
PMID:27239252 |
|
NCBI chr19:47,220,824...47,232,860
Ensembl chr19:47,220,822...47,232,766
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
affects expression multiple interactions decreases expression |
EXP ISO |
Rutin affects the expression of BCL2 protein Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 protein] Rutin results in decreased expression of BCL2 protein Rutin inhibits the reaction [[Copper Sulfate results in increased abundance of Copper] which results in increased expression of BCL2 protein]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 mRNA]; Rutin inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA]; Rutin inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 protein] Rutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] |
CTD |
PMID:15975156 PMID:19557821 PMID:26062544 PMID:28811126 PMID:29522708 PMID:32881150 PMID:33413359 More...
|
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of BCL2L1 mRNA] |
CTD |
PMID:26062544 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BGLAP |
bone gamma-carboxyglutamate protein |
multiple interactions |
EXP |
[Rutin co-treated with Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased secretion of BGLAP protein |
CTD |
PMID:34562440 |
|
NCBI chr 1:156,242,184...156,243,317
Ensembl chr 1:156,242,184...156,243,317
|
|
G |
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in increased phosphorylation of BRAF protein] |
CTD |
PMID:32864822 |
|
NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
|
|
G |
CASP1 |
caspase 1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in increased expression of CASP1 protein] |
CTD |
PMID:22426011 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CASP3 |
caspase 3 |
affects cleavage increases cleavage multiple interactions increases expression increases activity |
EXP ISO |
Rutin affects the cleavage of CASP3 protein Rutin results in increased cleavage of CASP3 protein Rutin inhibits the reaction [Cholesterol, Dietary results in increased cleavage of CASP3 protein]; Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of CASP3 mRNA]; Rutin inhibits the reaction [Oxidopamine results in increased expression of CASP3 mRNA]; Rutin inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP3 protein]; Rutin inhibits the reaction [Oxygen deficiency results in increased expression of CASP3 mRNA] [Rutin binds to Zinc] which results in increased expression of CASP3 mRNA; [Rutin co-treated with Meloxicam] affects the reaction [Formaldehyde affects the expression of CASP3 protein]; Rutin inhibits the reaction [Carbon Tetrachloride results in increased cleavage of CASP3 protein]; Rutin inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]; Rutin inhibits the reaction [Oxaliplatin results in increased expression of CASP3 protein] Rutin results in increased expression of CASP3 mRNA Rutin results in increased activity of CASP3 protein |
CTD |
PMID:15975156 PMID:24726691 PMID:24908156 PMID:25129099 PMID:26091902 PMID:27239252 PMID:28811126 PMID:29315975 PMID:29522708 PMID:33413359 PMID:35304134 More...
|
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP7 |
caspase 7 |
increases activity multiple interactions |
EXP ISO |
Rutin results in increased activity of CASP7 protein Rutin inhibits the reaction [Oxidopamine results in increased expression of CASP7 mRNA] |
CTD |
PMID:24726691 PMID:25129099 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP8 |
caspase 8 |
multiple interactions increases expression |
ISO |
[Rutin binds to Zinc] which results in increased expression of CASP8 mRNA Rutin results in increased expression of CASP8 mRNA |
CTD |
PMID:26091902 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
EXP |
Rutin inhibits the reaction [Cisplatin results in decreased expression of CASP9 protein] |
CTD |
PMID:29962303 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions |
EXP ISO |
Rutin inhibits the reaction [bifenthrin results in decreased activity of CAT protein] Rutin inhibits the reaction [Lipopolysaccharides results in decreased activity of CAT protein] Rutin inhibits the reaction [[Copper Sulfate results in increased abundance of Copper] which results in decreased activity of CAT protein]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of CAT mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of CAT protein]; Rutin inhibits the reaction [Cisplatin results in decreased expression of CAT protein]; Rutin inhibits the reaction [Cyclophosphamide results in decreased activity of CAT protein]; Rutin inhibits the reaction [Oxygen deficiency results in decreased activity of CAT protein] |
CTD |
PMID:19833193 PMID:21605616 PMID:25478064 PMID:25753322 PMID:29743444 PMID:32881150 PMID:33413359 More...
|
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CBR1 |
carbonyl reductase 1 |
multiple interactions |
EXP |
Rutin binds to and results in decreased activity of CBR1 protein; Rutin inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] |
CTD |
PMID:11306090 PMID:18579125 |
|
NCBI chr21:36,070,024...36,073,164
Ensembl chr21:36,069,941...36,073,166
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases secretion decreases expression |
EXP ISO |
Rutin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA] Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 protein] Rutin results in decreased secretion of CCL2 protein Rutin results in decreased expression of CCL2 mRNA |
CTD |
PMID:21756928 PMID:21967610 PMID:25478064 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
multiple interactions decreases expression |
ISO |
Lipopolysaccharides inhibits the reaction [Rutin results in decreased expression of CCL5 mRNA] |
CTD |
PMID:28693884 |
|
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CCN2 |
cellular communication network factor 2 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Isoproterenol results in increased expression of CCN2 mRNA]; Rutin inhibits the reaction [Isoproterenol results in increased expression of CCN2 protein] |
CTD |
PMID:24117263 |
|
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
|
|
G |
CCND1 |
cyclin D1 |
multiple interactions decreases expression |
ISO |
[Rutin binds to Zinc] which results in decreased expression of CCND1 mRNA Rutin results in decreased expression of CCND1 mRNA |
CTD |
PMID:26091902 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CD68 |
CD68 molecule |
decreases expression |
ISO |
Rutin results in decreased expression of CD68 protein |
CTD |
PMID:28693884 |
|
NCBI chr17:7,579,638...7,582,111
Ensembl chr17:7,579,491...7,582,111
|
|
G |
CHAT |
choline O-acetyltransferase |
multiple interactions |
ISO |
Rutin inhibits the reaction [Acrylamide results in decreased expression of CHAT protein] |
CTD |
PMID:36657526 |
|
NCBI chr10:49,609,095...49,667,942
Ensembl chr10:49,609,095...49,667,942
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
multiple interactions |
EXP |
[Rutin co-treated with Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of COL1A1 mRNA |
CTD |
PMID:34562440 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
CSF2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 mRNA] |
CTD |
PMID:15652231 |
|
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CX3CL1 |
C-X3-C motif chemokine ligand 1 |
decreases expression |
ISO |
Rutin results in decreased expression of CX3CL1 mRNA |
CTD |
PMID:28693884 |
|
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
multiple interactions decreases secretion decreases expression |
EXP |
Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] Rutin results in decreased secretion of CXCL10 protein Rutin results in decreased expression of CXCL10 mRNA |
CTD |
PMID:21756928 PMID:21967610 |
|
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL12 |
C-X-C motif chemokine ligand 12 |
multiple interactions decreases expression |
ISO |
Lipopolysaccharides inhibits the reaction [Rutin results in decreased expression of CXCL12 mRNA] |
CTD |
PMID:28693884 |
|
NCBI chr10:44,370,165...44,385,097
Ensembl chr10:44,370,165...44,386,493
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions decreases secretion |
EXP |
Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CXCL8 mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of CXCL8 protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL8 protein]; Rutin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL8 mRNA] Rutin results in decreased secretion of CXCL8 protein |
CTD |
PMID:18958421 PMID:21756928 PMID:21967610 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYCS |
cytochrome c, somatic |
multiple interactions |
ISO |
Rutin inhibits the reaction [Oxygen deficiency results in increased expression of CYCS mRNA]; Rutin inhibits the reaction [Oxygen deficiency results in increased expression of CYCS protein] |
CTD |
PMID:33413359 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYP19A1 |
cytochrome P450 family 19 subfamily A member 1 |
increases expression |
ISO |
Rutin results in increased expression of CYP19A1 protein |
CTD |
PMID:29899696 |
|
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases expression |
EXP |
Rutin results in increased expression of CYP1A1 mRNA |
CTD |
PMID:21756928 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
decreases activity |
EXP |
Rutin results in decreased activity of CYP1B1 protein |
CTD |
PMID:16271822 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
EGF |
epidermal growth factor |
multiple interactions |
ISO |
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of EGF mRNA] |
CTD |
PMID:26062544 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions |
EXP |
Rutin inhibits the reaction [TGFA protein affects the localization of EGFR protein] |
CTD |
PMID:21967610 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EGLN1 |
egl-9 family hypoxia inducible factor 1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Oxidopamine results in increased expression of EGLN1 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 1:231,363,756...231,422,287
Ensembl chr 1:231,363,751...231,422,287
|
|
G |
ESR2 |
estrogen receptor 2 |
increases expression |
ISO |
Rutin results in increased expression of ESR2 protein |
CTD |
PMID:29899696 |
|
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
|
|
G |
FADD |
Fas associated via death domain |
multiple interactions |
ISO |
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of FADD mRNA] |
CTD |
PMID:26062544 |
|
NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390
|
|
G |
FN1 |
fibronectin 1 |
increases expression multiple interactions |
EXP ISO |
Rutin results in increased expression of FN1 protein Rutin inhibits the reaction [Isoproterenol results in increased expression of FN1 protein] |
CTD |
PMID:24117263 PMID:26408079 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Rutin inhibits the reaction [oxaliplatin results in increased expression of FOS protein] |
CTD |
PMID:24908156 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
FOXO3 |
forkhead box O3 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Cisplatin affects the localization of FOXO3 protein] |
CTD |
PMID:33031932 |
|
NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
|
|
G |
FSHR |
follicle stimulating hormone receptor |
increases expression |
ISO |
Rutin results in increased expression of FSHR protein |
CTD |
PMID:29899696 |
|
NCBI chr 2:48,962,157...49,154,515
Ensembl chr 2:48,962,157...49,154,527
|
|
G |
GDNF |
glial cell derived neurotrophic factor |
increases expression |
ISO |
Rutin results in increased expression of GDNF mRNA |
CTD |
PMID:28693884 |
|
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of GPT protein]; Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of GPT protein]; Rutin inhibits the reaction [Cyclophosphamide results in increased activity of GPT protein] |
CTD |
PMID:25478064 PMID:25753322 PMID:26062544 PMID:27239252 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPX1 mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPX1 protein] |
CTD |
PMID:25478064 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
GSR |
glutathione-disulfide reductase |
decreases activity multiple interactions |
EXP ISO |
Rutin results in decreased activity of GSR protein Rutin inhibits the reaction [Cisplatin results in decreased expression of GSR protein]; Rutin inhibits the reaction [Cyclophosphamide results in decreased activity of GSR protein] |
CTD |
PMID:15782287 PMID:21605616 PMID:25753322 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
ISO |
Rutin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; Rutin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein] |
CTD |
PMID:33413359 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
ISO |
[Rutin co-treated with Carbon Tetrachloride] results in increased expression of HMOX1 protein |
CTD |
PMID:22902988 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
EXP |
Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL8 protein] |
CTD |
PMID:21756928 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IGF1 |
insulin like growth factor 1 |
multiple interactions |
ISO |
[Lipopolysaccharides co-treated with Rutin] results in decreased expression of IGF1 mRNA |
CTD |
PMID:28693884 |
|
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IGF1R |
insulin like growth factor 1 receptor |
multiple interactions |
EXP |
Rutin results in increased susceptibility to [Vitamin E results in decreased expression of IGF1R protein] |
CTD |
PMID:20015448 |
|
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
|
|
G |
IL10 |
interleukin 10 |
multiple interactions increases expression |
ISO |
Lipopolysaccharides promotes the reaction [Rutin results in increased expression of IL10 mRNA] Rutin results in increased expression of IL10 mRNA; Rutin results in increased expression of IL10 protein |
CTD |
PMID:28693884 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL18 |
interleukin 18 |
multiple interactions decreases expression |
ISO |
Rutin inhibits the reaction [Fructose results in increased expression of IL18 protein] Rutin results in decreased expression of IL18 mRNA |
CTD |
PMID:22426011 PMID:28693884 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions decreases expression |
EXP ISO |
Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein]; Rutin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of IL1B protein] Rutin results in decreased expression of IL1B mRNA Lipopolysaccharides inhibits the reaction [Rutin results in decreased expression of IL1B mRNA]; Rutin inhibits the reaction [Fructose results in increased expression of IL1B protein] [Rutin co-treated with Meloxicam] affects the reaction [Formaldehyde affects the expression of IL1B protein]; Rutin affects the reaction [Formaldehyde affects the expression of IL1B protein]; Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of IL1B protein]; Rutin inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; Rutin inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein] |
CTD |
PMID:15652231 PMID:18958421 PMID:19557821 PMID:22426011 PMID:28693884 PMID:29315975 PMID:29522708 More...
|
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions decreases expression |
EXP ISO |
Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; Rutin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA] Rutin results in decreased expression of IL6 mRNA; Rutin results in decreased expression of IL6 protein Lipopolysaccharides inhibits the reaction [Rutin results in decreased expression of IL6 mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [Cyclophosphamide results in increased expression of IL6 protein]; Rutin inhibits the reaction [Fructose results in increased expression of IL6 protein] Rutin inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] |
CTD |
PMID:15652231 PMID:18958421 PMID:21756928 PMID:22426011 PMID:25753322 PMID:26062544 PMID:27239252 PMID:28693884 PMID:29743444 More...
|
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in increased expression of INS1 protein] |
CTD |
PMID:19605544 |
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
INSR |
insulin receptor |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in decreased phosphorylation of INSR protein] |
CTD |
PMID:22426011 |
|
NCBI chr19:7,112,265...7,294,414
Ensembl chr19:7,112,255...7,294,414
|
|
G |
IRS1 |
insulin receptor substrate 1 |
decreases expression multiple interactions |
EXP ISO |
Rutin results in decreased expression of IRS1 protein Rutin inhibits the reaction [Fructose results in decreased phosphorylation of IRS1 protein] Rutin results in increased susceptibility to [Vitamin E results in decreased expression of IRS1 protein]; Vitamin E results in increased susceptibility to [Rutin results in decreased expression of IRS1 protein] |
CTD |
PMID:20015448 PMID:22426011 |
|
NCBI chr 2:226,731,312...226,799,820
Ensembl chr 2:226,731,312...226,799,820
|
|
G |
ITGAM |
integrin subunit alpha M |
multiple interactions increases expression |
ISO |
Lipopolysaccharides inhibits the reaction [Rutin results in increased expression of ITGAM protein] |
CTD |
PMID:28693884 |
|
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
|
|
G |
JAK1 |
Janus kinase 1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of JAK1 mRNA] |
CTD |
PMID:26062544 |
|
NCBI chr 1:64,833,229...65,067,746
Ensembl chr 1:64,833,223...65,067,754
|
|
G |
JAK2 |
Janus kinase 2 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in decreased phosphorylation of JAK2 protein] |
CTD |
PMID:22426011 |
|
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression multiple interactions |
EXP |
Rutin results in decreased expression of JUN protein Rutin results in increased susceptibility to [Vitamin E results in decreased expression of JUN protein]; Vitamin E results in increased susceptibility to [Rutin results in decreased expression of JUN protein] |
CTD |
PMID:20015448 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
LAMB2 |
laminin subunit beta 2 |
increases expression |
EXP |
Rutin results in increased expression of LAMB2 protein |
CTD |
PMID:26408079 |
|
NCBI chr 3:49,121,114...49,133,050
Ensembl chr 3:49,121,114...49,133,118
|
|
G |
LEP |
leptin |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in increased expression of LEP protein] |
CTD |
PMID:22426011 |
|
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
LEPR |
leptin receptor |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in increased expression of and results in increased phosphorylation of LEPR protein] |
CTD |
PMID:22426011 |
|
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
|
|
G |
LGALS9 |
galectin 9 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in decreased expression of LGALS9 mRNA]; Rutin inhibits the reaction [Fructose results in decreased expression of LGALS9 protein] |
CTD |
PMID:19605544 |
|
NCBI chr17:27,631,188...27,649,560
Ensembl chr17:27,629,798...27,649,560
|
|
G |
MAP2K5 |
mitogen-activated protein kinase kinase 5 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP2K5 mRNA] |
CTD |
PMID:26062544 |
|
NCBI chr15:67,542,703...67,807,114
Ensembl chr15:67,542,703...67,807,117
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions decreases phosphorylation |
EXP ISO |
Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein]; Rutin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] Rutin inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of MAPK1 protein] Rutin inhibits the reaction [Acrylamide results in decreased phosphorylation of MAPK1 protein]; Rutin inhibits the reaction [Fructose results in decreased phosphorylation of MAPK1 protein]; Rutin inhibits the reaction [pirarubicin results in increased phosphorylation of MAPK1 protein] Rutin results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:19557821 PMID:21756928 PMID:22426011 PMID:29522708 PMID:32864822 PMID:36657526 More...
|
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Cisplatin results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:35304134 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions decreases phosphorylation |
EXP ISO |
Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein]; Rutin inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein] Rutin inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of MAPK3 protein] Rutin inhibits the reaction [Acrylamide results in decreased phosphorylation of MAPK3 protein]; Rutin inhibits the reaction [Fructose results in decreased phosphorylation of MAPK3 protein]; Rutin inhibits the reaction [pirarubicin results in increased phosphorylation of MAPK3 protein] Rutin results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:19557821 PMID:21756928 PMID:22426011 PMID:29522708 PMID:32864822 PMID:36657526 More...
|
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Cisplatin results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:35304134 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MIR100 |
microRNA 100 |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in decreased expression of MIR100 mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr11:122,152,229...122,152,308
Ensembl chr11:122,152,229...122,152,308
|
|
G |
MIR125B1 |
microRNA 125b-1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in increased expression of MIR125B1 mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr11:122,099,757...122,099,844
Ensembl chr11:122,099,757...122,099,844
|
|
G |
MIR1306 |
microRNA 1306 |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in increased expression of MIR1306 mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr22:20,086,058...20,086,142
Ensembl chr22:20,086,058...20,086,142
|
|
G |
MIR152 |
microRNA 152 |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in decreased expression of MIR152 mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr17:48,037,161...48,037,247
Ensembl chr17:48,037,161...48,037,247
|
|
G |
MIR181C |
microRNA 181c |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in decreased expression of MIR181C mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr19:13,874,699...13,874,808
Ensembl chr19:13,874,699...13,874,808
|
|
G |
MIR185 |
microRNA 185 |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in increased expression of MIR185 mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr22:20,033,139...20,033,220
Ensembl chr22:20,033,139...20,033,220
|
|
G |
MIR195 |
microRNA 195 |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in decreased expression of MIR195 mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr17:7,017,615...7,017,701
Ensembl chr17:7,017,615...7,017,701
|
|
G |
MIR196A1 |
microRNA 196a-1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in increased expression of MIR196C mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr17:48,632,490...48,632,559
Ensembl chr17:48,632,490...48,632,559
|
|
G |
MIR199A2 |
microRNA 199a-2 |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in decreased expression of MIR199A2 mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr 1:172,144,535...172,144,644
Ensembl chr 1:172,144,535...172,144,644
|
|
G |
MIR204 |
microRNA 204 |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in increased expression of MIR204 mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr 9:70,809,975...70,810,084
Ensembl chr 9:70,809,975...70,810,084
|
|
G |
MIR208B |
microRNA 208b |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in decreased expression of MIR208B mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr14:23,417,987...23,418,063
Ensembl chr14:23,417,987...23,418,063
|
|
G |
MIR211 |
microRNA 211 |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in increased expression of MIR211 mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr15:31,065,032...31,065,141
Ensembl chr15:31,065,032...31,065,141
|
|
G |
MIR22 |
microRNA 22 |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in decreased expression of MIR22 mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr17:1,713,903...1,713,987
Ensembl chr17:1,713,903...1,713,987
|
|
G |
MIR26B |
microRNA 26b |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in decreased expression of MIR26B mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr 2:218,402,646...218,402,722
Ensembl chr 2:218,402,646...218,402,722
|
|
G |
MIR296 |
microRNA 296 |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in increased expression of MIR296 mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr20:58,817,615...58,817,694
Ensembl chr20:58,817,615...58,817,694
|
|
G |
MIR30C1 |
microRNA 30c-1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in increased expression of MIR30C1 mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr 1:40,757,284...40,757,372
Ensembl chr 1:40,757,284...40,757,372
|
|
G |
MIR365B |
microRNA 365b |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in increased expression of MIR365B mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr17:31,575,411...31,575,521
Ensembl chr17:31,575,411...31,575,521
|
|
G |
MIR494 |
microRNA 494 |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in increased expression of MIR494 mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr14:101,029,634...101,029,714
Ensembl chr14:101,029,634...101,029,714
|
|
G |
MIR760 |
microRNA 760 |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in increased expression of MIR760 mRNA] |
CTD |
PMID:32864822 |
|
NCBI chr 1:93,846,832...93,846,911
Ensembl chr 1:93,846,832...93,846,911
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP ISO |
Rutin results in decreased expression of and results in decreased activity of MMP2 protein Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP2 mRNA]; Rutin inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP2 protein] |
CTD |
PMID:26408079 PMID:29743444 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
decreases expression multiple interactions |
ISO |
Rutin results in decreased expression of MMP9 mRNA Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]; Rutin inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein] |
CTD |
PMID:16304905 PMID:29743444 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MPO |
myeloperoxidase |
multiple interactions |
ISO |
Rutin inhibits the reaction [[Copper Sulfate results in increased abundance of Copper] which results in increased activity of MPO protein] |
CTD |
PMID:32881150 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
MRC1 |
mannose receptor C-type 1 |
increases expression multiple interactions |
ISO |
Rutin results in increased expression of MRC1 protein [Lipopolysaccharides co-treated with Rutin] results in increased expression of MRC1 protein |
CTD |
PMID:28693884 |
|
NCBI chr10:17,809,348...17,911,164
Ensembl chr10:17,809,348...17,911,164
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
Rutin promotes the reaction [Carbon Tetrachloride results in increased expression of NFE2L2 protein] [Rutin co-treated with Hydrogen Peroxide] affects the localization of NFE2L2 protein; Rutin inhibits the reaction [Acrylamide results in decreased expression of NFE2L2 protein] |
CTD |
PMID:22902988 PMID:31412289 PMID:36657526 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
EXP |
Rutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of NFKBIA protein] |
CTD |
PMID:19557821 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NLRP3 |
NLR family pyrin domain containing 3 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in increased expression of NLRP3 protein] |
CTD |
PMID:22426011 |
|
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,416,156...247,449,108
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions decreases expression |
ISO |
Rutin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein]; Rutin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]; Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] Rutin results in decreased expression of NOS2 mRNA; Rutin results in decreased expression of NOS2 protein Rutin inhibits the reaction [[Copper Sulfate results in increased abundance of Copper] which results in increased expression of NOS2 protein]; Rutin inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 protein] |
CTD |
PMID:11500931 PMID:12512693 PMID:22902988 PMID:25080890 PMID:25753322 PMID:28693884 PMID:32881150 More...
|
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NSF |
N-ethylmaleimide sensitive factor, vesicle fusing ATPase |
multiple interactions |
ISO |
Rutin inhibits the reaction [Oxidopamine results in decreased expression of NSF mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr17:46,590,669...46,757,464
Ensembl chr17:46,590,669...46,757,679
|
|
G |
NSG1 |
neuronal vesicle trafficking associated 1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Oxidopamine results in decreased expression of NSG1 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 4:4,386,532...4,419,058
Ensembl chr 4:4,348,140...4,419,058
|
|
G |
OPA1 |
OPA1 mitochondrial dynamin like GTPase |
multiple interactions |
ISO |
Rutin inhibits the reaction [Oxidopamine results in decreased expression of OPA1 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 3:193,593,208...193,697,811
Ensembl chr 3:193,593,144...193,697,811
|
|
G |
PARK7 |
Parkinsonism associated deglycase |
multiple interactions |
ISO |
Rutin inhibits the reaction [Oxidopamine results in increased expression of PARK7 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 1:7,961,711...7,985,505
Ensembl chr 1:7,954,291...7,985,505
|
|
G |
PNPLA3 |
patatin like phospholipase domain containing 3 |
decreases expression |
ISO |
Rutin results in decreased expression of PNPLA3 mRNA |
CTD |
PMID:17032037 |
|
NCBI chr22:43,923,805...43,947,582
Ensembl chr22:43,923,792...43,964,488
|
|
G |
PON1 |
paraoxonase 1 |
multiple interactions increases expression |
ISO |
Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON1 mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON1 protein] Rutin results in increased expression of PON1 mRNA |
CTD |
PMID:25478064 |
|
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
|
|
G |
PON3 |
paraoxonase 3 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 protein] |
CTD |
PMID:25478064 |
|
NCBI chr 7:95,359,872...95,396,375
Ensembl chr 7:95,359,872...95,396,375
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in decreased expression of PPARA protein] |
CTD |
PMID:22426011 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
|
|
G |
PPARD |
peroxisome proliferator activated receptor delta |
multiple interactions |
ISO |
Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARD mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARD protein] |
CTD |
PMID:25478064 |
|
NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191
|
|
G |
PPID |
peptidylprolyl isomerase D |
multiple interactions |
ISO |
Rutin inhibits the reaction [Oxidopamine results in increased expression of PPID mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 4:158,709,127...158,723,396
Ensembl chr 4:158,709,127...158,723,396
|
|
G |
PRKN |
parkin RBR E3 ubiquitin protein ligase |
multiple interactions |
ISO |
Rutin inhibits the reaction [Oxidopamine results in increased expression of PRKN mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775
|
|
G |
PTEN |
phosphatase and tensin homolog |
multiple interactions |
ISO |
Rutin inhibits the reaction [Cisplatin results in increased phosphorylation of PTEN protein] |
CTD |
PMID:33031932 |
|
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases expression |
EXP ISO |
[Rutin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of PTGS2 mRNA; Rutin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of PTGS2 protein] Rutin results in decreased expression of PTGS2 mRNA Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein]; Rutin inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA]; Rutin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]; Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] Rutin inhibits the reaction [[Copper Sulfate results in increased abundance of Copper] which results in increased expression of PTGS2 protein]; Rutin inhibits the reaction [Cyclophosphamide results in increased expression of PTGS2 protein] |
CTD |
PMID:11500931 PMID:15652231 PMID:19557821 PMID:21756928 PMID:22902988 PMID:25080890 PMID:25753322 PMID:28693884 PMID:32881150 More...
|
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PYCARD |
PYD and CARD domain containing |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in increased expression of PYCARD protein] |
CTD |
PMID:22426011 |
|
NCBI chr16:31,201,486...31,202,760
Ensembl chr16:31,201,486...31,203,450
|
|
G |
RAP1A |
RAP1A, member of RAS oncogene family |
multiple interactions |
ISO |
Rutin inhibits the reaction [pirarubicin results in increased expression of RAP1A mRNA]; Rutin inhibits the reaction [pirarubicin results in increased expression of RAP1A protein] |
CTD |
PMID:32864822 |
|
NCBI chr 1:111,542,009...111,716,691
Ensembl chr 1:111,542,218...111,716,691
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP ISO |
Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein]; Rutin inhibits the reaction [Glucose affects the localization of RELA protein]; Rutin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of RELA protein] Rutin inhibits the reaction [Carbon Tetrachloride affects the localization of RELA protein] |
CTD |
PMID:19557821 PMID:21756928 PMID:29522708 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RUNX2 |
RUNX family transcription factor 2 |
multiple interactions |
EXP |
[Rutin co-treated with Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 mRNA |
CTD |
PMID:34562440 |
|
NCBI chr 6:45,328,330...45,551,082
Ensembl chr 6:45,328,157...45,664,349
|
|
G |
SIRT1 |
sirtuin 1 |
increases expression |
ISO |
Rutin results in increased expression of SIRT1 mRNA; Rutin results in increased expression of SIRT1 protein |
CTD |
PMID:30365940 |
|
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
|
|
G |
SLAMF1 |
signaling lymphocytic activation molecule family member 1 |
increases expression multiple interactions |
ISO |
Rutin results in increased expression of SLAMF1 protein Lipopolysaccharides inhibits the reaction [Rutin results in increased expression of SLAMF1 protein] |
CTD |
PMID:28693884 |
|
NCBI chr 1:160,608,106...160,647,044
Ensembl chr 1:160,608,106...160,647,044
|
|
G |
SLC22A1 |
solute carrier family 22 member 1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in decreased expression of SLC22A1 mRNA]; Rutin inhibits the reaction [Fructose results in decreased expression of SLC22A1 protein] |
CTD |
PMID:19605544 |
|
NCBI chr 6:160,121,815...160,158,718
Ensembl chr 6:160,121,815...160,158,718
|
|
G |
SLC22A12 |
solute carrier family 22 member 12 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in increased expression of SLC22A12 mRNA]; Rutin inhibits the reaction [Fructose results in increased expression of SLC22A12 protein] |
CTD |
PMID:19605544 |
|
NCBI chr11:64,591,220...64,602,344
Ensembl chr11:64,590,641...64,602,353
|
|
G |
SLC22A2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in decreased expression of SLC22A2 mRNA]; Rutin inhibits the reaction [Fructose results in decreased expression of SLC22A2 protein] |
CTD |
PMID:19605544 |
|
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
|
|
G |
SLC22A6 |
solute carrier family 22 member 6 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in decreased expression of SLC22A6 mRNA]; Rutin inhibits the reaction [Fructose results in decreased expression of SLC22A6 protein] |
CTD |
PMID:19605544 |
|
NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
|
|
G |
SLC2A9 |
solute carrier family 2 member 9 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in increased expression of SLC2A9 mRNA SNP]; Rutin inhibits the reaction [Fructose results in increased expression of SLC2A9 protein SNP] |
CTD |
PMID:19605544 |
|
NCBI chr 4:9,771,025...10,040,270
Ensembl chr 4:9,771,153...10,054,936
|
|
G |
SLCO1B1 |
solute carrier organic anion transporter family member 1B1 |
multiple interactions |
EXP |
Rutin inhibits the reaction [SLCO1B1 protein results in increased import of Sulfobromophthalein] |
CTD |
PMID:22394605 |
|
NCBI chr12:21,131,194...21,239,796
Ensembl chr12:21,131,194...21,239,796
|
|
G |
SLCO1B3 |
solute carrier organic anion transporter family member 1B3 |
multiple interactions |
EXP |
Rutin inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein] |
CTD |
PMID:22394605 |
|
NCBI chr12:20,810,705...20,916,911
Ensembl chr12:20,810,702...20,916,911
|
|
G |
SLCO2B1 |
solute carrier organic anion transporter family member 2B1 |
affects localization multiple interactions |
EXP |
Rutin affects the localization of SLCO2B1 protein Rutin promotes the reaction [SLCO2B1 protein results in increased uptake of Cholic Acid]; Rutin promotes the reaction [SLCO2B1 protein results in increased uptake of estrone sulfate]; Rutin promotes the reaction [SLCO2B1 protein results in increased uptake of Rosuvastatin Calcium]; Rutin promotes the reaction [SLCO2B1 protein results in increased uptake of Taurocholic Acid] |
CTD |
PMID:24285294 |
|
NCBI chr11:75,151,107...75,206,549
Ensembl chr11:75,100,563...75,206,549
|
|
G |
SMAD2 |
SMAD family member 2 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of SMAD2 mRNA] |
CTD |
PMID:27239252 |
|
NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146
|
|
G |
SMAD4 |
SMAD family member 4 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of SMAD4 mRNA] |
CTD |
PMID:27239252 |
|
NCBI chr18:51,030,213...51,085,042
Ensembl chr18:51,028,528...51,085,045
|
|
G |
SOCS3 |
suppressor of cytokine signaling 3 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Fructose results in increased expression of SOCS3 protein] |
CTD |
PMID:22426011 |
|
NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Carbon Tetrachloride results in decreased activity of SOD1 protein] |
CTD |
PMID:22902988 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SORD |
sorbitol dehydrogenase |
multiple interactions |
ISO |
[Rutin co-treated with Meloxicam] inhibits the reaction [Formaldehyde affects the activity of SORD protein]; Rutin inhibits the reaction [Formaldehyde affects the activity of SORD protein] |
CTD |
PMID:29315975 |
|
NCBI chr15:45,023,195...45,077,185
Ensembl chr15:45,023,147...45,077,185
|
|
G |
STAR |
steroidogenic acute regulatory protein |
increases expression |
ISO |
Rutin results in increased expression of STAR protein |
CTD |
PMID:29899696 |
|
NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of STAT3 mRNA]; Rutin inhibits the reaction [Fructose results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:22426011 PMID:26062544 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
TGFA |
transforming growth factor alpha |
multiple interactions |
EXP |
Rutin inhibits the reaction [TGFA protein affects the localization of EGFR protein] |
CTD |
PMID:21967610 |
|
NCBI chr 2:70,447,284...70,553,826
Ensembl chr 2:70,447,284...70,554,193
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein] Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of TGFB1 mRNA]; Rutin inhibits the reaction [Isoproterenol results in increased expression of TGFB1 mRNA]; Rutin inhibits the reaction [Isoproterenol results in increased expression of TGFB1 protein]; Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of TGFB1 mRNA] |
CTD |
PMID:22902988 PMID:24117263 PMID:27239252 PMID:28693884 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TH |
tyrosine hydroxylase |
multiple interactions |
ISO |
Rutin inhibits the reaction [Oxidopamine results in decreased expression of TH mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions decreases expression |
EXP ISO |
Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL8 protein]; Rutin inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of TNF protein] Rutin results in decreased expression of TNF mRNA; Rutin results in decreased expression of TNF protein Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]; Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] Rutin inhibits the reaction [Carrageenan results in increased expression of TNF protein]; Rutin inhibits the reaction [Cisplatin results in increased expression of TNF protein]; Rutin inhibits the reaction [Cyclophosphamide results in increased expression of TNF protein]; Rutin inhibits the reaction [Fructose results in increased expression of TNF protein] |
CTD |
PMID:14654164 PMID:18958421 PMID:19557821 PMID:21605616 PMID:21756928 PMID:22426011 PMID:22902988 PMID:25753322 PMID:28693884 PMID:29743444 More...
|
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions |
ISO EXP |
Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of TP53 mRNA] Rutin inhibits the reaction [Cisplatin results in increased expression of TP53 protein] Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of TRP53 protein] |
CTD |
PMID:27239252 PMID:29522708 PMID:29962303 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
UCHL1 |
ubiquitin C-terminal hydrolase L1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [Oxidopamine results in increased expression of UCHL1 mRNA] |
CTD |
PMID:25129099 |
|
NCBI chr 4:41,256,928...41,268,455
Ensembl chr 4:41,256,413...41,268,455
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
Rutin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of VCAM1 protein] |
CTD |
PMID:25080890 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|
G |
VEGFA |
vascular endothelial growth factor A |
multiple interactions decreases expression |
EXP ISO |
Rutin results in decreased secretion of and results in decreased expression of VEGFA protein; Rutin results in increased susceptibility to [Vitamin E results in decreased expression of VEGFA mRNA]; Rutin results in increased susceptibility to [Vitamin E results in decreased secretion of and results in decreased expression of VEGFA protein]; Vitamin E results in increased susceptibility to [Rutin results in decreased expression of VEGFA mRNA]; Vitamin E results in increased susceptibility to [Rutin results in decreased secretion of and results in decreased expression of VEGFA protein] Rutin inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; Rutin inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA protein] |
CTD |
PMID:20015448 PMID:33413359 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
G |
XDH |
xanthine dehydrogenase |
multiple interactions |
ISO |
Rutin inhibits the reaction [Cyclophosphamide results in increased activity of XDH protein] |
CTD |
PMID:25753322 |
|
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
|
|
|
G |
APP |
amyloid beta precursor protein |
multiple interactions |
ISO |
scutellarin inhibits the reaction [APP protein binds to APP protein] |
CTD |
PMID:17323972 |
|
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
multiple interactions |
ISO |
scutellarin inhibits the reaction [cobaltous chloride results in decreased expression of BCL2L1 mRNA] |
CTD |
PMID:18442013 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
CASP1 |
caspase 1 |
multiple interactions |
ISO |
scutellarin inhibits the reaction [Streptozocin results in increased expression of CASP1 mRNA] |
CTD |
PMID:37081038 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
ISO |
scutellarin inhibits the reaction [cobaltous chloride results in increased activity of CASP3 protein] scutellarin affects the reaction [RIPK1 protein affects the reaction [Zearalenone results in increased cleavage of CASP3 protein]]; scutellarin inhibits the reaction [Zearalenone results in increased cleavage of CASP3 protein] |
CTD |
PMID:18442013 PMID:36252740 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
EP300 |
E1A binding protein p300 |
multiple interactions |
EXP |
scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]] |
CTD |
PMID:25192544 |
|
NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,592...41,180,077
|
|
G |
FGF2 |
fibroblast growth factor 2 |
decreases expression |
ISO |
scutellarin results in decreased expression of FGF2 protein |
CTD |
PMID:16297343 |
|
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
|
|
G |
GSDMD |
gasdermin D |
multiple interactions |
ISO |
scutellarin inhibits the reaction [Streptozocin results in increased expression of GSDMD protein] |
CTD |
PMID:37081038 |
|
NCBI chr 8:143,553,387...143,563,062
Ensembl chr 8:143,553,207...143,563,062
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
multiple interactions decreases expression |
EXP |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [scutellarin results in decreased expression of HIF1A protein]; epoxomicin inhibits the reaction [scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]]; epoxomicin inhibits the reaction [scutellarin results in decreased expression of HIF1A protein]; MG 262 inhibits the reaction [scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]]; MG 262 inhibits the reaction [scutellarin results in decreased expression of HIF1A protein]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose co-treated with Cycloheximide] results in decreased expression of HIF1A protein]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of and results in decreased ubiquitination of HIF1A protein]; scutellarin promotes the reaction [Cycloheximide inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of HIF1A protein]] |
CTD |
PMID:25192544 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
IL18 |
interleukin 18 |
multiple interactions |
ISO |
scutellarin inhibits the reaction [Streptozocin results in increased expression of IL18 protein] |
CTD |
PMID:37081038 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
scutellarin inhibits the reaction [Zearalenone results in increased expression of JUN protein] |
CTD |
PMID:36252740 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
MAP2K4 |
mitogen-activated protein kinase kinase 4 |
multiple interactions |
ISO |
scutellarin inhibits the reaction [Zearalenone results in increased expression of MAP2K4 protein] |
CTD |
PMID:36252740 |
|
NCBI chr17:12,020,877...12,143,828
Ensembl chr17:12,020,829...12,143,830
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
multiple interactions |
EXP |
scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein] |
CTD |
PMID:25192544 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
NLRP3 |
NLR family pyrin domain containing 3 |
multiple interactions |
ISO |
scutellarin inhibits the reaction [Streptozocin results in increased expression of NLRP3 protein] |
CTD |
PMID:37081038 |
|
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,416,156...247,449,108
|
|
G |
NOS2 |
nitric oxide synthase 2 |
decreases expression |
ISO |
scutellarin results in decreased expression of NOS2 protein |
CTD |
PMID:16297343 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
increases expression |
ISO |
scutellarin results in increased expression of NOS3 protein |
CTD |
PMID:16297343 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
PCNA |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of PCNA mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of PCNA protein] |
CTD |
PMID:25192544 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PKM |
pyruvate kinase M1/2 |
increases activity |
EXP |
scutellarin results in increased activity of PKM protein |
CTD |
PMID:25388478 |
|
NCBI chr15:72,199,029...72,231,591
Ensembl chr15:72,199,029...72,231,819
|
|
G |
PLA2G2A |
phospholipase A2 group IIA |
affects activity |
EXP |
scutellarin affects the activity of PLA2G2A protein |
CTD |
PMID:8190018 |
|
NCBI chr 1:19,975,431...19,980,434
Ensembl chr 1:19,975,431...19,980,416
|
|
G |
RIPK1 |
receptor interacting serine/threonine kinase 1 |
multiple interactions |
ISO |
scutellarin affects the reaction [RIPK1 protein affects the reaction [Zearalenone results in increased cleavage of CASP3 protein]]; scutellarin inhibits the reaction [Zearalenone results in increased expression of RIPK1 mRNA]; scutellarin inhibits the reaction [Zearalenone results in increased expression of RIPK1 protein] |
CTD |
PMID:36252740 |
|
NCBI chr 6:3,063,967...3,115,187
Ensembl chr 6:3,063,824...3,115,187
|
|
G |
VEGFA |
vascular endothelial growth factor A |
decreases expression multiple interactions |
ISO EXP |
scutellarin results in decreased expression of VEGFA protein scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of VEGFA mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of VEGFA protein] |
CTD |
PMID:16297343 PMID:25192544 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|